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Abstract
This thesis investigates mechanistic links between genome integrity and the
recruitment of chromatin organizing proteins to repetitive DNA sequences mediated by the
retinoblastoma tumor suppressor protein (pRB). I demonstrate that a CDK-resistant
interaction between the pRB C-terminus and the E2F1 coiled-coil marked box (CM) domain
establishes a scaffold that facilitates recruitment of multiple chromatin-organizing proteins to
repetitive sequences across the genome throughout the cell cycle. Specifically, pRB recruits
the enhancer-of-zeste-homologue 2 (EZH2) histone methyltransferase to establish repressive
facultative heterochromatin at repetitive sequences, and the Condensin II complex to ensure
proper DNA replication and mitotic progression. To disrupt the CDK-resistant pRB-E2F1
interaction in vivo, a gene-targeted mutant mouse strain bearing a germline F832A
substitution (Rb1S) is generated. Viable homozygous mutants permit exploration of CDKresistant pRB-E2F1 functions in cell culture and in vivo. Rb1S/S MEFs and adult splenocytes
exhibit pronounced misregulation of endogenous retroviruses (ERVs), long interspersed
nuclear elements (LINEs) and major satellites (MaSats). Misexpression is associated with
reduced co-occupancy of pRB and EZH2, along with reduced H3K27me3 at repetitive
genomic regions but not developmental H3K27me3 targets. Furthermore, Rb1S/S MEFs
exhibit increased γH2AX, aneuploidy, ppRPA32, and chromosome segregation errors.
γH2AX accumulates specifically at major satellites that exhibit reduced co-occupancy of
pRB and Condensin II. Collectively, the consequences of perturbed EZH2 and Condensin II
recruitment contribute to a state of genomic instability in Rb1S/S cells that likely underlie the
onset of spontaneous lymphomas that arise from the spleen or mesenteric lymph nodes of
aged homozygous mutant mice. Finally, I explore whether the pRB-E2F1 scaffold provides
an opportunity for therapeutic exploitation, and whether these properties directly alter tumor
phenotypes in combination with p53 inactivation. Overall, this work suggests that chromatinorganization mediated through the CDK-resistant pRB-E2F1 complex underscores a
previously unknown facet of pRB-mediated tumor suppression.
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Chapter 1

1

Introduction
Recent advancements in sequencing capabilities have illuminated the sheer

magnitude of repetitive sequences within the human genome. Nearly half of the
mammalian genome is comprised of repetitive sequences, while single copy proteincoding sequences account for only 1-2% of total sequence content (Lander et al., 2001).
Current models of the molecular genetics that underlie disease and development are
predominantly based upon extensive characterizations of protein-coding sequences and
the interactions of their protein products. In contrast, the contributions of repetitive
sequences remain poorly understood and largely unaccounted for within these models.
This omission is especially surprising upon consideration that investigations of
repetitive elements have yielded seminal concepts within the field of eukaryotic genetics,
many of which earned Nobel Prizes. For example, Barbara McClintock’s discovery of
maize colour patterns driven by ‘controlling elements’ that could transpose to different
chromosomal regions demonstrated that transposable elements existed and could regulate
overt phenotypes of the individual (McClintock, 1950). A mechanism of transposition
would emerge following the discovery that serologic tests against viral Gag proteins of
the avian leukosis virus (ALV) could produce a positive signal in uninfected individuals
(Dougherty and Di Stefano, 1966; Dougherty et al., 1967). The presence of viral-encoded
proteins in the genome of uninfected individuals suggested that RNA viruses must
integrate as DNA proviruses into the host germline. The discovery of reverse
transcriptase by David Baltimore and Howard Temin provided a mechanism to explain
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how RNA tumor viruses could ‘endogenize’ within the host (Baltimore, 1970; Temin and
Mizutani, 1970). It also provided an explanation for the presence of the src viral
oncogene (v-src) of the Rous Sarcoma Virus (RSV) within the genomes of uninfected
chickens. Reactivation of endogenized RSV facilitated acquisition of src from the
infected host (Stehelin et al., 1976). Thus, the concepts of mobile endogenous
retroviruses that could regulate host phenotypes emerged.
Characterization of endogenous retroviruses revealed multiple repeating instances
of their sequences within various eukaryotic genomes. Numerous classes and structural
features of these repeating sequences were uncovered (Figure 1.1) (Weiss, 2006). Due to
the mutagenic potential of mobilization, and homology of endogenous retroviruses to
RNA tumor viruses, early investigations focused on potential links between repetitive
sequence activity and genome instability (Mager and Stoye, 2015).
This thesis explores potential links between genome integrity and the recruitment
of chromatin organizing proteins to repetitive DNA sequences. Propagation strategy
underlies two possible genomic distribution patterns used to classify repetitive elements:
tandem or interspersed (Wicker et al., 2007). Understanding the structural features and
propagation strategies of tandem and interspersed repeats is fundamental to
understanding how host responses to repetitive sequences create vulnerabilities that may
underlie genome instability. Following this review, a survey of structure-function
characteristics suggests that the retinoblastoma tumor suppressor protein may provide a
link between genome instability and chromatin organization at repetitive sequences. The
data chapters that follow present the results from experimental exploration of this
hypothesis.

3

Figure 1.1: Classification of repetitive elements.
Repetitive elements are generally classified based upon genomic arrangement, expansion
mechanism, and structural components. Only select families are listed for each repetitive
element class.

4

1.1

Tandem repetitive elements

Tandem repetitive elements are characterized by sequential adjacent ‘head-to-tail’
recurrences of a particular sequence that most often accumulate at either end of a
chromosome arm. Tandem repeats are further sub-classified based on the length of a
single element that repeats sequentially (Gemayel et al., 2010). Tandem repeats have long
been hypothesized to expand through strand slippage replication, in which either the
template or nascent DNA strand denatures during replication and re-anneals such that one
of the strands is ‘looped out’ and then re-anneals to another part of the repeat on the other
stand. If the template strand is looped out, contraction occurs on the nascent strand, while
looping out of the nascent strand results in expansion of the repeat (Levinson and
Gutman, 1987; Tachida and Iizuka, 1992).
The visible accessory bands formed from density gradient centrifugation of
genomic DNA were coined as ‘satellite’ DNA (Meselson et al., 1957). These bands were
discovered to be comprised of the tandem DNA repeats that are primarily found at or
near chromosome centromeres (Figure 1.2) (Walker, 1971). A satellite element that
ranges from 1-10 nucleotides is classified as a microsatellite, also known as a simple
sequence repeat, while elements that range from 10-60 nucleotides are minisatellites.
Elements greater than this threshold are referred to as ‘satellites’ until 135bp in length,
beyond which they are classified as megasatellites. Human centromeres and
pericentromeres are both comprised of 171 bp α-satellites. In contrast, mouse
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Figure 1.2: Structural features underlie expansion strategies of repetitive elements.
Structural features reveal whether repetitive elements encode machinery required for
autonomous transposition. Full-length endogenous retroviruses (ERVs) are flanked by
long terminal repeats and encode machinery required for autonomous retrotransposition.
The two open reading frames (ORFs) of long interspersed nuclear elements (LINEs)
encode machinery required for autonomous retrotransposition, and transposition of short
interspersed nuclear elements (SINEs). In contrast to retrotransposons, DNA transposons
are flanked by terminal inverted repeats (TIRs) and encode a transposase that facilitates
transposition that is inherently non duplicative. Tandem repetitive elements may be
comprised of as few as a single repeating subunit arranged in tandem as a result of
replication errors. Relative RNA polymerase and polyadenylation sites are shown.
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centromeres are comprised of 123-bp minor satellites, while their pericentromeres are
comprised of 234-bp major satellites (Gemayel et al., 2010).
Satellite expansion occurs through replication machinery errors characterized as
strand-slippage. However, recent evidence demonstrates that mammalian centromeric and
pericentromeric repeats can also expand through an RNA intermediate that is reverse
transcribed prior to re-integration into the host genome (Bersani et al., 2015). This
provides a putative explanation for the identification of tandem repeat units found
interspersed in isolation.
While satellites constitute their own class of tandem repeats, certain satellites are
segregated within the ‘variable number of tandem repeat’ (VNTR) class. This includes
microsatellites that are also called short tandem repeats or simple sequence repeats.
Opposite to the centromere are another family of VNTRs. Vertebrate telomeric
chromosome ends are comprised of tandem ‘TTAGG’ sequences that repeat from a few
to over 100 kb depending on organism and age (Figure 1.2). These repeats extend into
subtelomeric regions as well that encode G-rich transcripts known as telomere repeatcontaining RNA (TERRA) that range from 0.1-10kb (Ye et al., 2014).

1.2

Interspersed repetitive elements

In contrast to tandem repetitive elements, interspersed repetitive elements are
predominantly dispersed throughout the intergenic regions of the genome. Structural
features and expansion strategies define classification systems of interspersed repeats.
Unlike tandem repeats that expand primarily through replication errors, interspersed
repeats expand through variations of transposition. For this reason, interspersed repeats
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are alternatively referred to as transposable elements (Kazazian, 2004). Intact
transposable elements encode machinery required to transpose and propagate
autonomously throughout the host genome, and facilitate non-automomous mobilization
of partial elements. Mechanisms of propagation distinguish transposable element type
and class (Jurka et al., 2007).

1.2.1

Type I transposable elements
Type I transposable elements undergo reverse-transcription during duplicative

retrotransposition and are thus commonly referred to as retrotransposons (Boeke et al.,
1985; Garfinkel et al., 1985; Kazazian and Moran, 1998). These elements are commonly
flanked by target site duplications as a result of staggered nicks at the integration site that
are ‘filled in’ upon repair. Sub-classifications of Type I elements are based on the
presence or absence of long terminal repeat (LTR) elements (Figure 1.1) (Mager and
Stoye, 2015). Non-LTR retrotransposons account for approximately 30-35% of the
mammalian genome, and are further distinguished by the absence of an encoded envelope
protein (Treangen and Salzberg, 2012).
The most abundant and active non-LTR retrotransposons are long interspersed
nuclear elements (LINEs) that comprise ~21% of the human genome and were first
characterized in human haemophilia (Dombroski et al., 1991; Kazazian et al., 1988;
Rogan et al., 1987; Treangen and Salzberg, 2012). LINEs are believed to originate from
host RNAs that were retrotransposed by active retrotransposons. The majority of the 1.5
million LINEs within the human genome are thought to reside as inactive fragments that
often lack the promoter element due to 5' end truncations, however, approximately 80100 full-length LINEs are thought to remain active (Beck et al., 2011). Full-length LINEs
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possess a 5'UTR composed of tandem repeats with an internal RNA pol II promoter,
followed by two open reading frames that encode machinery sufficient for autonomous
retrotransposition, and finally a 3'UTR (Figure 1.2). ORF1 encodes an RNA-binding
protein, while ORF2 encodes an endonuclease and reverse transcriptase (Kazazian and
Moran, 1998). Structural variations of these modular domains distinguish phylogeny of
LINE families into groups that are subdivided into clades. LINE ORF products are used
to execute the mechanism of LINE retrotransposition called target-primed reverse
transcription (TPRT) (Levin and Moran, 2011).
Short-interspersed nuclear elements (SINEs) represent the second most abundant
group of non-LTR retrotransposons. SINEs comprise ~13% of the mammalian genome,
and are derived from small functional RNAs transcribed by RNA pol III such as transfer
RNAs (tRNAs) or 7S or 5S ribosomal RNAs (rRNAs) (Treangen and Salzberg, 2012).
Thus due to their origins, SINEs contain 5' internal RNA pol III promoters. The 3' ends
contain poly(A) tails that can be recognized by LINE ORF products (Figure 1.2). SINEs
utilize machinery encoded by LINEs to achieve non-autonomous retrotransposition.
SINEs also contribute to SVA retrotransposons that can contain LTR sequences (Slotkin
and Martienssen, 2007).
LTR-containing retrotransposons, more commonly referred to as endogenous
retroviruses (ERVs), comprise approximately 8% of the human genome and 10% of the
mouse genome (Treangen and Salzberg, 2012). These elements derive from ancient
exogenous retroviruses that infected germ cells or progenitors of germ cells and lost the
potential for extracellular mobility and infection following host integration. Replicationcompetent full-length ERVs contain 300-1000 bp LTRs flanking open reading frames
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that collectively range from 6-9kb and encode Gag, Pol, and Env proteins to facilitate
autonomous retrotransposition. More specifically, the Pol protein possesses a reverse
transcriptase, endonuclease, and aspartyl protease domains (Figure 1.2). Gag encodes a
‘group-specific’ retroviral antigen, while env encodes an envelope protein (Göke and Ng,
2016). In addition, these elements contain an internal RNA polymerase II promoter
sequence in the 5'LTR, an RNA polyadenylation sequence in the 3'LTR, signals for
splicing, packaging, a tRNA primer-binding site, and a polypurine tract. Today, ERVs are
more commonly found missing some ORFs, or missing all ORFs. Approximately 90%
simply exist as solo LTRs. Phylogenetic analysis of the conserved regions of the pol gene
dictates classification of ERVs into one of three classes that are further stratified into
families (Thompson et al., 2016).
Beyond LINEs, SINEs, and ERVs, NGS-based exploration continues to uncover
retrotransposons that do not meet all criteria for existing Type I transposable element
categories. For example, Penelope retrotransposons possess a single ORF that encodes a
protein with reverse transcriptase and endonuclease activity, are flanked by LTR-like
inverted terminal repeats, but lack LTRs. However, phylogenetic analysis of the Penelope
reverse transcriptase groups it closer to telomerases than reverse-transcriptases of other
non-LTR retrotransposons. Thus, structural and phylogenetic divergence underlies
classification of Penelope as a separate class of retrotransposons (Jurka et al., 2007).
Likewise analysis of reverse-transcriptase domains suggests Dictyostelium intermediate
repeat sequence (DIRS) retrotransposons derive from the ancestor of an LTR
retrotransposon currently in the mammalian genome. However the endonuclease domain
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most resembles analogous domains found in DNA transposon-like elements found in
species of fungi and other ciliates (Wicker et al., 2007).

1.2.2

Type II transposable elements
Type II transposable elements, also known as DNA transposons, are most distinct

from Type I counterparts based upon their mechanism of mobilization throughout the
host genome. DNA transposons encode a transposase that recognizes flanking 10-400 bp
long terminal inverted repeats (Figure 1.2). Upon recognition, the transposase excises the
DNA element, and nicks a new target site to integrate the element into new 'acceptor' site.
At no point is an RNA intermediate generated. The gap left at the original 'donor' site is
repaired. Colloquially, this approach is referred to as ‘cut-and-paste’ transposition, and is
distinct from the ‘copy-and-paste’ transposition approaches of Type I elements (MunozLopez and García-Pérez, 2010). Differences in transposase homology primarily
distinguish DNA transposase superfamilies. In addition to a transposase, some DNA
transposon superfamilies also encode for DNA-binding proteins. Multiple instances of
the same DNA transposon suggests that duplication of DNA transposons must occur
despite the fact that DNA ‘cut-and-paste’ mobilization is not inherently duplicative. One
model by which this can occur is transposition during replication. If a template element
has been replicated and then transposes to a region that is yet to be replicated, the result is
duplication of the element (Jurka et al., 2007).

1.3
1.3.1

Host responses to repetitive elements
Host exaptation of genomic parasites

The potential mutagenic consequences of indiscriminate repetitive element
mobilization threaten host genome stability. Therefore the host adopts strategies that
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reduce mobilization potential of these elements. Over evolutionary time, this results in
the accumulation of relatively dormant repetitive sequences that eventually fragment to
varying degrees. Host genomes co-opt portions of these fragments to serve as novel genes
or transcriptional regulatory elements. This co-option is referred to as exaptation (Cowley
and Oakey, 2013). Utility for host exaptation may underlie the long-term success of
particular elements in host colonization. Such repeat-derived genes and regulatory
elements are commonly utilized in a cell type-specific and temporal manner. Review of
how repetitive elements have become intricate components of host regulatory networks
illuminates the vulnerabilities associated with this dependence.
Repetitive element ORF sequences can be exapted as exons, or even full length
genes. Up to 100 mammalian genes are believed to have evolved from repetitive
elements. Over 50 protein-coding genes derive from the LTR retrotransposon gag
protein, more than half of which reside on the X-chromosome (Thompson et al., 2016).
Host dependence on such genes is most evident in the evolution of regulatory networks.
For example in placental development, the human syncytin-1 and syncytin-2 proteins
required for placental trophoblast formation derive from HERV ENV genes. Knock out
of the mouse homologues syncytin-A and syncytin-B disrupts placental formation and
impedes trophoblast fusion (Blaise et al., 2003).
Exaptation of repetitive elements is more frequently employed towards
maximizing transcriptional regulatory control for existing host genes. Intact ERV LTRs
are particularly favourable for exaptation since recombination between the 5' and 3' LTRs
removes the internal ERV ORFs but preserves a residual ‘solo’ LTR for the host genome
to utilize. These LTRs contain promoters, enhancers, transcription factor binding sites,
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and can provide polyadenylation sites for host mRNA. Evolutionary exaptation of such
elements now confers tissue-specific control over entire regulatory networks that are
active within the mammalian placenta, the developing embryo, germ cells, and erythroid
cells (Chuong et al., 2017).
Screening the 5' ends of host mRNA for evidence of LTR sequence identifies
ERV LTRs that serve as functional host promoters. As promoters, ERV LTRs contribute
functional binding sites for an expanding list of transcription factors that include p53,
CTCF, ERα, c-Myc, and the pluripotency transcription factors NANOG, OCT4, and
SOX2. Overall, 30% of all mammalian transcriptional start sites intersect with
retrotransposons. The ability to direct pluripotency transcription factors in embryonic
stem cells (ESCs) illustrates the prevalent exaptation of ERV LTRs by the host genome
as tissue and cell type-specific promoters (Thompson et al., 2016).
ChIP-seq profiling has identified numerous repetitive sequences that bear the
epigenetic marks associated with enhancer elements, such as H3K4me3, H3K27Ac,
H3K9Ac. DNase-seq demonstrates that accessibility of these repetitive element-derived
enhancers varies in a cell-type specific and tissue specific manner. ChIP-seq also reveals
that these enhancers are extensively bound by pluripotency transcription factors in ESCs,
germ cells, the placenta, and tissues that participate in sexual reproduction (Göke and Ng,
2016). While prediction of enhancer function is largely based upon gene proximity and
epigenetic mark enrichment, direct loss-of-function approaches continue to confirm
enhancer activity of these elements (Chuong et al., 2016).
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1.3.2

Host epigenetic silencing of repetitive elements
Prior to repetitive sequence exaptation, the host modulates accessibility of

repetitive sequences through alterations to the structural organization of DNA to render
these elements dormant (Groh and Schotta, 2017). In the nucleus of a eukaryotic cell, the
entire genome is wrapped around histone proteins in a compact arrangement referred to
as chromatin. This arrangement consists of a repeating nucleosome core that possesses
approximately 147 base pairs of DNA wrapped around a core histone protein octamer
comprised of two H3-H4 dimers bound to two H2A-H2B dimers. The nucleosome base
possesses an H1 ‘linker’ histone involved in higher order compaction. Adjacent
nucleosomes are connected by 10 - 80 bp of free ‘linker’ DNA (Venkatesh and
Workman, 2015). Nucleosome compaction broadly distinguishes two general states of
DNA accessibility. De-condensed chromatin establishes a ‘relaxed’ state referred to as
‘euchromatin’ in which nucleosome-wrapped DNA is most accessible. In contrast, the
most compact form of chromatin, referred to as ‘heterochromatin’, characterizes the least
accessible state (Figure 1.3) (Mozzetta et al., 2015).
Modulation of structure to regulate accessibility is achieved through a series of
chemical modifications that do not alter DNA sequence. These modifications target the
association between DNA and histones. Histones contain positively charged residues in
their protruding tails that interact with the negatively charged double-stranded DNA
backbone to facilitate an electrostatic interaction that maintains wrapped DNA around the
nucleosome (Mozzetta et al., 2015). Covalent modifications imposed on histone tails or
DNA alter the strength of the interaction with the double-stranded DNA backbone,
leading to altered states of DNA accessibility. Through a combination of different
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Figure 1.3: DNA and histone modifications underlie chromatin accessibility.
Relative DNA accessibility per chromatin state is indicated along with typically
associated epigenetic modifications. Representative nucleosomes depict arrangements of
modifications associated with constitutive or facultative heterochromatin.
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modifications, repression can be achieved through establishment of ‘constitutive’
heterochromatin, or the more readily reversible and dynamic ‘facultative’
heterochromatin.

1.3.2.1

Constitutive heterochromatin through lysine methylation

Constitutive heterochromatin is characterized by a combination of epigenetic
marks to both histone tails and DNA, and enrichment of the heterochromatin protein
HP1. The most prevalent of these modifications consist of histone methylation (Saksouk
et al., 2015). Histone methylation occurs primarily on the side-chains of lysines and
arginines of histone H3 and histone H4. Methylation does not alter the charge of the
histone, and can occur in successive magnitude as mono-, di-, or tri- methylation. When
certain residues are methylated they hold DNA together strongly and restrict access to
various enzymes. Since histone methylation can either compact or loosen chromatin, an
empirically derived ‘histone code’ has emerged to classify the effects of differential
methylation (Mozzetta et al., 2015).
Constitutive heterochromatin is most concentrated over centromeric and telomeric
tandem repeats. In mice, pericentric heterochromatin can be readily visualized as DAPIdense foci (Peters et al., 2003). H3K9me3 enrichment defines the fundamental H3 lysine
methylation mark that distinguishes constitutive heterochromatin from facultative
heterochromatin (Figure 1.3). In mammals, H3K9 residues are methylated by the
suppressor of variegation 3-9 homolog (SUV39h) and SET domain bifurcated (SETDB1)
histone methyltransferases (HMTs) (Martens et al., 2005). Dependence of either HMT
depends on chromosome region, developmental context, and cell type. At pericentric
heterochromatin, SUV39h HMTs are the dominant HMTs. Individual knockout of either
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Suv39h1 or Suv39h2 does not perturb viability and causes minimal changes to global
H3K9me3 levels. In contrast, Suv39h1/2 double knock out mice are viable at submendelian ratios, and succumb to B-cell lymphomas with ~30% penetrance. Suv39h1/2
double-knockout MEFs and ESCs exhibit pronounced reductions of H3K9me3 at
pericentric major satellites and telomeric repeats (Table 1.1) (Lehnertz et al., 2003; Peters
et al., 2001; Peters et al., 2003).
Unlike SUV39h HMTs, the role of SETDB1 at tandem repeats remains poorly
understood. While ChIP-seq suggests that SETDB1 accumulates at pericentric repeats,
other techniques fail to detect this accumulation (Dejardin and Kingston, 2009). Loss of
SETDB1 diminishes H3K9me3 at pericentric repeats, indicating some degree of nonredundancy with SUV39h HMTs at these regions (Bulut-Karslioglu et al., 2012; Matsui
et al., 2010). SETDB1 also targets interspersed repetitive elements. In mESCs, early
embryos, and during gametogenesis, SETDB1 trimethylates H3K9 at repeats that include
LINEs, and ERV classes I and II (Table 1.1) (Karimi et al., 2011; Liu et al., 2014; Matsui
et al., 2010; Sharif et al., 2016). Following nucleation at interspersed repeats, H3K9me3
spreads across the retrotransposon gene body to extend into neighbouring genes, a
phenomenon referred to as position effect variegation (Allis and Jenuwein, 2016).
Constitutive heterochromatin is also characterized by methylation of H4 lysine 20
(Figure 1.3) (Schotta et al., 2004). The SUV4-20H1 and 2 HMTs catalyze H4K20me2/3
deposition at centrometric, pericentric, and telomeric repeats (Jørgensen et al., 2013).
Since recruitment is dependent on HP1 which itself recognizes H3K9me3, this is thought
to be a downstream event relative to H3K9me3 (Schotta et al., 2004). Surprisingly,
germline deletion of either Suv4-20h1 or Suv4-20h2 is not embryonic lethal

17

Table 1.1: Epigenetic alterations at repetitive elements in methyltransferase
knockout models.
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in mice, and Suv4-20h-double knockout mice are born at sub-mendelian ratios. Suv420h1-/- MEFs exhibit modestly reduced H3K20me2 at pericentric repeats, while Suv420h1-/- reduces H3K20me3 at pericentric repeats (Table 1.1). Ablation of both HMTs
results in monomethylation at H4K20 residues normally di- or tri-methylated (Schotta et
al., 2008).

1.3.2.2

Constitutive heterochromatin through hypoacetylation

Another epigenetic feature of constitutive heterochromatin is the absence of
modifications that neutralize electrostatic interactions between DNA and histones
(Jeppesen and Turner, 1993). Histone acetylation and phosphorylation both neutralize the
positive charge of histone tails to diminish affinity for proximal negatively charged DNA
strands (Brehove et al., 2015; Saksouk et al., 2015). This leads to a less compact
chromatin structure that facilitates DNA accessibility. Examples of phosphorylation
marks that achieve this include phosphorylation of H2A.X at serine 129 during DNA
damage (Brehove et al., 2015). However, for the context of constitutive heterochromatin,
regulation of histone acetylation is more pertinent.
Acetylation marks on histone tail lysines are commonly enriched at enhancer
elements and gene promoters to facilitate access for transcription factors (Figure 1.3).
Histone acetyl transferases (HATs) catalyze the transfer of acetyl groups from acetylcoenzyme A (acetyl CoA) to positively charged lysines on histone tails such as H3K9,
H3K18, and H3K27 (Verdin and Ott, 2015). Conversely, histone de-acetylases (HDACs)
catalyze the removal of acetyl groups from histone tails to re-compact chromatin
(Taunton et al., 1996). Thus constitutive heterochromatin is also characterized by
hypoacetylated histones due to HDAC activity. Accordingly, disruption of HDAC
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activity using HDAC inhibitors can suffice to de-repress repetitive elements silenced by
constitutive heterochromatin (Garcia-Perez et al., 2010).

1.3.2.3

Constitutive heterochromatin through DNA methylation

DNA methylation describes the addition of a methyl (CH3) group predominantly
to carbon 5 of a cytosine residue adjacent to a guanosine that forms the repetitive unit of
CpG dinucleotides. The addition of the methyl group reduces DNA accessibility to
proteins that bind chromatin (Jones, 2012). This reduced accessibility contributes to the
suppressive properties of constitutive heterochromatin used to silence repetitive DNA
sequences (Smith and Meissner, 2013). DNA methyltransferases (DNMTs) methylate
target cytosines. In mammalian cells, DNMT3A and DNMT3B catalyze de
novo methylation, while DNMT1 is required for the maintenance of DNA methylation in
particular during genome replication when passive demethylation can occur (Okano et
al., 1999) (Li et al., 1992). The recently discovered DNMT3C also imparts de novo DNA
methylation, however its activity is exclusive to male germ cells (Barau et al., 2016). The
DNMT3 homologue DNMT3L lacks catalytic activity but enhances DNA binding and
activity of the de novo DNMTs (Hata et al., 2002).
DNA methylation is enriched at centomeric and subtelomeric tandem repeats in
addition to interspersed repetitive sequences. Surprisingly, individual ablation of de novo
DNMTs results in minimal CpG methylation reductions at repetitive sequences. Dnmt3a/-

mice are viable up to four weeks of age, while Dnmt3b-/- mice are embryonic lethal at

E9.5 (Okano et al., 1999). Examination of E9.5 ESCs from either model reveals that
notable CpG methylation reductions are limited to minor satellites in Dnmt3b-/- cells
(Table 1.1) (Okano et al., 1999). Likewise, disruption of DNMT3C activity has limited
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effects on methylation of repetitive sequences. The Dnmt3cIAP allele disrupts expression
of the full length Dnmt3c transcript due to an IAP insertion that results in exclusion of the
last exon. This exclusion diminishes CpG methylation at a select number of ERV-K and
L1 members only in the testes of day 20 homozygous mutant animals (Table 1.1) (Barau
et al., 2016).
Analogous to Dnmt3c inactivation, deletion of Dnmt3l in murine models does not
induce embryonic lethality (Hata et al., 2002). Dnmt3l-/- cells exhibit loss of de novo
cytosine methylation at specific IAP LTRs and certain LINE1s but not centromeric or
pericentric satellites (Table 1.1) (Bourc'his and Bestor, 2004; Hata et al., 2002). Dnmt1-/mice are embryonic lethal at E9, and exhibit reductions of CpG methylation at IAP and
centromeric satellites in ESCs (Table 1.1) (Colum et al., 1998; Li et al., 1992). A
germline Dnmt1 hypomorphic murine model exhibits reductions of CpG methylation at
IAPs in MEFs, with novel MMTV integrations detectable in a subset of the resulting Tcell lymphomas in adult mice (Gaudet et al., 2003; Howard et al., 2008).

1.3.2.4

Facultative heterochromatin dynamics at repetitive
sequences

In contrast to constitutive heterochromatin, facultative heterochromatin
establishes a more readily reversible form of chromatin compaction (Trojer and Reinberg,
2007). Facultative heterochromatin is distinguished by H3 methylation at K27 by the
enhancer-of-zeste homologue (EZH) HMTs, EZH1 and EZH2 (Figure 1.3). Each HMT
belongs to multi-subunit complexes referred to as Polycomb Group (PcG) complexes that
were originally identified and characterized in D.melanogaster (Abel et al., 1996; Hobert
et al., 1996; Jones and Gelbart, 1990, 1993). H3K27me2/H3K27me3 is largely
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established by polycomb repressive complex 2 (PRC2) that contain suppressor of zeste
12 homologue (SUZ12), embryonic ectoderm development (EED), and either
retinoblastoma-associated protein 46 (RBAP46) or retinoblastoma-associated protein 48
(RBAP48) (O'Carroll et al., 2001; Su et al., 2003; van der Vlag and Otte, 1999). Distinct
PRC2 complexes contain either EZH1 or EZH2, however EZH2-containing PRC2
complexes are most prevalent in mammalian cells. PRC2 establishes facultative
heterochromatin in concert with polycomb repressor complex 1 (PRC1) that deposits
H2AK119Ub1 (Figure 1.3) (Hauri et al., 2016; Margueron et al., 2008). In contrast to
constitutive heterochromatin, the contribution of facultative heterochromatin-based repeat
silencing remains poorly understood in mammalian ESCs, and relatively uninvestigated
in somatic cells (Casa and Gabellini, 2012; Leeb et al., 2010). Expression patterns of
repetitive elements in germline knockouts for effectors of constitutive heterochromatin
provide some indication of possible roles of facultative heterochromatin and polycomb
contributions towards repetitive element silencing.
Redundancy of repetitive sequence silencing has been most characterized within
the context of embryogenesis, during which successive rounds of DNA methylation and
demethylation occur. Despite reductions of DNA methylation, silencing of repetitive
elements is maintained through modification of histone tails (Leung and Lorincz, 2012;
Rowe and Trono, 2011). This phenomenon is recapitulated in Dnmt1, Dnmt3a, and
Dnmt3b triple-knockout ESCs that exhibit proper silencing of repetitive elements (Karimi
et al., 2011). In these cells, pronounced reductions in CpG methylation and H3K9me2/3
precede compensatory recruitment of PRC2 and H3K27me3 deposition at pericentric
repeats (Saksouk et al., 2014). In contrast to germline knockouts that may be confounded
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by long-term adaptation, acute loss of DNA methylation can be modeled through the
‘2i+VitC’ treatment in which GSK2β and Mek1/2 inhibitors are used to ensure passive
demethylation, while vitamin C stimulates TET enzymes that engage in active
demethylation (Walter et al., 2016). In ESCs treated with 2i+VitC, H3K9me2 levels
decrease, H3K9me3 levels remain constant, but H3K27me3 increases to maintain
repetitive element silencing (Walter et al., 2016).
The sensitivity of H3K9me2/3 deposition to CpG methylation loss in Dnmt tripleknockout ESCs suggests that facultative heterochromatinization may compensate for loss
of H3K9me3 alone (Déjardin, 2015). Indeed, in SUV39h1/2-deficient ESCs, PRC2 and
H3K27me3 are recruited to repetitive sequences (Cooper et al., 2014). Pronounced
misregulation of repetitive elements is only achieved upon 2i+VitC treatment of
SUV39h1/2-deficient ESCs in combination with Eed knockout to disrupt PRC2 function
(Walter et al., 2016). Likewise, depletion of all three HP1 isoforms in ESCs does not
result in strong de-repression of repetitive elements (Maksakova et al., 2011). Even in
MEFs, SETDB1 ablation results in minimal ERV de-repression, indicating presence of
compensatory silencing in more differentiated cells (Maksakova et al., 2011). This
suggests that facultative heterochromatin provides a sensitive and dynamic compensatory
response to maintain repetitive element silencing upon disruption of constitutive
heterochromatin marks. Its contributions towards silencing in normal somatic cells
remain unknown.
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1.4
Genome instability is associated with repetitive
element activation
Despite redundancy and compensatory potential of epigenetic silencing
mechanisms, associations between repetitive element misregulation and genomic
instability are well established (Belancio et al., 2010; Dombroski et al., 1991; Ionov et al.,
1993; Kazazian et al., 1988; Miki et al., 1992; Strand et al., 1993). Consequences of this
misregulation are directly related to host strategies of repetitive element exaptation and
silencing. For instance, alleviation of epigenetic silencing permits cis- or trans- regulatory
activation by repetitive elements of adjacent genes (Lau et al., 2014). This has been
observed for the MaLR THE solo LTR that activates the normally silenced CSF1R in
Hodgkin lymphoma (Lamprecht et al., 2010). Furthermore, re-integration of tandem or
interspersed repeats can drive mutagenesis by ablating expression, causing hypomorphic
expression, or conferring oncogenic gain-of-function by providing alternate splice sites
within gene bodies. This has been observed most frequently with mobile centromeric
satellite repeats or LINE elements in human colorectal tumors (Bersani et al., 2015;
Doucet-O'Hare et al., 2015; Miki et al., 1992; Rodic et al., 2015; Shukla et al., 2013). In
addition, the meiotic and mitotic defects that accompany repetitive element misregulation
suggest a yet unidentified connection between repeat-derived organization of
chromosome structure and chromosome segregation (Ionov et al., 1993). Evidence that
these may be early events in human cancer appears to be corroborated by NGS-based
characterizations of pre-malignant lesions that harbor active repetitive elements (Ewing et
al., 2015; Rodic et al., 2015).
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Disruption of broad mechanisms that regulate chromatin structure likely underlie
frequent resurrection of repetitive elements under conditions of genomic instability.
While the effectors of these marks have been characterized to varying degrees,
mechanisms of recruitment to repeats remain poorly understood. An unexplored link
between the organization of heterochromatin at repetitive sequences and cancer-initiating
mechanisms may be the RB tumor suppressor protein (pRB). Thorough review of known
pRB activities illuminates multiple connections that position pRB as a likely candidate to
mediate recruitment to repetitive elements for broad organizers of chromatin structure.

1.5
Retinoblastoma onset reveals the existence of a
tumor suppressor gene
Loss of growth control through tumor suppressor inactivation is a universal
‘hallmark’ of every human cancer (Hanahan and Weinberg, 2011). The concept of tumor
suppressor inactivation in cancer originates from studies of fusions between normal and
cancer cells, and analyses of retinoblastoma incidence (Harris and Miller, 1969;
Knudson, 1971). By the early 1970s, multiple studies suggested that cancers likely arose
through multistage accumulation of mutations (Ashley, 1969). However, in 1971, Dr.
Alfred Knudsen’s statistical analysis suggested that retinoblastomas arose through a
minimum of two ‘events’. This analysis noted that bilateral inherited cases of
retinoblastoma occurred at a younger age than unilateral non-inherited retinoblastoma.
David Comings proposed that differences in time of cancer onset and tumor frequency
amongst the two groups must be caused by ‘loss-of-function’ mutations to both alleles of
a single critical ‘tumor-suppressive’ gene (Comings, 1973).
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Assuming a constant rate of mutation for this gene, individual differences in
complete inactivation must be due to a difference in the number of functional copies
inherited. Individuals who inherit a germline mutation in one allele simply require the
acquisition of a single inactivating mutation in the remaining functional allele to
completely inactivate the gene. This would decrease tumor latency and increase tumor
burden relative to patients that must acquire two independent inactivating somatic
mutations (Comings, 1973; Knudson, 1971). This conclusion would be coined the ‘twohit’ hypothesis. Subsequent genetic studies of retinoblastomas identified that loss of the
q14 segment of chromosome 13 was associated with the appearance of retinoblastoma
(Cavenee et al., 1984; Cavenee et al., 1983; Cavenee et al., 1985; Dryja et al., 1986;
Godbout et al., 1983). In 1986, a single gene mapped from this segment of chromosome
13 was cloned and confirmed to be deleted in retinoblastomas and sarcomas (Friend et
al., 1986; Lee et al., 1987). This gene became known as the retinoblastoma susceptibility
gene, abbreviated as RB1.
Today, the RB1 gene product, pRB, is recognized as one of the most frequently
inactivated tumor suppressors in human cancer, and has been the center of intense
investigation within the field of cancer biology (Dyson, 1998; Weinberg, 1995).
Homozygous deletion of murine Rb1 results in embryonic lethality, while Rb1+/- mice
succumb to pituitary tumors in concert with loss of the remaining wild-type allele (Clarke
et al., 1992; Jacks et al., 1992; Lee et al., 1992). Therefore, early loss-of-function
molecular investigations were predominantly limited to cell culture experiments with
Rb1-/- MEFs, or characterizations of patient-derived cancer cells with RB1 deficiency
(DeCaprio et al., 1989; Ewen et al., 1991; Goodrich et al., 1991; Hannon et al., 1993;
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Horowitz et al., 1989; Muncaster et al., 1992; Williams et al., 1994). These early
investigations identified two more RB1-like genes, p107 and p130, and characterized
numerous pRB functions that would prove advantageous if disabled in cancer (Dyson,
1998; Ewen et al., 1991; Hannon et al., 1993; Weinberg, 1995). Notably, pRB was
observed to impart negative growth control through restriction of G1 exit. However,
identification of a single indispensible tumor suppressor activity remains an area of
contention, and currently appears to be multifaceted (Dyson, 2016). The known functions
of pRB have emerged in tandem with discovery of the pRB interactome. Therefore,
understanding of pRB function requires understanding of the structural underpinnings
that govern the pRB interactome.

1.6
The pocket domain defines the pRB pocket protein
family
The structural feature that defines the pRB-family is the hydrophobic small
pocket domain that consists of two cyclin-like folds, referred to as the A and B
subdomains respectively, separated by an unstructured linker region (Chow and Dean,
1996; Huang et al., 1993; Qin et al., 1992). For this reason, pRB and the pRB
homologues p107 and p130 are collectively referred to as the ‘pocket protein’ family.
The small pocket domain contains the minimal segment required to interact with viral
oncoproteins that include adenovirus E1A, human papilloma virus E7, and Simian
vacuolating virus 40 large T antigen (DeCaprio et al., 1988; Dyson et al., 1989; Huang et
al., 1993; Whyte et al., 1988). This minimal segment harbors a shallow hydrophobic
binding cleft found within the B subdomain referred to as the LxCxE binding cleft since
oncoproteins found to bind this region possess a conserved LxCxE peptide motif (Kaelin
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et al., 1990; Lee et al., 1998). Discovery that DNA tumor viruses targeted pocket proteins
and that the interaction appeared necessary for transformation proved amongst the
earliest evidence for a tumor suppressive role for pRB family proteins.
Downstream of the small pocket domain of pocket proteins is the intrinsically
unstructured carboxy-terminus (C-terminus). Within human pRB, the small pocket and
C-terminus encompass a region from residues 379-928 and are referred to as the large
pocket. This region was originally defined as the minimal region required to maintain
negative growth control (Qin et al., 1992). Early mechanistic investigations attributed this
restriction to an interaction with the differentiation-regulated transcription factor 1
(DRTF1) that was determined to be the E2a-binding factor (E2F) (Bandara and La
Thangue, 1991; Chellappan et al., 1991; Kovesdi et al., 1987). This transcription factor
was found to bind DRTF1-polypeptide-1 (DP1) to form a functional heterodimeric
transcription factor (Girling et al., 1993). Through the use of tumor-derived RB1 mutants,
viral oncoprotein-induced inactivation, and E2F interaction studies, an emerging model
of mammalian cell cycle control proposed that pRB-family proteins associated with
E2F/DP transcription factors to silence genes involved in cell cycle progression. These
genes were discovered to contain an E2F-consensus or recognition motif within their
promoters that were responsive to E2F-dependent transcription in transfection-based
reporter assays (Boeuf et al., 1990; Kovesdi et al., 1987; Yee et al., 1987). Temporal
signals governed dissociation of pRB proteins from E2F/DP to permit the transcription of
these genes in a controlled manner (DeCaprio et al., 1989; Hurford et al., 1997). DNA
tumor virus proteins could bind the pRB-family small pocket to perturb this temporal
control and prevent negative growth control in cancer.
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1.7
E2F transcription factors recruit pocket proteins to
DNA
Since pocket proteins were discovered to lack intrinsic DNA binding activity, the
discovery of E2F-mediated pocket protein recruitment to cell cycle promoters presented a
starting point to investigate differential transcriptional properties of pocket proteins. In
mammals, the pocket protein-E2F network expanded considerably to eventually consist
of eight E2F genes that encode 9 protein products, as E2F3a and E2F3b are generated by
the use of alternative promoters (Johnson and Degregori, 2006). E2Fs are defined by their
ability to bind to a sequence element that was originally identified in the adenovirus E2
promoter (Boeuf et al., 1990; Kovesdi et al., 1987; Yee et al., 1987).
With respect to structure, all E2F family members possess a highly conserved
DNA binding domain (Morgunova et al., 2015; Zheng et al., 1999). A highly conserved
dimerization domain allows E2F1-6 to interact with DP family members to confer
specificity of DNA binding. As with the E2Fs, the DP family has expanded to consist of
four members that exhibit differential preference for endogenous association with E2Fs.
In contrast, E2F7 and E2F8 do not dimerize with DP family members, but instead bind as
homodimers or E2F7-E2F8 heterodimers (Morgunova et al., 2015). E2F1-5 possess a
transactivation domain required for activation of respective gene targets. Embedded
within the E2F transactivation domain is a highly conserved segment that mediates
binding of E2F1-4 to the pRB small pocket. E2F4 and E2F5 interact with p107, and
p130. E2F6, E2F7, and E2F8 do not interact with any pocket proteins (Dimova and
Dyson, 2005; van den Heuvel and Dyson, 2008).
Historically, the E2F transcription factors have been classified into two distinct
functional categories based upon their observed ability to either activate or repress
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transcription of simple reporter constructs possessing multiple E2F-binding sites in cell
culture-based assays. E2F1, E2F2, and E2F3a, comprise one subfamily referred to as
‘activator E2Fs’, while the remaining E2F family members are classified as ‘repressor
E2Fs’. This historical classification appears to be an oversimplification as large-scale
expression studies demonstrate that ‘activator E2Fs’ repress almost as many targets as
they activate (Henley and Dick, 2012).

1.8
Cyclin Dependent Kinases govern cell cycle entry
and progression
As the rudimentary model of pRB-mediated E2F repression emerged, a family of
serine/threonine kinases, called the cyclin-dependent kinases (CDKs), were identified as
likely determinants of cell-cycle dependent pRB-E2F dissociation (Bremner et al., 1995;
DeCaprio et al., 1992; DeCaprio et al., 1989). CDK-consensus sites were discovered
throughout the pRB protein, and over expression of Cyclin E or Cyclin A was discovered
to allow cells to escape pRB-mediated cell cycle arrest (Bandara et al., 1991). These
observations appeared to complement early observations that pRB became heavily
modified during the G1-to-S transition (DeCaprio et al., 1989). However, the nature of
these modifications and their effects on proliferative control would emerge in tandem
with elucidation of the cyclin-CDK signaling network.
Cyclin dependent kinases comprise the core components of eukaryotic cell cycle
regulatory machinery. In mammals, there are currently 20 members of the CDK family,
each of which possess a conserved catalytic core comprised of an ATP-binding pocket, a
PSTAIRE-like cyclin-binding domain, and an activating T-loop motif (Malumbres,
2014). CDK activity depends on association with regulatory subunits called cyclins that
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are defined by a conserved sequence involved in CDK-binding and activation. While
endogenous CDK levels remain relatively consistent, cyclin protein levels fluctuate in
accordance with cell cycle stage (Evans et al., 1983). Upon stabilization of a certain
cyclin, association with the appropriate CDK forms a cyclin-CDK complex in which the
cyclin enhances CDK activity, and directs the complex to the appropriate target protein.
Activation of the kinase requires phosphorylation of a conserved threonine residue on the
activating CDK T-loop. In metazoans, CDK7 binds cyclin H to initiate CDK T-loop
activation (Tassan et al., 1994).
Cell cycle entry begins with an increase in D-type cyclins (D1, D2, and D3) that
bind CKD4 and CDK6 to initiate progression past the G1 ‘restriction point’, a crucial
point at which the cell irreversibly commits to cell cycle entry (Hochegger et al., 2008).
Different D-type cyclins are activated in response to extracellular signals that stimulate
different surface receptors. For example, mitogenic growth factors activate receptor
tyrosine kinases on the cell surface to induce signalling cascades that ultimately result in
the AP-1 transcription factor binding to and activating the cyclin D1 promoter, resulting
in rapid accumulation of cyclin D1 (Donjerkovic and Scott, 2000).
After the restriction point in late G1, E-type cyclins (E1 and E2) associate with
CDK2. Cyclin E-CDK2 complexes phosphorylate substrates to promote entry into Sphase, upon which A-type cyclins (A1 and A2) replace E-type cyclins to form cyclin ACDK2 complexes. As S-phase progresses, CDK1 becomes the most abundant CDK
associated with the A-type cyclins (Bertoli et al., 2013). In late G2 phase, B-type cyclins
(B1 and B2) replace A-type cyclins to form Cyclin B-CDK1 complexes required for
mitotic entry and progression. Rapid increase of one type of cyclin just prior to cyclin-
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CDK complex formation occurs in accordance with rapid degradation of the preceding
prominent cyclin (Glotzer et al., 1991). Thus, beyond the G1 restriction point, cyclinCDK complex formation and activation occurs in an autonomous manner to ensure
completion of the cell cycle.
Just as mitogenic signals positively regulate cyclin-CDK activity, antimitogenic
signals exert antagonistic effects through endogenous CDK inhibitors (CKIs) (Sherr and
Roberts, 1995). CDK inhibitors are generally classified within two families. The first is
an abbreviation based on originally observed functions towards inhibiting CDK4. The
inhibitors of CDK4, or INK4, family of CKIs target G1 cyclin-CDK4/CDK6 complexes.
The four INK4 proteins, p16INK4A, p15INK4B, p18INK4C, and p19INK4D bind and distort the
cyclin-binding site and the ATP-binding site of CDK4/6 to compromise catalytic activity
through allosteric inhibition of cyclin and ATP binding. The CDK interacting
protein/Kinase inhibitory protein, or Cip/Kip, family of CKIs consists of p21Cip1/Waf1,
p27Kip1, and p57Kip2. Like INK4 CKIs, Cip/Kip CKIs obstruct the ATP-binding site of
their target CDKs to achieve allosteric inhibition. However, Cip/Kip CKIs typically
target cyclin-CDK complexes active in late G1 and S-phase, specifically CDK4 and
CDK2. As negative regulators of cell cycle entry and progression, both Ink4 and Cip/Kip
CKIs are frequently inactivated in human cancers (Asghar et al., 2015).
Despite the emergence of a complex cyclin-CDK regulatory network, viable CDK
knock out mouse models suggest a high degree of redundancy amongst CDKs involved
in mammalian cell cycle progression. In contrast to cell cycle regulation, CDK members
involved in transcriptional control function non-redundantly as ablation results in
embryonic lethality for knockouts of CDK7, CDK8, and CDK11. Likewise, viable CKI
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knockout models reveal a high degree of functional redundancy, with overt phenotypes
most apparent in compound mutant backgrounds. The exception to this is p57Kip2
knockout that causes embryonic lethality (Malumbres, 2014).

1.9
CDK-induced structural alterations govern pRBE2F association dynamics
The elucidation of the cyclin-CDK network has proven crucial to understanding
determinants of pRB-E2F association and function throughout the mammalian cell cycle.
Prior to the G1-S transition, hypophosphorylated pRB binds E2Fs at E2F cell cycle
promoters. Inhibition of E2F-dependent transactivation depends on a direct physical
interaction between the A-B interface of the pRB large pocket (RBLP) domain (residues
379-928) and the C-terminal transcriptional activation domain of E2Fs (Qin et al., 1992)
(Chow and Dean, 1996; Dick et al., 2000; Huang et al., 1993). Co-crystalization studies
of the pRB small pocket and the E2F2 transactivation domain identify molecular contact
points which occur primarily through basic residues of the A region of RBLP, and acidic
residues of the E2F transactivation domain (Lee et al., 2002). However, stable binding
and full repression of E2F activity requires the pRB C-terminus as well (Burke et al.,
2013; Sengupta et al., 2015). This binding and physical masking of the E2F
transactivation domain is thought to be one of the mechanisms by which pRB renders
E2Fs transcriptionally inactive.
Alleviation of E2F transcriptional repression occurs in tandem with CDKmediated phosphorylation of pRB at the G1-S transition. This is initiated by cyclin DCDK4/6 followed by cyclin E-CDK2 complexes (Calbó et al., 2002). Consensus mapping
identifies 16 potential CDK phosphorylation sites on human pRB, 13 of which have been
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confirmed in vivo. The majority of these sites occur in pairs distributed primarily
throughout the intrinsically disordered regions of the protein (Rubin, 2013). A minimal
docking site mapped within pRB-C-terminus mediates competitive association with
either CDKs or the PP1 phosphatase (Hirschi et al., 2010). The conformational effects of
CDK-induced phosphorylation ultimately dissociates pRB from E2Fs (Burke et al.,
2012). The elucidation of a CDK phosphorylation code on pRB has evolved through
structural and functional investigations.
The current model of how particular CDK phosphorylation events displace E2Fs
from the small pocket is based upon structural investigation that utilized pRB and E2F
fragments with truncated or absent linker regions and phosphomimetic residue
substitutions. These investigations conclude that phosphorylation at S608/S612 within the
linker region between the cyclin-like folds of the small pocket causes a sequence within
the linker to bind the pocket as a helix that competes with the E2F transactivation domain
(Burke et al., 2010). Furthermore, phosphorylation at T356/T373 causes regions of the
pRB N-terminus to dock against the pocket subdomains, widening the E2F-binding site
between the cyclin-like folds to a degree that allosterically inhibits E2F transactivation
domain binding to the pocket. This also occludes protein binding to the LxCxE binding
cleft. This effect can be recapitulated to a lesser extent with phosphorylation of T373
alone (Burke et al., 2012). Phosphorylation of S788/S795 induces an association between
a region within the pRB-C-terminus, and the pocket domain to disrupt pocket contact
points with the most upstream residues of the E2F transactivation domain (Burke et al.,
2013). Collectively, multiple CDK phosphorylations induce intramolecular interactions
between both pRB termini into the pocket region to achieve an additive effect that
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enhances disruption between the pRB pocket and E2F transactivation domain (Dick and
Rubin, 2013).

1.10 E2F1 binds the pRB C-terminus independent of
small pocket interactions
The model of CDK-induced conformational changes suffices to explain
association and dissociation dynamics of most of the ‘activator’ E2Fs with pRB.
However, synthetic pRB mutants designed to disrupt RBLP-E2F complexes led to the
discovery of a second E2F1 binding site outside of the A-B interface within the Cterminal region of pRB (Dick and Dyson, 2003). Subsequently, GST-tagged recombinant
protein fragments were used in pulldown assays to map minimal interaction domains on
both the pRB C-terminus and E2F1. Within the pRB C-terminus, residues 825-860 were
found to be indispensible to this interaction (Julian et al., 2008). Within E2F1, a minimal
fragment from residues 1-374 that encompasses a region termed the ‘marked box’
domain (MBD), but excludes the transactivation domain, was required for the pRB Cterminus interaction (Dick and Dyson, 2003). Substitution of the E2F1 MBD into E2F3
could confer pRB C-terminal binding, while the analogous domain swap into E2F1
abrogated the pRB C-terminus interaction with E2F1 (Julian et al., 2008). Conversely,
pulldowns with GST-tagged recombinant C-terminal fragments of the pocket proteins
demonstrate that this interaction is exclusive to the pRB C-terminus (Cecchini and Dick,
2011).
Although highly conserved amongst the E2Fs, the marked box domains of other
activator E2Fs fail to bind the pRB C-terminus due to a proline located at a critical
binding interface between the E2F MBD and pRB. The MBD of E2F1 is distinguished by
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a valine instead of a proline at residue 276 that suffices to allow for the unique interaction
when substituted for the analogous proline in E2F3 (Cecchini and Dick, 2011). Since
E2F1 can utilize two distinct binding sites on pRB, the two binding interfaces are named
according to E2F-binding specificity. The A-B interface of the pRB large pocket is
referred to as the ‘general’ E2F binding site because it shows no preference for binding
between E2F1-4, while the C-terminal binding surface is referred to as the E2F1‘specific’ binding site (Dick and Dyson, 2003).
Co-crystalization studies of a pRB C-terminal fragment and a fragment of the
E2F1-DP1 heterodimer identified specific molecular contact points between pRB-C and
the E2F1 marked box domain and the DP1 coiled-coil domain (Rubin et al., 2005). These
crucial residues would be used to generate a panel of pRB C-terminus mutants to be
utilized in interaction assays with E2F1 (Cecchini and Dick, 2011; Julian et al., 2008).
Ultimately, this screen yielded several pRB mutants that could disrupt the E2F1-pRB Cterminus interaction with considerably fewer substitutions as compared to the original
pRB mutant used to discover the interaction that harbored 11 amino acid substitutions.

1.11 Distinct biochemical properties underlie the
alternate pRB-E2F1 interaction
Initial biochemical characterizations yielded curious properties of this alternate
pRB-E2F1 conformation. Electromobility shift assays demonstrate that within this
conformation, pRB-E2F1 exhibit reduced affinity for a probe with the E2F consensus
sequence (Dick and Dyson, 2003). Accordingly, luciferase reporters under the control of
E2F promoters are not repressed by this alternate pRB-E2F1 conformation (Julian et al.,
2008). Consistent with these properties, pRB mutants that disrupt small pocket E2F
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interactions but retain the C-terminal interaction with E2F1 fail to induce a complete G1
cell cycle arrest upon overexpression in SaOS-2 cells (Dick and Dyson, 2003).
Perhaps the most striking feature of this alternate pRB-E2F1 interaction is its
resistance to classic pRB-E2F dissociation signals. The first of these signals to be
investigated was competitive binding between pRB and adenoviral oncoprotein E1A.
Viral oncoproteins that bind the pRB LxCxE binding cleft dissociate the E2F
transactivation domain from the pRB small pocket. Through utilization of the pRB Cterminal interaction, pRB-E2F1 complexes are resistant to this disruption by either the
12S or 13S forms of E1A. In contrast, both forms of E1A competitively displace other
E2Fs, such as E2F4, that rely predominantly on the pRB small pocket interaction
(Seifried et al., 2008).
However, the biochemical property that has provided the most insight into the
potential endogenous functions of this alternate conformation has been its behavior in
response to CDK phosphorylation. Overexpression of cyclin D-CDK4 and cyclin ECDK2 in T98G cells enriches for a hyperphosphorylated pRB species that no longer
associates with E2Fs that primarily bind pRB through the small pocket. In contrast, pRBE2F1 complexes are resistant to CDK phosphorylation of pRB due to utilization of the Cterminal pRB interaction (Figure 1.4). This phenomenon is recapitulated with
endogenous IPs in which E2F1 co-immunoprecipitates with both hypo and
hyperphosphorylated pRB (ppRB) enriched from synchronized extracts. In contrast,
E2F3 only associates with hypophosphorylated pRB (Cecchini and Dick, 2011). This
complements observations of endogenous ppRB-E2F1 complexes by multiple
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Figure 1.4: pRB-E2F dissociation dynamics at the G1/S transition
During the G1 phase of the cell cycle, pRB binds heterodimeric E2F/DP transcription
factors and recruits co-repressor complexes to render the transcription factors
transcriptionally inactive. This interaction forms in part through the pRB ‘small pocket’
domain that binds the E2F transactivation domain. Upon cell cycle entry, activated
cyclin/CDK complexes phosphorylate pRB to dissociate interactions between the pRB
small pocket and the E2F transactivation domain. Unbound E2Fs activate transcription of
genes required for DNA synthesis. An alternate interaction between the pRB C-terminus
and the E2F1 marked box domain exhibits resistance to CDK phosphorylation. The
biological relevance of CDK-resistant pRB-E2F1 association remains largely unknown.
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independent groups (Calbó et al., 2002; Cecchini and Dick, 2011; Ianari et al., 2009;
Wells et al., 2003).

1.12 Biochemical properties suggest cell cycleindependent functions of pRB-E2F1
The unique biochemical properties of this CDK-resistant pRB-E2F1 interaction
dictated initial investigations of potential endogenous functions. Since this complex does
not recognize or suppress classic E2F cell cycle promoters and is resistant to CDK
phosphorylation, cell cycle-independent functions of pRB or E2F1 provided a logical
starting point to initiate exploration. An extended repertoire of transcriptional regulatory
functions distinguishes E2F1 from other E2Fs. For instance, DNA damage activates
transcription of machinery involved in DNA repair or induction of pro-apoptotic caspase
cascades (Wu et al., 2009). E2F1 loss-of-function models reveal that E2F1 functions
extensively in cell cycle-independent transcriptional regulation of components involved
in either process (Irwin et al., 2000; Lin et al., 2001).
Overexpression of pRB mutants in pRB-null C33A cell cultures suggest that the
pRB C-terminus binds the E2F1 MBD to negatively regulate E2F1-induced apoptosis
(Dick and Dyson, 2003). This complements reports that the E2F1 MBD activates proapoptotic effectors independent of the transactivation domain (Hallstrom and Nevins,
2003). DNA damage investigations suggest that the post-translational modifications
imposed on both pRB and E2F1 following etoposide treatment establish populations of
E2F1 which are resistant to pRB-binding, and others that form an pRB-E2F1 complex
with hyperphosphorylated pRB, presumably through the pRB C-terminus. Paradoxically,

39

both populations localize to and activate the same pro-apoptotic E2F1 targets following
DNA damage (Carnevale et al., 2011). Nevertheless, this provides evidence that alternate
pRB-E2F1 conformations bind promoters devoid of E2F consensus motifs to regulate
transcription of non-cell cycle genes in a cell cycle-independent manner. Whether this
complex imparts transcriptional control at other non-cell cycle targets remains unknown.
Beyond transcriptional control at the G1-S interface, pRB maintains genome integrity
through transcription-independent activities on chromatin post-G1. While a post-G1 pRB
recruitment mechanism has remained elusive, the CDK-resistant pRB-E2F1 interaction
provides a possible mechanism that may underlie these functions. For instance, the pRB
N-terminus interacts with Mcm7, DNA polymerase α and Ctf4 to restrict initiation of
DNA replication (Borysov et al., 2015). Upon S-phase entry, Orc1 bound to pRB is
displaced by E2F1 (Mendoza-Maldonado et al., 2010). This event regulates firing of the
Lamin B2 and GM-CSF replication origins (Avni et al., 2003). To halt progression of the
replication fork, pRB displaces PCNA (Braden et al., 2006).
pRB also associates with chromatin post-G1 to ensure proper mitotic entry and
progression (Bourgo et al., 2011). Mitotic defects in pRB-deficient cells were originally
attributed to misregulation of E2F target genes involved in mitotic control, such as MAD2
(Srinivasan et al., 2007). However, the use of synthetic pRB mutants demonstrates that
pRB mediates mitotic regulation through transcription-independent means as well. Cells
from a gene-targeted mouse model encoding alanine substitutions at I746, N750, and
M754 residues within the pRB LxCxE binding cleft exhibit discrete loss of pRB
interactions that form through the LxCxE binding cleft. This mutant is referred to as the
pRBLXCXE or pRBL mutant (Isaac et al., 2006). The majority of proteins that bind pRB
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through this cleft exhibit enzymatic activities used to alter chromatin structure, and often
lack the LxCxE motif present in the original viral oncoproteins found to bind the cleft
(Talluri and Dick, 2012). In this regard, it appears surprising that all of these interactions
are largely dispensable for certain aspects of proliferative control as Rb1L/L mice are
viable, and Rb1L/L cells exhibit proper induction of quiescence, with anomalies most
apparent within the context of senescence and mammary gland development (Francis et
al., 2009; Isaac et al., 2006; Talluri et al., 2010). Amongst the repertoire of pRBinteractors that bind this cleft, the mitotic defects in Rb1L/L cells have largely been
attributed to loss of pRB binding to the Condensin II complex (Coschi et al., 2014).
pRB-Condensin interactions were first noted in D.melanogaster where chromatin
loading of the dCAPD3 subunit of the Condensin complex appeared to be dependent on
the D.melanogaster pRB homologue RBF1 (Longworth et al., 2008). In mammals, two
multimeric Condensin complexes exist, both of which contain SMC2 and SMC4 subunits
that bind to form a hinge that connects two protruding coiled-coil arms that form a ring
(Uhlmann, 2016). In Condensin I, this ring is completed by the CAPH subunit bound to
CAPD2 and CAPG, while the SMC ring of Condensin II is connected by CAPH2 bound
to CAPD3 and CAPG2. Condensin II associates with interphase chromosomes, and
facilitates chromosome condensation during prophase (Hirano, 2012). As mitosis
progresses, nuclear envelope breakdown permits entry of cytoplasmic Condensin I
complexes that bind and further condense mitotic chromosomes during prometaphase and
metaphase (Hirano, 2016).
The mitotic functions of Condensins appear to underlie the overt aberrations present
in Rb1L/L cells. These cells exhibit slightly increased G2/M content accompanied by
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lagging chromosomes, centromere fusions, and aneuploidy (Isaac et al., 2006). Further
inspection of mitotic progression reveals chromosome condensation and segregation
errors characterized by a diffuse metaphase plate and prolonged anaphase. Upon
inspection of Condensin loading onto chromatin as a possible underlying mechanism,
chromatin fractions reveal reduced enrichment of Condensin II subunits, but not
Condensin I (Coschi et al., 2010). Collectively, this suggests that pRB recruits Condensin
II to ensure proper chromosome condensation and segregation. Condensin II subunits are
particularly enriched at pericentric heterochromatin. However, the mechanism by which
pRB recruits Condensin II to pericentric satellite repeats during mitosis remains
unknown.
Collectively, misregulation of pRB functions during replication and mitosis likely
contribute to the pronounced endoreduplication, aneuploidy, replication stress, and
segregation defects that characterize a state of genomic instability in pRB-deficient cells.
A common feature that underlies these activities is the ability of pRB to function as an
adapter that recruits a diverse spectrum of machinery to modulate local chromatin
structure. Indeed, pRB deficient cells exhibit defective heterochromatinization of
pericentric and telomeric repeats (Gonzalo et al., 2005; Isaac et al., 2006; Manning et al.,
2014). However, since the mechanism of post-G1 pRB chromatin recruitment remains
poorly understood, it remains unknown whether defective heterochromatinization is
directly due to perturbed pRB function, or simply a by product of perturbed replication
and mitotic progression. The CDK-resistance coupled with altered DNA binding
specificity merits investigation into whether the CDK-resistant pRB-E2F1 interaction
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exists endogenously and whether it may underlie the aforementioned post-G1 functions
of pRB.

1.13

Rationale

Next-generation sequencing approaches detect repetitive element activation in
premalignant lesions (Lee et al., 2012). A mechanistic basis for why misregulation is an
early event in the initiation of tumorigenesis remains elusive. Mechanisms of repetitive
element silencing provide a starting point to identify cancer-susceptible aspects of
silencing. Knockout models for epigenetic silencers of repeats demonstrate extensive
compensatory effects exerted by facultative heterochromatin (Déjardin, 2015). This
suggests that disruption of facultative heterochromatin is likely a rate-limiting event that
underlies constitutive misregulation of repetitive elements in cancer.
The retinoblastoma tumor suppressor protein provides a potential mechanistic link
between repetitive element misregulation upon initiation of tumorigenesis. Epigenetic
writers that silence repetitive elements in ESCs are recruited to particular genes in a pRBdependent manner. This includes DNMTs, H3K9me3 HMTs, H3K27me3 HMTs, and
HDACs (Kotake et al., 2007; Robertson et al., 2000). Whether this recruitment occurs at
repeats has remained largely unexplored. More direct evidence comes from investigation
of triple-knockout (TKO) MEFs that lack expression of all three pocket proteins. Extracts
from proliferating TKO MEFs exhibit pronounced expression of L1 ORF2p (MontoyaDurango et al., 2009). Whether this misexpression can be attributed to a single pocket
protein remains unexplored.
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Since repetitive element expression remains suppressed throughout the cell cycle, a
repeat-silencing mechanism must be resistant to fluctuations in cell cycle phase. An
interaction between the pRB C-terminus and the E2F1 marked box domain exhibits
resistance to CDK-mediated phosphorylation that dissociates other pRB-E2F interactions
that form primarily through the pRB small pocket (Cecchini and Dick, 2011). Within this
conformation, pRB and E2F1 demonstrate altered DNA binding sensitivity (Carnevale et
al., 2011; Dick and Dyson, 2003; Julian et al., 2008). Whether this altered DNA binding
sensitivity underlies recruitment to repetitive sequences remains unexplored. If this is the
case, this justifies investigation into whether post-G1 pRB-Condensin II recruitment to
pericentric satellite repeats occurs through this mechanism. Overall, this work focuses on
whether a CDK-resistant pRB-E2F1 interaction underlies both known and yet-unknown
post G1 functions of pRB that are required to maintain genome integrity through
recruitment of chromatin remodelers to repetitive genomic regions.

1.14

Objectives

In chapter 2, a novel gene targeted mouse model encoding an F832A substitution
in the Rb1 gene, called Rb1S, is generated to disrupt the CDK-resistant pRB-E2F1
interaction in order to investigate its endogenous functions. I hypothesized that the CDKresistant pRB-E2F1 complex functions as a scaffold to mediate epigenetic silencing of
repeats genome-wide. To test this hypothesis, I mapped pRB occupancy at repeats across
the genome using chromatin-immunoprecipiration-sequencing (ChIP-seq) and ChIPqPCR. To determine whether occupancy was functional, I performed RNA-seq and
microarray analysis using mutant cells. DNA methylation and histone tail modifications
were also compared at repetitive elements in order to determine potential epigenetic
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regulatory roles of pRB at repetitive sequences. Finally, homozygous mutant animals
were aged until animal protocol endpoints to determine whether loss of this interaction
resulted in any overt phenotypes.
In both chapter 3 and the appended paper (Coschi, Ishak, et. al 2014), I used
Rb1S/S MEFs to investigate contributions of the CDK-resistant pRB-E2F1 interaction to
the maintenance of genome integrity. I hypothesized that pRB-E2F1 were required to
ensure proper replication and mitotic progression independent of transcriptional
regulation of E2F cell cycle target genes. In order to test this hypothesis, γH2AX foci and
>4N DNA content were compared as overt indicators of genome stability. Microarray
analysis and western blots were conducted to assess expression of E2F targets involved in
replication and mitosis. To assess whether certain post-G1 functions of pRB utilized this
scaffold, ppRPA accumulation, chromosome congression, chromosome segregation, and
micronuclei frequency were assessed. Finally, we investigated whether this pRB-E2F1
scaffold recruits the Condensin II complex to particular repetitive sequences, and whether
such sequences were enriched for γH2AX foci upon loss of this recruitment.
In chapter 4, the pRB-EZH2 complex was assessed as a potential target for druginduced epigenetic modulation. Specifically, acute EZH2 inhibition was assessed as a
means of activating repetitive elements silenced by pRB-EZH2 in cell culture and in vivo.
To determine how constitutive alleviation of multiple tumor suppressor-based chromatinorganizing mechanisms affects tumorigenesis, Rb1S/S mice were crossed into a Trp53-/background, and characterized upon animal protocol endpoints for evidence of altered
cancer phenotypes.
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Chapter 2

2

An RB-EZH2 complex mediates cell cycle independent
silencing of repetitive DNA sequences
2.1

Abstract

Repetitive genomic regions include tandem sequence repeats, and interspersed repeats
such as endogenous retroviruses and LINE-1 elements. Repressive heterochromatin
domains silence expression of these sequences through mechanisms that remain poorly
understood. Here, we present evidence that the retinoblastoma protein (pRB) utilizes a
cell cycle-independent interaction with E2F1 to recruit enhancer of zeste homologue 2
(EZH2) to diverse repeat sequences. These include simple repeats, satellites, LINEs and
endogenous retroviruses, as well as transposon fragments. We generate a mutant mouse
strain carrying an F832A mutation in Rb1 that is defective for recruitment to repetitive
sequences. Loss of pRB-EZH2 complexes from repeats disperses H3K27me3 from these
genomic locations and permits repeat expression. Consistent with maintenance of
H3K27me3 at the Hox clusters, these mice are developmentally normal. However,
susceptibility to lymphoma suggests that pRB-EZH2-recruitment to repetitive elements
may be cancer relevant.

2.2

Introduction

Repetitive genomic regions comprise approximately 50% of the human genome
(Lander et al., 2001). These repetitive elements include tandem repeats, such as satellite
sequences that underpin the heterochromatin at centromeres, in addition to interspersed
repeats that are capable of transposition (Slotkin and Martienssen, 2007). Expression of
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repetitive elements poses a mutagenic threat to the host through multiple possible
aberrations (Mager and Stoye, 2015). For example, de-repression of satellite repeats
disrupts organization of centromeric heterochromatin and coincides with defects in
chromosome segregation and meiosis (Slotkin and Martienssen, 2007). At the
transcriptional level, de-repressed repeat sequences can serve as alternate enhancers or
promoters that permit ‘read-through’ transcription and cis-activation of proximal genes,
including proto-oncogenes that have been established as initiating events in human
lymphomas (Lamprecht et al., 2010). More recently, sequencing-based studies
demonstrate that re-integration of activated mobile repetitive elements can generate
cancer-relevant mutations in pre-malignant lesions that precede various human cancers
(Helman et al., 2014; Iskow et al., 2010; Lamprecht et al., 2010; Lee et al., 2012; Lock et
al., 2014). Likewise, re-integration of activated satellites expands centromere repeats and
can fuel cancer cell growth (Bersani et al., 2015). The frequent co-occurrence of
repetitive element reactivation with genome instability suggests that the antagonism of
repeat silencing may be achieved through mechanisms commonly employed to initiate
tumorigenesis. Recent evidence of p53-mediated transposon repression indicates that this
may indeed be the case (Leonova et al., 2013; Wylie et al., 2016). Thus, any potential
contribution of repetitive sequences to cancer initiation must ultimately be mitigated
through transcriptional silencing. Understanding how silencing is achieved is
fundamental to understanding how cancer-initiating mechanisms may circumvent this
facet of genome regulation.
Repetitive elements are transcriptionally repressed by DNA methylation and
histone tail modifications (Schlesinger and Goff, 2015). Sustained repression of repetitive
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elements during periods of genome-wide DNA hypomethylation in early embryogenesis
has stimulated investigation of histone-dependent repression mechanisms in ES cells
(Leung and Lorincz, 2012; Levin and Moran, 2011). Repetitive sequences in ES cells are
enriched for H3K9me2/3, H4K20me3, and H3K27me3 (Day et al., 2010). Upon loss of
DNA methylation, H3K27me3 expands to maintain silencing of interspersed and tandem
repeat sequences (Walter et al., 2016). Following genetic ablation of H3K9 histone
methyl transferases, H3K27me3 compensates for H3K9me3 loss at interspersed and
pericentromeric repeats (Peters et al., 2003). However, additional deletion of the
Polycomb repressor complex 2 (PRC2) subunit EED can de-regulate these repetitive
sequences indicating redundancy of repressive mechanisms (Walter et al., 2016).
Proteomic analysis of ES cells indicates that 60% of histone H3 proteins are comprised of
H3K27me2/3 modifications (Peters et al., 2003). Collectively, these data suggest
H3K27me3-based heterochromatinization provides a dynamic epigenetic mechanism that
silences repeat sequence expression in response to alterations in other silencing
mechanisms, and likely contributes extensively on its own (Bulut-Karslioglu et al., 2014;
Karimi et al., 2011; Liu et al., 2014). Despite this fundamental contribution to genomewide repeat silencing, little is known about the mechanism of H3K27me3 deposition and
expansion at repetitive sequences, as investigation of Polycomb at non-unique genomic
regions primarily concerns the regulation of neighbouring genes (Bauer et al., 2015; Casa
and Gabellini, 2012). Beyond ES cells, investigation of repetitive DNA silencing by
PRC2 remains even less understood.
Dynamic response to various genomic alterations positions Polycomb as a robust
barrier to reactivation of repeat sequences. Thus, disruption of genome stability through
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repeat sequence resurrection likely requires disruption of Polycomb-mediated
heterochromatin. A surprising link between Polycomb, repetitive sequences, and cancerinitiating mechanisms may be the RB tumor suppressor protein (pRB). While pRB is best
known as a repressor of E2F transcription factors at cell cycle genes during the G1 phase
of the cell cycle, pRB family proteins also direct H3K27me3 to repress transcription
during differentiation and stress (Blais et al., 2007; Bracken et al., 2007; Kareta et al.,
2015; Kotake et al., 2007). In addition, RB cell cycle-independent interactions with
chromatin (Avni et al., 2003; Wells et al., 2003) have been observed, but genome-wide
analysis of pRB at repeat sequences is lacking (Coschi et al., 2014; Montoya-Durango et
al., 2009). In addition, there is no evidence pRB-mediated regulation of H3K27me3 is
sufficiently widespread to match the magnitude of H3K27me3 abundance and
distribution at repeats.
In this study we demonstrate that pRB and EZH2 form a complex that directs
H3K27me3 deposition at most repeat element types from simple sequence repeats and
satellites, to DNA transposons, LINEs, SINEs, and endogenous retroviruses. We report
the generation of a new strain of mice carrying a targeted point mutation, F832A (called
Rb1S), that is specifically defective for recruitment of EZH2 to repetitive sequences. In
the absence of pRB recruitment, EZH2 no longer directs H3K27me3 to these elements,
leading to dispersion or loss of heterochromatin. Rb1S/S fibroblast cells and splenocytes
express diverse repeat sequences, including tandem and interspersed elements, and aged
Rb1S/S mice develop spontaneous lymphomas. Collectively, these data suggest that
silencing of repetitive elements contributes to pRB’s function as a tumor suppressor.
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2.3
2.3.1

Experimental Procedures
Cell Culture and Mice

Mouse embryonic fibroblasts (MEFs) were generated from E13.5 embryos using standard
procedures and cultured as previously described (Coschi et al., 2014). Cells were
typically arrested by serum starvation for at least 3 days.

2.3.2

Chromatin immunoprecipitation

ChIP methods were based on previously published work (Cecchini et al., 2014). Briefly,
cells were cross-linked with 2mM ethylene glycol bissuccinimidylsuccinate (EGS) and
1% formaldehyde. Chromatin was sonicated to ≤ 400 bp in length and normalized
between experimental groups. Samples were pre-cleared with protein G Dynabeads and
ChIP antibodies were added to immunoprecipitate proteins. Samples had their cross-links
reversed at 65°C and were treated with RNase and proteinase K. DNA was isolated for
qPCR or library preparation followed by single-end sequencing using Illumina
HiSeq2500. See supplemental tables for list of ChIP-qPCR primers. Further details of
ChIP-reChIP and ChIP-seq are available in supplemental experimental procedures.

2.3.3

RNA expression

Total RNA was isolated using Trizol reagent, treated with DNaseI, and reversetranscribed to generate cDNA using random primers and Superscript III reverse
transcriptase (Invitrogen). qRT-PCR was performed using iQ SYBR green Super Mix
(Bio-Rad) using a CFX96 Real-Time PCR Detection System (Bio-Rad). Relative changes
in gene expression were calculated by normalizing to β-actin. Primer sequences are
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described in supplemental materials. Some expression microarray experiments have been
reported previously (Cecchini et al., 2014), or can be found in GEO (GSE85640).

2.3.4

Analysis of ChIP-seq and RNA-seq experiments

Sequence reads from ChIP experiments were mapped to the mm9 genome assembly
without allowing mismatches as previously reported (Bulut-Karslioglu et al., 2014).
Reads with more than one exact match were randomly assigned amongst these locations.
RNA-seq reads were mapped to a custom repeat index (Day et al., 2010), assigning reads
to their best match allowing up to two sequence mismatches. Further details on
computational analyses are available in supplemental materials. Sequence data is
available in GEO (accession number GSE85640).

2.3.5

Generation of gene targeted mice

A targeting vector encoding a floxed PGK-Neomycin cassette and an F832A missense
point mutation in exon 24 of the Rb1 gene was generated and electroporated into mouse
R1 embryonic stem (ES) cells in the London Regional Transgenic and Gene-Targeting
facility. After G418 selection, positive clones were identified by Southern blotting and
microinjected into blastocysts to generate chimeric males that were intercrossed with
EIIa-Cre transgenic females essentially as we have reported previously (Isaac et al.,
2006). Primers designed to flank the floxed Neomycin cassette amplified a product
approximately 80 bp larger than the wild-type product, indicating presence of a residual
LoxP site after successful Cre-mediated excision of the floxed marker in targeted F1
offspring. DNA sequencing confirmed germline transmission of the targeted allele.
Targeted F1 progeny were intercrossed to generate mice that did not express the Cre-
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recombinase. Heterozygous F2 crosses produced offspring genotypes according to
expected Mendelian frequencies, with viable, fertile, homozygous mutant mice that
developed into adulthood without overt developmental defects. Animals were housed and
handled as approved by the Canadian Council on Animal Care.

2.3.6

Cell cycle analysis

Asynchronous or serum-starved MEFs were pulse-labeled with bromodeoxyuridine
(BrdU; Amersham Biosciences) for 2 hours, detached with 3 mM EDTA, and ethanolfixed. Cells were then permeabilized with 2 N HCl and 0.5% TritonX-100, neutralized
with 0.1M NaB4O7 (pH 8.5), immunostained with anti-BrdU (BD Biosciences), followed
by FITC-conjugated secondary (Vector laboratories), then stained with propidium iodide.
Cells were treated with RNase, strained, and analyzed by flow cytometry on a BeckmanCoulter EPICS XL-MCL (Cecchini et al., 2012).

2.3.7

Cell extracts

Nuclear extracts were generated according to methods described by Cecchini and Dick
(Cecchini and Dick, 2011). Briefly, cells were washed twice and collected in 1 ml of
PBS. Cells were then re-suspended in three times cell volume of hypotonic lysis buffer
(20 mM Tris-HCl, pH 7.5, 10 mM KCl, 3 mM MgCl2, 1 mM EDTA) supplemented with
protease inhibitors. After 5 minutes on ice, 0.05% Nonidet P40 was added, extracts were
iced 5 minutes before nuclei were pelleted by centrifugation at 1700 g for 10 minutes at
4°C and washed twice with hypotonic lysis buffer containing 0.05% Nonidet P40. Nuclei
were re-suspended in Gel Shift Extract (GSE) buffer (20mM Tris pH 7.5, 420 mM NaCl,
1.5mM MgCl2, 0.2mM EDTA, 25% glycerol) and frozen at −80°C. Extracts were
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thawed, cellular debris was cleared by centrifugation, and extracts were quantified for
interaction assays. To generate whole-cell lysates, cells were washed twice with PBS,
and scraped in ice-cold RIPA buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1%
Triton X-100, 0.5% sodium deoxycholate, and 0.1% SDS) supplemented with protease
inhibitors. After 20 minutes on ice, lysates were centrifuged at 20800 g for 20 min at 4°C.
Supernatant was isolated, quantified, boiled 5 minutes in Laemmli sample buffer, and
then resolved by SDS-PAGE (Yu et al., 2012). See appendix F for antibodies used.

2.3.8

Chromatin Fractionation

Chromatin isolation method was adapted from Mendez and Stillman (Méndez and
Stillman, 2000). Briefly, cells were resuspended in buffer A (10 mM Tris [pH 8.0], 10
mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT) supplemented with
protease inhibitors at 4x107 cells/ml, and incubated on ice for 5 minutes. Equal volume of
0.3mg/ml digitonin in buffer A was added, and the cells were further incubated for 10
minutes on ice in the presence of detergent. Approximately 5-10% of this total volume
was stored to preserve a whole-cell extract fraction. Centrifugation at 1300 xg for 5
minutes at 4°C pelleted nuclei, and supernatant containing the cytoplasmic fraction was
collected. Nuclei were washed in buffer A, then lysed 30 minutes on ice in buffer B (3
mM EDTA, 0.2 mM EGTA, 1 mM DTT) supplemented with protease inhibitors using a
volume ~2x that of the pellet. Insoluble chromatin was pelleted by centrifugation at 1,700
xg for 5 minutes at 4°C, and supernatant containing the nucleoplasmic fraction was
collected. The chromatin pellet was resuspended in DNaseI buffer (20mM Tris [pH 7.5],
10 mM MgCl2) at a volume ~2x that of the pellet, supplemented with 200U of DNaseI
(Sigma), and incubated 1 hour on ice. All fractions were quantified, boiled in Laemmli
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buffer, resolved by SDS-PAGE, and coomassie stained to assess fraction purity and
histone normalization. Fractions were then used for western blotting. See Appendix F for
antibodies used.

2.3.9

GST pulldowns

GST-fusion proteins were expressed in and purified from 500 ml cultures of BL21-DE3Gold Escherichia coli (Stratagene) using glutathione–Sepharose beads according to
standard protocols. Purified GST-fusion protein (4 μg) was incubated with 400μg of
nuclear extract diluted with low salt GSE buffer (20 mM Tris-HCl pH 7.5, 200 mM
NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM DTT and 0.1% Nonidet P40), and rocked
1-2 hours at 4°C. GST–protein complexes were collected with glutathione–Sepharose,
washed twice with low salt GSE buffer, and eluted with Laemmli sample buffer for
western blot analysis (Dick et al., 2000). See table S1 for antibodies used.

2.3.10

Immunoprecipitation

For immunoprecipitations, nuclear extract was diluted 1:1 in IP wash buffer (20mM Tris
pH 7.5, 200 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25 mM DTT and 0.1% NP-40).
Protein complexes were immunoprecipitated overnight at 4°C with antibodies pre-bound
to washed protein G Dynabeads. Antibody-protein complexes were washed twice with IP
wash buffer, then eluted in Laemmli sample buffer for western blot analysis. See table S1
for antibodies used (Cecchini and Dick, 2011).

2.3.11

Splenocyte ChIP

Splenocyte ChIP experiments were conducted following splenocyte isolation from 6week old adult mice. Briefly, spleens were isolated from freshly sacrificed mice, and
mashed through a 40μm sterile cell strainer in a 10cm dish containing 3-4ml of media.
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Cells were then isolated, pelleted at 4°C, and incubated 5 minutes in 1x RBC lysis buffer
(0.15M NH4Cl, 10mM KHCO3, 0.1mM EDTA) to lyse erythrocytes. Splenocytes were
washed twice in 1x PBS, rocked 1 hour at room temperature in 10ml of 2mM EGS-PBS,
then supplemented with formaldehyde to a final concentration of 1% and rocked for
another 15 minutes at room temperature before fixation was quenched with 2.5M glycine
for 15 minutes. Fixed splenocytes were pelleted, and processed in ChIP buffers 1-3 as
described in methods. Splenocytes were resuspended in a final volume of 200µL of ChIP
lysis buffer and sonicated to ≤400 bp before ChIP experiments were conducted as per
MEF ChIP experiments.

2.3.12

ChIP-reChIP

For ChIP-reChIP experiments, we adapted methods from Thillainadesan and colleagues
(Thillainadesan et al., 2012). Protein-DNA complexes were eluted 30 minutes at 37°C in
10 mM DTT with 5 mM β-mercaptoethanol. Eluted DNA was diluted 10x in reChIP
buffer (1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl pH 8.1, 150 mM NaCl), and
incubated with second antibody overnight at 4°C. Antibody-protein complexes were
immunoprecipitated with washed protein G Dynabeads for 2 hours at 4°C, then washed
with low salt buffer, high salt buffer, and TE. Reverse-crosslinking and purification were
done as described in ChIP methods section. See table S1 for antibodies used.

2.3.13

ChIP-seq and Read Alignment

ChIP was conducted as described in methods according to protocols adapted from
Cecchini et al. (Cecchini et al., 2014). DNA from multiple replicates per genotype were
pooled to achieve DNA yield required for library preparation (Illumina TruSeq). For pRB
ChIP-seq in proliferating MEFs, 6 IPs were pooled, while 11-18 IPs were pooled in
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arrested MEFs. For H3K27me3 ChIP-seq in proliferating MEFs, 9 IPs were pooled,
while 12 IPs were pooled for IPs in arrested MEFs. For EZH2 ChIP-seq in proliferating
MEFs, 9 IPs were pooled. Libraries were sequenced using an Illumina HiSeq 2500.
Resulting FASTQ reads were aligned to mouse genome build mm9 using Bowtie version
2.2.3 (Langmead and Salzberg, 2012). Reads aligning to multiple locations of a particular
repeat element were distributed randomly to these positions, while reads mapping to the
same location were retained as previously described (Bulut-Karslioglu et al., 2014). The
following command was used: bowtie2 -t -p 24 -D 15 -R 2 -L 32 -i S,1,0.75 -x mm9 -U
reads.fastq -S output.SAM.

2.3.14

Peak Calling and annotation

Peaks were identified using MACS1.4 or MACS2 version 2.0.10 according to parameters
stated below, and the options to detect broad peak distributions for histone marks (Feng
et al., 2012; Zhang et al., 2008). The results from this peak calling were stored as BED
files. The following commands were used:
macs14 -t ChIP.sam -c input.sam -n output -g mm -p 0.01 -m 5,50 --bw 180 --keep-dup
all -B -S –w; MACS2 callpeak -t ChIP.sam -c input.sam -n ouput -g mm -q 0.05 --broad -keep-dup all -B (q 0.01 for histones). Peak enrichment per genomic region was
determined using HOMER (Heinz et al., 2010). Peak intersection and enrichment at
repetitive elements was determined using BEDintersect of MACS peaks against repeat
indices derived from UCSC RepeatMasker (Quinlan and Hall, 2010).

2.3.15

deepTools enrichment analysis

bamCompare was used generate bigWig files of ChIP reads normalized to input (Ramirez
et al., 2014). computeMatrix was used to calculate read enrichment scores at wild-type
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repeat peak intersects or promoter regions. heatMapper was used to plot enrichment at
each repElement per repFamily +/-1kb of wild-type repeat peak intersect locations
(Ramirez et al., 2014).

2.3.16

RNA-sequencing

Total RNA from quiescent MEFs was isolated using TRIzol reagent protocol
(Invitrogen). rRNA was depleted from total RNA using RiboMinus Euk System V2 (Life
technologies). rRNA-depleted RNA samples were submitted for picoanalyzer analysis to
determine concentration, purity, and rRNA content. Samples with <10% rRNA remaining
were submitted for library construction at the Sick Kids/TCAG (Toronto) facility
followed by paired end sequencing on an Illumina HiSeq 2500.

2.3.17

Expression microarray analysis

Total RNA was extracted according to Trizol manufacturer protocol, and quality control
tested using an Agilent 2100 Bioanalyzer. Preparations that met quality control standards
were used to prepare biotin end-labeled single strand cDNA. 5.5 ug of prepared cDNA
was hybridized for 16 hours at 45°C on GeneChip Mouse Gene 1.0 ST Arrays that were
subsequently washed, stained, and scanned using the Affymetrix GeneChip Scanner 3000
7G. RMA expression values derived from CEL files were log-transformed prior to
ANOVA analysis using Partek Genomics Suite. Log2 values of mutant/wild-type were
plotted as heatmaps using matrix to PNG at chibi.ubc.ca/matrix. Annotations were
derived from Affymetrix MoGene-1 0-st-v1 Transcript Cluster Annotations, CSV,
Release 32.
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2.3.18

RNA-seq read alignment and analysis

Single end sequence reads were aligned using Bowtie v1.0.0 to indices of repeats derived
from Repbase and Tandem Repeats Databases(Day et al., 2010). Bowtie parameters were
established to report the single best alignment per read, with a default value of 2 for the
maximum number of mismatches; the following Bowtie v1.0.0 parameters were used:
bowtie –S –best –k 1 –chunckmbs 500 –p24 –t –un. Read enrichments were binned using
the awk command according to functional categories, based on RepeatMasker’s
annotation. Residual rRNA reads were subtracted from the total number aligned reads
reported for each sample. The number of reads for each category were then normalized to
the corrected number of total aligned reads per sample. Expression per biological
replicate relative to the control average was compared between repFamily categories as a
LOG2 ratio, and plotted as a heatmap using matrix to PNG at chibi.ubc.ca/matrix.

2.3.19

Bisulfite sequencing

Bisulfite sequencing was conducted as previously described (Denomme et al., 2012;
White et al., 2015). Briefly, P4 MEFs were trypsinized, washed and re-suspended in 1 ml
of 1X PBS. 1 μL of cell suspension was embedded into a 2:1 3% low melting point
(LMP) agarose (Sigma) and lysis [100 mM Tris–HCl, pH 7.5 (Bioshop), 500 mM LiCl
(Sigma), 10 mM EDTA, pH 8.0 (Sigma), 1% LiDS (Bioshop), and 5 mM DTT (Sigma),
1 μL of 2 mg/ml proteinase K (Sigma), and 1 μL 10% Igepal (Sigma)] solution for
bisulfite mutagenesis. This mixture was iced 10 minutes, then lysed 20 hours overnight in
500 μL of SDS lysis buffer (450 μL TE pH 7.5, 50 μL 10% SDS, 1 μL proteinase K) at
50°C. Lysis buffer was replaced with 300 μL of mineral oil, and samples were processed
for bisulfite mutagenesis or stored at -20°C 1-5 days, then processed for bisulfite to
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amplify IAP (Lane, 2003) and LINE1 sequences as previously described (Denomme et
al., 2012; White et al., 2015). Briefly, proteinase K was inactivated at 90°C, then samples
were iced 10 minutes, incubated 15 minutes at 37°C with 0.1 M NaOH solution to
denature DNA, and covered with 300 μL of mineral oil. Following addition of 500 μL of
2.5 M bisulfite solution, samples were incubated 3.5 hours at 50°C, then desulfonated 15
minutes in 1 mL of 0.3 M NaOH at 37°C. Samples were washed twice in TE pH 7.5 then
water. Negative controls were processed in parallel. For first round PCR, 10 μL of
agarose bead with bisulfite converted DNA was added to Hot Start Ready-To-Go (RTG)
(GE Healthcare) PCR beads hydrated with 0.5 μL of 10 μM IAP (Lane, 2003)_F1/R1 or
L1_F/R1 external primers, 1 μL of 240 ng/mL transfer RNA and 13 μL water with a
25 μL mineral oil overlay. 5 μL of amplicon was added to 20 μL of RTG beads mixed
with 0.5 μL of each 10 μM IAP (Lane, 2003)_F2/R2 or L1_F/R2 internal primer and
19 μL water for nested PCR. PCR amplification was performed as follows: 94°C for 3
minutes, followed by 35 cycles of 94°C for 1 minute, 53°C (IAP)/56°C (L1) for 1 minute,
72°C for 1 minute, and a final extension of 72°C for 5 minutes.

2.3.20

qRT-PCR analysis of expression

Tissues from 6-8 week-old mice were harvested and processed for RNA isolation using
the SIGMA GenElute mammalian total RNA kit. RNA was DNaseI (SIGMA) treated and
reverse transcribed to cDNA using the BIO-RAD iScript RT Supermix kit. Isolated
cDNA was used in qRT-PCR reactions. Resulting target Cq values were normalized to βactin, then expressed as fold change relative to the global wild-type mean. Normalized
fold change was plotted as a heatmap using matrix to PNG at chibi.ubc.ca/matrix.
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2.4
2.4.1

Results
The RB protein associates with repetitive genomic
sequences

To explore emerging chromatin regulatory functions beyond cell cycle control,
we compared pRB association with chromatin in arrested and proliferating mouse
embryonic fibroblasts (MEFs). While noticeably reduced, pRB retains some chromatin
binding in proliferating cells (Figure 2.1A). We sought to further investigate genome
wide distribution of pRB across growth conditions by chromatin immunoprecipitationsequence analysis (ChIP-seq). We used a stringent sequence alignment approach that
prohibited mismatches. We also randomized read assignments where more than one exact
match existed to enhance potential alignments to repetitive regions of the genome (see
methods and (Bulut-Karslioglu et al., 2014)). Analysis of peak distribution across broad
genomic regions reveals a dramatic abundance of peaks in introns and intergenic
locations (Figure 2.1B). The proportion of peaks that localize to introns and intergenic
regions remains unaltered by proliferative status, suggesting that even though pRB
occupancy on chromatin may be reduced in proliferating cells, this distribution pattern
displays cell cycle-independence for pRB at these regions. Comparison of enrichment at
wild type peak locations within promoters to the same genomic locations in Rb1-/controls confirms a high degree of stringency in peak assignment (Figure 2.1C). Since an
abundance of peaks localize to non-coding regions, we next annotated peaks based on
categories of repetitive sequences (Figure 2.1D). Analysis of peak distribution reveals
pRB association with SINEs, long terminal repeat (LTR)- containing endogenous
retroviruses (ERVs), LINEs, and simple repeat sequences among others. Importantly,
these surprising findings are mirrored in a meta-analysis of a recently published human
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Figure 2.1: pRB associates with genomic repeats in murine and human fibroblasts
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Figure 2.1: pRB associates with genomic repeats in murine and human fibroblasts
(A) pRB western blots of MEF chromatin fractions. Coomassie stained histones indicate
relative chromatin quantities per lane. (B) Overall genomic distribution of pRB ChIP-seq
peaks. Growth conditions are indicated above the pie charts; n=424588 peaks and
n=77809 peaks for mouse pRB in arrested and proliferating MEFs respectively; n=71511
peaks for human pRB in arrested IMR90 cells. (C) Heat maps display scaled pRB ChIPseq read build ups from the indicated genotypes at proximal promoter regions occupied
by wild type pRB peaks. Each row contains ±1 kb of flanking sequence. The intensity
scale indicates magnitude of read enrichment (D) Percent distribution of pRB ChIP-seq
peaks amongst indicated repeat sequence classes; n=321892 peaks for mouse pRB
arrested, n=49210 peaks for mouse pRB proliferating, and n=99186 peaks for human
pRB arrested. RNA repeats include tRNA, snRNA and others. (E) Genome browser
tracks display mouse pRB ChIP-seq reads at Ccne2. Genomic co-ordinates are indicated
above the tracks. Repeat Masker and RefSeq tracks are shown below. Red bars denote
regions of pRB enrichment (peaks) determined with MACS. (F) The analogous region of
human CCNE2 is shown and labeled akin to panel D. (G) Example of mouse pRB
occupancy at a LINE-1 element 3' of the Ccne2 gene. (H) Example of a human pRB peak
5' of CCNE2 that simultaneously overlaps multiple repeat elements.
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pRB ChIP-seq study, although promoter occupancy is noticeably greater in human data
(Figure 2.1B and 2.1D)(Ferrari et al., 2014).
The RB protein is best known for its regulation of E2F-responsive cell cycle
genes, and our mapping of ChIP-seq reads detects these promoter occupancy events in
mouse and human data sets (Figure 2.1E and 2.1F). Repeat occupying peaks are also
found in neighboring regions of the same chromosomes (Figure 2.1 G and 2.1H). Our
analysis of peak distribution in murine cells demonstrates that at least two thirds of pRB
occupying peaks map to repetitive sequences (Figure 2.1B and 2.1D). It is difficult to
draw a similar conclusion in human data because many pRB peaks contain multiple
repetitive elements in the same peak (Figure 2.1H). Collectively these data indicate that
pRB associates with diverse repetitive elements in mouse and human fibroblasts. We
describe this pattern of pRB distribution as cell cycle independent because it is similar
between growth states, but recognize that its magnitude is altered.

2.4.2

Loss of a CDK-resistant pRB-E2F1 interaction disrupts
repeat association
We previously identified an interaction between pRB and E2F1 that confers

reduced binding to consensus E2F sequence elements and resistance to disruption by
CDK phosphorylation(Cecchini and Dick, 2011; Dick and Dyson, 2003). We sought to
determine whether the properties of this interaction could underlie the cell-cycle
independent pRB occupancy observed in our ChIP-seq. We generated a targeted mutant
mouse strain bearing a single F832A substitution to disrupt the unique interaction
between pRB and E2F1, and named this allele Rb1S (Figure 2.2A-D). Rb1S/S mice are
indistinguishable from their littermates (Figure 2.2E&F), and cells isolated from these
mice exhibit ostensibly normal pRB expression levels with no indication of
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Figure 2.2: In vivo disruption of the CDK-resistant pRB-E2F1 interaction.
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Figure 2.2: In vivo disruption of the CDK-resistant pRB-E2F1 interaction.
(A) Schematic diagram showing the minimal interaction regions for the different pRBE2F interactions. E2F1-4 transactivation domains (TAD) bind the pRB large pocket
domain, while the E2F1 coiled coil and marked-box domain (CM) binds a minimal
interaction surface mapped to the pRB-C-terminus. (B) Diagram of the Rb1 locus along
with the targeting vector encoding the F832A missense point mutation in exon 24. Gene
structure of a correctly targeted locus is shown with the PGK-neo cassette and the
structure of the Rb1S gene following excision of the PGK-neo cassette. Locations of
probes used in Southern blots are shown. (C) Southern blots of two correctly targeted ES
clones are shown. The left most blot shows the banding pattern from the 5' probe, the neo
probe shows a single band corresponding to recombination of the targeting vector, and
the right most blot shows the expected fragment sizes from hybridization with the 3'
probe. (D) DNA sequencing of Rb1 exon 24 codon from genomic DNA of the indicated
genotypes of mice. (E) Photographs of 6-8 week old wild type and Rb1S/S mice. (F)
Genotype frequencies from heterozygous intercrosses.
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compensatory expression of RB-related family members p107 and p130 (Figure 2.4A).
Furthermore, analysis of the F832A substitution in pRB demonstrates a specific defect in
binding the E2F1 coiled coil and marked box domain, without effects on E2F
transcriptional activation domain binding to pRB (Figure 2.3A-D). Consistent with these
biochemical properties, cell cycle regulation and E2F target gene expression are
indistinguishable from wild type controls (Figure 2.3E and 2.3G).
Western blots of chromatin fractions reveal diminished pRBS association with
chromatin under both proliferating and arrested conditions (Figure 2.4A). ChIP-qPCR
was performed to assess pRB recruitment in arrested and proliferating growth conditions
at the cell cycle responsive Mcm3 promoter. In addition to Rb1S/S cells, we utilized the
previously characterized Rb1G mutant that disrupts canonical pRB-E2F transcriptional
control through R461E and K542E substitutions for comparison (Cecchini et al.,
2014)(Figure 2.4B). Under arrested conditions, the pRBS protein exhibits similar
association with the Mcm3 transcriptional start site (TSS) as wild type pRB, while the
pRBG mutant exhibits reduced occupancy. Under proliferating conditions, wild type and
pRBS occupancy of the Mcm3 promoter diminishes, consistent with CDK-dependent
regulation of pRB-E2F interactions at this genomic location.
Given the retention of pRBS at E2F cell cycle targets, but the clear loss of chromatin
association revealed by fractionation, we conducted ChIP-seq for pRB in Rb1S/S cells to
discover genomic locations that require this pRB-E2F1 interaction. Since pRBS
chromatin association was globally reduced in Figure 2.4A, we focused our analysis on
wild type locations lost in Rb1S/S cells. Under both growth conditions, ChIP-
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Figure 2.3: The Rb1S/S mutant maintains pRB cell cycle regulatory functions in
primary mouse fibroblasts.
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Figure 2.3: The Rb1S/S mutant maintains pRB cell cycle regulatory functions in
primary mouse fibroblasts.
(A) Nuclear extracts were prepared from wild type and Rb1S/S primary mouse embryonic
fibroblasts (MEFs) and pRB was isolated using a GST-E7 pulldown. A western blot
demonstrates pRB binding to E7 and a coomassie stained gel shows the loading levels of
GST proteins. (B) Western blotting and commassie stained gels of GST-pulldowns using
GST-E2F1CM (aa 200-301) in complex with HIS-DP1CM (aa 198-350) to isolate pRB
from nuclear extracts using its unique interaction with E2F1. (C) GST-E2F1-TAD
pulldowns were performed to assess binding at the canonical pRB-E2F interaction site.
(D) IP-western blotting experiment using extracts from the indicated genotypes of MEFs.
The left most blots show levels of pRB, E2F1, and E2F3 present in extracts and pRB
associated levels of E2F1 and E2F3 are shown to the right. (E) Asynchronous or 72-hour
serum-starved passage 4 MEFs were BrdU pulse-labeled for 2 hours, ethanol-fixed,
immunostained, and PI-stained for signal quantification via flow cytometry. Graphs show
the proportions of each cell cycle phase from this analysis. (F) qRT-PCR of cDNA from
total RNA of 72-hour serum-starved P4 MEFs for indicated targets in pRB mutant MEFs.
(G) Western blots of the indicated cell cycle and E2F regulated proteins from whole cell
extracts of 72-hour serum-starved P4 MEFs of the indicated genotypes. For all graphs,
error bars indicate +/- 1 standard deviation; an asterisk represents a significant difference
from the wild type control P≤0.05 by t-test.
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Figure 2.4: Cell cycle independent pRB-repeat association.
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Figure 2.4: Cell cycle independent pRB-repeat association.
(A) Western blots of whole cell extracts display expression levels of wild type and the
F832A mutant (Rb1S) pRB, as well as related family members p107 and p130. Western
blot detects pRB association with chromatin fractions from arrested and proliferating
cells. Coomassie stained histones serve as a loading control. (B) pRB ChIP-qPCR at the
Mcm3 transcriptional start site (TSS) and 2 kb 5' of Mcm3 for the indicated genotypes
under arrested and proliferating conditions. (C) Heat maps of pRB ChIP-seq read
enrichment per repClass for the indicated growth conditions and genotypes. Each row
represents one scaled wild type peak location at an element within the repClass and
includes ±1 kb of flanking sequence. The intensity scale indicates magnitude of read
enrichment. (D) ChIP-qPCR for pRB at the indicated repetitive elements conducted in
proliferating and arrested MEFs. (E) Two representative genomic regions depict wild
type and mutant pRB repeat association at LINE-1 fragments across growth conditions.
Red bars mark regions of pRB enrichment (peaks). For all graphs, error bars indicate one
standard deviation from the mean and an asterisk represents a significant difference from
wild type (P≤0.05 by t-test).
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seq in Rb1S/S fibroblasts uncovers a dramatic loss of pRB enrichment at repetitive
elements occupied by wild type pRB that is equally evident by ChIP-qPCR (Figure 2.4CE). Comparison of read build-ups at wild type peak locations reveals that pRB
localization is disrupted by the F832A substitution at the vast majority of elements in
these repClass groups, and resembles Rb1-/- controls at these locations (Figure 2.4C).
Quantitatively, greater than 80% of wild type pRB peak intersections at repetitive
elements are lost in Rb1S/S chromatin under both growth conditions (Figure 2.5A).
In contrast to repetitive elements, the pRBS enrichment profile at E2F cell cycle
genes parallels that of wild type pRB (Figure 2.5B). Interestingly, pRB localizes
extensively to repeat-containing regions within 1kb of non-E2F target genes, and indeed,
pRBS exhibits a loss of enrichment at these regions under both growth conditions (Figure
2.5C). ChIP-qPCR for pRB at major satellites, LTR-containing, and non-LTR
retrotransposon repeat classes confirms diminished pRBS occupancy at repetitive
elements, while the pRBG mutant parallels the cell cycle independent occupancy
displayed by wild type pRB at these elements (Figure 2.4D). Genome browser tracks
show two examples of pRB peak loss in Rb1S/S cells at fragments of LINE-1 elements
(Figure 2.4E). Lastly, ChIP-qPCR detects E2F1 at these repetitive sequences, consistent
with a model of E2F1 contributing to pRB localization to repeats (Figure 2.5D).
Collectively, these data indicate that disrupting pRB’s CDK-resistant binding site
for E2F1 prevents its localization to repetitive regions of the genome. Analysis of mutant
forms of pRB with distinct defects for E2F interaction type across different growth
conditions further supports the conclusion that pRB possesses a cell cycle independent
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Figure 2.5: Occupancy of repetitive sequences by pRB and E2F1.
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Figure 2.5: Occupancy of repetitive sequences by pRB and E2F1.
(A) Peak retention relative to wild type-repeat intersections was determined using
BEDintersect. Bar graphs show peak location by repeat element class using the indicated
color scheme. RNA repeats include tRNA, snRNA and others. The frequency of peak
retention in Rb1S/S mutant cells compared with wild-type at these repeat elements is
shown for both growth conditions. N=321892 peaks for wild-type pRB in arrested cells,
n=49210 peaks for mouse pRB in proliferating cells. (B) Average pRB ChIP-seq
enrichment profiles across the 1kb upstream region of pRB regulated E2F cell cycle
target genes for the indicated genotypes visualized using deepTools profiler. (C) Heat
maps of pRB ChIP-seq read enrichment within 1kb regions that contain wild type pRB
peaks upstream of RefSeq genes. The intensity scale indicates the magnitude of read
enrichment. Pie charts indicate relative repeat content of such regions, followed by
enrichment profiles at the repeat-void regions within this category. (D) ChIP-qPCR
assays were performed to detect E2F1 at the indicated repetitive sequences. Error bars
indicated one standard deviation from the mean. An asterisk indicates a significant
difference compared to wild type P≤0.05 by t-test.
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mechanism for repeat occupancy that is distinct from its transcriptional regulatory role
during the G1-S phase transition.

2.4.3

pRB-repeat association is required for silencing of repetitive
sequence expression.
To investigate the functional role of repeat occupancy by pRB, we performed

RNA-seq on arrested wild type and Rb1S/S MEFs. Total RNA was depleted of rRNA prior
to library construction, and reads were aligned to repeat indices and binned according to
repeat classification and family. The number of reads in each category was normalized to
the total number of aligned reads per sample. Columns display expression from three
separate Rb1S/S MEF preparations as a log2 ratio normalized to the average of three wild
type samples (Figure 2.6A). Rb1S/S MEFs exhibit increased expression of type I and type
II transposable elements (e.g. Gypsy, Mariner/Tc2, LINE_other, RTE, and SINE/ID),
satellites, and simple repeats in all three biological replicates. In two samples, many
families of LTR containing repeats, DNA transposons, LINEs, and SINEs show
widespread de-regulation in mutant MEFs. Collectively, this demonstrates transcriptional
misregulation of repeats that matches the occupancy pattern of pRB among repetitive
sequences. We note variability of expression in sample C5137_E3, however, broad
differences between biological replicates are common to investigations of repeat
sequence expression (Howard et al., 2008; Muotri et al., 2010; Wylie et al., 2016), and
limited misregulation appears specific to this MEF preparation alone.
Representative elements from highly deregulated repeat classes were selected to
further explore pRB-repeat regulation. Mapping sequence reads to instances of LINE-1,
IAP, and major satellite sequences confirms increased read abundance across these
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Figure 2.6: pRB silences repetitive element expression.
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Figure 2.6: pRB silences repetitive element expression.
(A) Heat map of repeat expression from three Rb1S/S MEF preparations relative to the
average of three wild type replicates. RNA-seq reads were aligned to repeat indices,
binned according to repClass and repFamily, and normalized to the total number of
aligned reads in the sample. Expression was quantified as a log2 ratio relative to the
average of three wild type replicates. (B) RNA-seq reads aligned to instances of LINE,
IAP endogenous retrovirus, and major satellite repeats. (C) qRT-PCR of the indicated
repetitive elements in proliferating MEFs plotted as log2 of the ratio with wild type,
using actin as an internal control. Each MEF pair was cultured independently three times
and expression levels for each replicate is shown to illustrate variability in expression
between culture and genotypes. (D) Expression microarrays performed with RNA from
arrested MEFs of the indicated genotypes. Log2 values of mutant/wild type are shown as
a heat map to depict expression levels of endogenous retrovirus detecting probe sets on
the arrays.
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elements (Figure 2.6B). Furthermore, elevated transcript levels from major satellites,
LINE-1 elements, and IAP endogenous retroviruses are readily detectable in arrested and
proliferating cultures of Rb1S/S MEFs by qRT-PCR (Figure 2.6C and 2.7A). Elevated
LINE-1 5' UTR and IAP LTR-containing transcript levels are consistent with full length
element expression (Figures 2.6B and 2.6C). Again, we note that MEFs from embryo
C5137_E3 are refractory to expression in three separate analyses of these cells (Figure
2.6C). Microarray analysis was performed to compare the specificity of endogenous
retroviral expression in Rb1S/S cells with other structure-function mutants of pRB that
disrupt binding to the E2F transactivation domain (Rb1G/G) or to LXCXE motif
containing proteins (Rb1L/L). This analysis reveals increased expression of repeats
specifically in the Rb1S/S mutant and not the other genotypes (Figure 2.6D). Importantly,
expression of canonical E2F target genes appears increased only in Rb1G/G and Rb1L/L
cells (Figure 2.7B), further emphasizing the unique alteration in gene expression found in
Rb1S/S mutants.
These experiments demonstrate that pRB occupancy of repetitive sequences is
functionally important for their silencing, as loss of binding correlates with increased
expression of a wide array of repeats that are detectable using a number of expression
profiling methods. Curiously, many examples of pRB occupancy in Figures 2.1 and 2.4
are fragments of repetitive elements that may not be capable of autonomous expression.
This suggests that this pRB-dependent silencing mechanism is broad and indiscriminate
both in the elements that it silences and their potential for expression.
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Figure 2.7: Distinct transcript expression patterns in Rb1S/S cells.
(A) Expression levels of the indicated repetitive elements was determined by qRT-PCR
in serum starved wild type and Rb1S/S MEFs. Error bars indicate +/- 1 standard deviation
from the mean and an asterisk indicates a significant difference (t-test, P<0.05). (B)
Expression microarrays were performed with RNA isolated from arrested MEFs of the
indicated genotypes. Log2 values of mutant/wild type are shown as a heat map to depict
expression levels of known pRB-E2F target genes.
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2.4.4

H3K27me3 enrichment at repetitive sequences is pRBdependent
DNA methylation and histone modifications contribute to both redundant and

non-redundant silencing of repetitive elements. The contribution of each was assessed in
fibroblasts from our mutant mice. ChIP was used to detect histone tail modifications
regulated by pRB and present at repetitive elements in ES cells. While H4K20me3 and
H3K9me3 enrichment remain unchanged between genotypes at major satellites, LINEs,
and LTR-containing endogenous retroviruses (Figure 2.8A and 2.8B), a prominent
reduction of H3K27me3 appears evident (Figure 2.9A). Beyond methylation, Rb1S/S cells
exhibit elevated H3K9Ac enrichment at these repetitive elements, and derepression by
Trichostatin A further suggests that histone deacetylation functionally contributes to this
regulation (Figure 2.8C). In contrast, H19 and Gapdh maintain equivalent enrichment of
these histone tail modifications between genotypes.
We performed ChIP-seq for H3K27me3 to expand upon the pRB-dependence
observed at repetitive elements by ChIP-qPCR. Similar to pRB, the vast majority of wild
type H3K27me3 peaks reside within intronic and intergenic regions, irrespective of
proliferative status (Figure 2.9B). A number of distinct effects of the Rb1S/S mutation on
H3K27me3 distribution emerge from this data. H3K27me3 reductions are readily
observed in sequence tracks over repeat-rich intergenic regions (Figure 2.9C). Many
canonical genes regulated by H3K27me3, such as in Hox clusters, Cdkn2a, and Sox2,
retain normal H3K27me3 enrichment in Rb1S/S MEFs (Figure 2.9D and 2.8D).
Comparison of H3K27me3 read build-up at wild type peak locations across repeat classes
reveals diminished enrichment in Rb1S/S cells, particularly under arrested growth
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Figure 2.8: The Rb1S/S mutant maintains normal H3K9 and H4K20 lysine
methylation at repeats.
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Figure 2.8: The Rb1S/S mutant maintains normal H3K9 and H4K20 lysine
methylation at repeats.
(A) H3K9me3 ChIP-qPCR was performed using chromatin from wild type and Rb1S/S
MEFs for the indicated repetitive families and unique location controls under arrested
conditions. (B) H4K20me3 ChIP-qPCR of the same repetitive element families in
arrested MEFs. (C) H3K9Ac ChIP-qPCR at the indicated repetitive sequences in arrested
MEFs. For all graphs, error bars indicate +/- 1 standard deviation, an asterisk indicates a
significant difference compared to wild type P≤0.05 by t-test. Wild-type MEFs were
treated with 2.5 μM Trichostatin A for 24 hours and extracts were prepared for western
blotting. Blots show expression of L1 Orf2p and H3K9Ac respectively. (D) Genome
browser tracks display mouse H3K27me3 ChIP-seq reads at Cdkn2a and Sox2 loci.
Genomic co-ordinates are indicated above the tracks. Repeat Masker and RefSeq tracks
are shown below. Red bars denote regions of pRB enrichment (peaks) determined with
MACS. (E) Overall genomic distribution of H3K27me3 ChIP-seq peaks at repetitive
elements is shown for wild type MEFs, and peak retention frequency for Rb1S/S is shown
for both growth conditions. RNA repeats include tRNA, snRNA and others. N=622358
peaks for H3K27me3 in arrested cells, n=539696 peaks for H3K27me3 in proliferating
MEFs.
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Figure 2.9: H3K27me3 enrichment at repetitive elements is pRB-dependent.
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Figure 2.9: H3K27me3 enrichment at repetitive elements is pRB-dependent.
(A) ChIP-qPCR for H3K27me3 at the indicated repetitive and unique targets in arrested
MEFs. Error bars indicate one standard deviation from the mean and an asterisk
represents a significant difference from wild type (P≤0.05 using a t-test). (B) Overall
genomic distribution of H3K27me3 ChIP-seq peaks. Growth conditions are indicated
above pie charts; n=656342 peaks in arrested cells, n=143252 peaks in proliferating cells.
(C) Genome viewer tracks depict H3K27me3 read build up at L1 elements (highlighted
by red boxes). Genomic co-ordinates and scale are indicated above peak tracks. (D)
H3K27me3 distribution at a Hox gene cluster. (E) Heat maps of H3K27me3 read
enrichment per repClass for the indicated growth conditions. Each row represents one
scaled wild type peak location at an element within the repClass and includes ±1 kb of
flanking region. The intensity scale indicates magnitude of read enrichment.
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conditions (Figure 2.9E). However, some individual repeat elements disperse or broaden
their H3K27me3 distribution, and this is more common in proliferating cells. Comparison
of peak intersections at repetitive elements reveals that 75% of wild type H3K27me3
peaks in repeat regions are lost in Rb1S/S chromatin in both arrested and proliferating
conditions (Figure 2.8E). The retention of reads at many repeats in proliferating Rb1S/S
cells (Figure 2.9E) at magnitudes below the threshold of peak calling suggests that
H3K27me3 becomes dispersed, but not altogether lost under proliferating conditions.
This is important because elevated expression levels of repeats in proliferating Rb1S/S
cells (Figure 2.6C) suggests silencing by H3K27me3 is compromised.
These data demonstrate an extremely broad mechanism of heterochromatin
establishment among many distinct repeat element types. To our knowledge, DNA
methylation is perhaps the only other mechanism that is as indiscriminate in its choice of
sequences to silence. Therefore, we investigated the status of DNA methylation in Rb1S/S
MEFs by bisulfite sequencing (Figure 2.10A and 2.10B), to determine if H3K27me3 and
DNA methylation may be functionally related by pRB. Amplification of the same
families of LINE-1 and IAP LTR viruses as in Figure 2.4D and 2.6C bears no obvious
DNA methylation differences. We also cultured wild type and Rb1S/S fibroblasts in the
presence of 5-aza-cytidine to inhibit DNA methylation, and analyzed repeat expression
by qPCR (Figure 2.10C). As expected, repeat sequence expression increases in Rb1+/+
cells but not Rb1S/S MEFs, suggesting that they are already derepressed.
Our data reveals a dramatic loss of H3K27me3 organization at repetitive genomic
sequences. The loss of H3K27me3 is similar in magnitude to loss of pRB recruitment to
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Figure 2.10: Rb1S/S mutant cells retain DNA methylation at repetitive elements.
(A&B) Bisulfite sequencing of MEF DNA for IAP-LTR and LINE-1 families of repeats.
Each row of circles represents a separate clone sequence. Lack of a circle in a particular
row represents the absence of a CpG detected at that position in the clone. Black circles
represent meCpG. (C) qRT-PCR of cDNA from total RNA of vehicle- or 5-aza-cytidinetreated MEFs for the indicated repeat targets. Error bars indicate +/- 1 standard deviation,
with t-test p-value indicated.
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repeat sequences in Rb1S/S fibroblasts. Our data further suggests that alterations to DNA
methylation do not underlie widespread changes to heterochromatin in Rb1S/S cells. For
this reason, we interpret our experiments to be indicative of a mechanism for silencing
repetitive DNA sequences that acts in parallel to DNA methylation in primary fibroblasts.

2.4.5

pRB-chromatin association is required for EZH2 recruitment
to repetitive sequences.
The polycomb repressor 2 complex (PRC2) contains the enhancer of zeste

homologue 2 (EZH2) histone methyltransferase that methylates H3K27 to establish the
trimethylation mark. We explored whether pRB-dependent regulation of EZH2 might
underlie epigenetic and transcriptional changes observed in Rb1S/S cells.
ChIP-seq was used to determine whether EZH2 association at repeat elements
was affected in growth arrested Rb1S/S cells. This analysis reveals that EZH2 also
displays primarily intronic and intergenic distribution (Figure 2.11A). Across all repeat
classes, wild type locations of EZH2 enrichment diminish in Rb1S/S MEFs (Figure
2.11B), with more than 80% of wild type peak intersections at repetitive elements lost in
Rb1S/S fibroblasts (Figure 2.12A). ChIP-qPCR confirms pRB-dependent EZH2
association with chromatin at major satellites, LINEs, and endogenous retroviral
sequences (Figure 2.11C). Since pRB and E2Fs control EZH2 expression (Bracken et al.,
2003; Jung et al., 2010), we confirm that EZH2 levels remain unchanged in Rb1S/S MEFs,
and therefore do not mislead our investigation of function or localization (Figure 2.12B).
pRB-dependent EZH2 localization suggests regulation beyond transcriptional control of
EZH2 at repetitive sequences. Indeed, ChIP-reChIP indicates that EZH2 and pRB colocalize at LINE-1 and IAP LTRs, while chromatin association in Rb1S/S MEFs is
comparable to background (Figure 2.12D). Co-immunoprecipitation demonstrates that
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Figure 2.11: pRB-chromatin association mediates EZH2 recruitment to repetitive
DNA.
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Figure 2.11: pRB-chromatin association mediates EZH2 recruitment to repetitive
DNA.
(A) Overall genomic distribution of EZH2 ChIP-seq peaks in arrested wild type MEFs;
n= 840543 peaks. (B) Heat maps of EZH2 read enrichment per repClass. Each row
represents one scaled wild type peak location at an element within the repClass that
includes ±1 kb of flanking region. Intensity scale indicates magnitude of read enrichment.
(C) ChIP-qPCR for EZH2 at the indicated repetitive elements. (D) ChIP-reChIP for
EZH2 followed by pRB, quantified at the indicated repetitive elements with genetic
knockouts as controls. (E) Two representative genomic regions depict ChIP-seq tracks
for EZH2, pRB, and H3K27me3 in arrested MEFs. Genomic co-ordinates and scale are
indicated above peak tracks. Red boxes highlight peak overlaps across datasets. For all
graphs, error bars indicate one standard deviation from the mean and an asterisk
represents a significant difference from wild type (P≤0.05 using a t-test).
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Figure 2.12: pRB-E2F1 dependent and independent roles for EZH2.
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Figure 2.12: pRB-E2F1 dependent and independent roles for EZH2.
(A) Peak distribution of EZH2 ChIP-seq peaks at repetitive elements is shown for wild
type MEFs, and peak retention frequency for Rb1S/S is shown for both growth conditions.
RNA repeats include tRNA, snRNA and others. N=465495 peaks analyzed. (B) Western
blots of the indicated Polycomb proteins from whole cell extract of P4 MEFs of the
indicated genotypes under the indicated growth conditions. (C) IP-western blot analysis
to detect pRB associated with EZH2 in nuclear cell extracts from the indicated genotypes
of MEFs. (D) ChIP-reChIP for EZH2 followed by pRB quantified at the indicated
repetitive elements. Chromatin was derived from the indicated genotypes. Error bars
indicate one standard deviation from the mean and an asterisk represents a significant
difference from wild type (P≤0.05 using a t-test). (E) Heat maps of EZH2 read
enrichment per repClass that intersect with pRB peaks. Each row represents one scaled
wild-type peak location at an element within the repClass that includes ±1 kb of flanking
region. Intensity scale indicates magnitude of read enrichment. (F) Graph depicting the
percentage peak intersection between pRB and EZH2 as a proportion of total pRB peaks
in wild type chromatin for the indicated repClass categories. (G) Graph showing log2 Δct
values for qRT-PCR of repetitive sequence expression in tumor samples isolated from
Rb1S/S mice.
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both wild type and pRBS bind EZH2 (Figure 2.12C). In addition, ChIP-reChIP reveals
that E2F1 deficiency prevents pRB and EZH2 co-localization to LINE-1, IAP, and major
satellite repeats (Figure 2.12D). Collectively, this suggests a model whereby pRBS can
bind EZH2, but fails to localize to repetitive sequences because of its deficiency for
binding E2F1, while wild type pRB is capable of both EZH2 and E2F1 interactions,
leading to H3K27me3 deposition at repetitive locations (Figure 2.11E).
Our data indicates that pRB, E2F1, and EZH2 are capable of forming a complex
at repetitive genomic regions. However, while peak intersections between pRB and
EZH2 at repetitive sequences in Rb1S/S cells indicate a genetic requirement for pRB to
recruit EZH2, they do not co-localize stoichiometrically (Figure 2.12E and 2.12F). This
suggests that pRB and E2F1 may recruit EZH2 initially, but subsequent spreading of
EZH2 and H3K27me3 may occur independent of pRB.

2.4.6

Rb1S/S mice succumb to spontaneous lymphoma
In order to determine where this repeat silencing mechanism is most relevant, we

assessed repeat expression in tissues of adult mice using qRT-PCR (Figure 2.13A). For
most tissues, expression varies between individuals with no consistent trend relative to
wild type controls. However, four of eight Rb1S/S mice display elevated levels of all
repeats tested in the spleen (F241, F242, F248, and F307), while only one of eight wild
type mice expresses repeats in this tissue (F233). This suggests that pRB dependent
silencing may be most relevant in the spleen. However, a survey of major tissues in these
mice, including the spleen, reveals no obvious histological differences. Given that
expression of repetitive sequences stimulates an immune response to eliminate these
cells, we searched for evidence of interferon activation. Figure 2.13B shows qRT-PCR
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Figure 2.13: Altered chromatin and repeat expression in Rb1S/S splenocytes.
(A) Heat map of repeat element expression in tissues of 6-8 week old wild type and
Rb1S/S mutant mice quantified by qRT-PCR. Log2 ratio of expression is displayed
relative to the average of all wild type measurements for a given element in each tissue.
(B) Heat map of interferon gene expression in splenocytes from the same mice analyzed
above. (C) H3K27me3 and H3 ChIP from freshly harvested splenocytes of 6 week-old
wild type and Rb1S/S mutant mice. Enrichment at the indicated repeat element families
was determined by qPCR. Error bars indicate one standard deviation from the mean (n=3,
an asterisk indicates P<0.05, t-test).
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analysis of Ifn-α and Ifn-β expression in splenocytes. Again, expression varies between
individuals, but we note that two Rb1S/S mice display high level expression of both (F296
and F307), further suggesting that Rb1S/S mice are responding to abnormal repeat
expression in their splenocytes. Conversely, this magnitude of interferon response is
largely absent from wild type mice. Since normal mammalian immune function seeks to
eliminate repeat misexpressing cells, we further sought evidence of altered repression by
investigating H3K27me3 deposition at repetitive sequences in splenocytes. ChIP-qPCR
assays demonstrate that H3K27me3 is reduced at IAP ERVs, LINE-1 elements, and
major satellites, but H3 levels remain comparable between genotypes (Figure 2.13C).
These experiments suggest that H3K27me3 is altered in chromatin from Rb1S/S
splenocytes, and that repeats can be misexpressed, but these cells are likely unable to
accumulate in young adult mice with a functional immune system.
To determine the long-term consequences of the Rb1S mutation, we generated
cohorts of Rb1S/S mutant mice and wild type siblings to monitor over the course of their
lifetime for the manifestation of pathology. Mutant mice exhibit a significantly reduced
tumor free survival with a median lifespan of 576 days (Figure 2.14A). Necropsy and
histopathological analysis reveals that the majority of mice succumb to lymphomas,
particularly in the spleen and mesenteric lymph node (Figure 2.14B). Examples of lesions
evident upon necropsy are shown in Figure 7C as well as the normal abdominal cavity of
an unaffected wild type mouse at 2 years of age. The corresponding histology for each
example is shown (Figure 2.14D). In addition, qRT-PCR of RNA derived from these
tumor samples indicates that diverse repetitive sequences are expressed in these
malignancies (Figure 2.12G). This suggests that pRB’s ability to form complexes with
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Figure 2.14: Aged Rb1S/S mice are tumor-prone.
(A) Kaplan-Meier plot of tumor free survival for mice of the indicated genotypes aged
until animal protocol endpoints. Tick marks indicate animals necropsied at intermediate
ages. Mutant mice are significantly more cancer prone than wild type (log rank test,
P<0.05). (B) The table indicates anatomical location and cancer type listed by frequency
of occurrence. (C) Images of the peritoneal cavity upon necropsy for the indicated
animals. A white arrow indicates an abnormal mass in the spleen of mouse C6217. A
dashed line highlights the mesenteric lymph node of mouse C6209. A white arrow
indicates abnormal liver and a black arrow indicates a normal lobe in mouse C5360. (D)
H&E staining of tissue sections from the abnormality indicated in the mutant animals
above. A black arrow indicates the lymph node in mouse C6209. The scale bars indicate
300µm.
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E2F1 at repetitive sequences and establish H3K27me3 dependent silencing is highly
relevant to its tumor suppressive functions.
Collectively, our work suggests a model in which pRB recruits EZH2 to repeat
sequences where it catalyzes H3K27me3 to silence expression, and a point mutation in
pRB that blocks localization to these sequences prevents recruitment of EZH2 and causes
dispersion of H3K27me3. Endogenously, this mechanism is important in splenocytes
where deregulated expression of repeats is most detectable, and these cells eventually
give rise to lymphomas in older Rb1S/S mice.

2.5

Discussion

Our data reveals a mechanism in which pRB and EZH2 co-operate to establish
H3K27me3 that silences expression of genomic repeat sequences. This mechanism is
largely indiscriminate as it silences tandem repeats, such as simple sequence repeats and
satellites, in addition to retrotransposons. These characteristics indicate that pRB-EZH2
dependent silencing of repeats plays a broad but previously unappreciated role in genome
organization.
Investigation of Polycomb-based repeat regulation by H3K27me3 in mammals
primarily concerns critical steps of early embryonic development (Leeb et al., 2010;
Macfarlan et al., 2012). Misregulation typically manifests in defects that prevent
embryonic development before implantation (Leeb et al., 2010; Macfarlan et al., 2012),
or that have overt consequences in adult mice (Li et al., 2015). Lack of developmental
impediments in Rb1S/S mice, and retention of H3K27me3 at developmentally regulated
loci, such as Hox genes and Sox2, suggests the pRB-EZH2 complex must be recruited to
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repeats through a mechanism that is distinct from previous studies, or this pRB dependent
mechanism is not functional in cells during early development.
Comprehensive understanding of Polycomb function requires detailed elucidation
of chromatin recruitment mechanisms (Bauer et al., 2015; Casa and Gabellini, 2012).
Previous studies demonstrate that non-coding transcripts can target Polycomb repressor
complexes to specific loci, as observed upon X-chromosome inactivation (Blackledge et
al., 2015). Based on the co-immunoprecipitation of pRB and EZH2 and their cooccupancy of repeats by ChIP-reChIP, it is likely that pRB directly recruits EZH2 to
repeats. Diminished pRB binding to repeats in Rb1S/S cells resulted in loss of EZH2 and
H3K27me3 peaks, but our data also suggests that EZH2 may not stably associate with
pRB at all of these locations and may spread H3K27me3 heterochromatin without it.
Beyond non-coding RNAs, sequence specific transcription factors can recruit
Polycomb to specific genomic locations to initiate such nucleation and spreading (Bauer
et al., 2015; Casa and Gabellini, 2012). Our study indicates that E2F1 can fulfill this role,
and while some repeats contain consensus E2F elements (Montoya-Durango et al., 2009),
E2F1 site selection appears increasingly diverse in the post-genomic era. Early ChIP-chip
experiments revealed considerable heterogeneity in binding sites (Bieda et al., 2006), and
sequence-independent roles in DNA damage recognition and repair further suggest that
E2F1 is not simply a sequence specific transcription factor (Biswas and Johnson, 2012).
Our initial identification of pRB’s unique interaction with E2F1 was based on the
inability of this complex to recognize a consensus E2F promoter element (Dick and
Dyson, 2003). Major satellite repeats exemplify this in vivo where GC-rich consensus
E2F elements are missing, but pRB and E2F1 bind cooperatively such that E2F1 binding
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is greatly diminished without pRB (Coschi et al., 2014). Therefore, pRB-E2F1
interactions underlie recruitment of Polycomb to repeats, however a recognition
mechanism for E2F1 at the variety of repeat sequences identified remains unclear and is
highly reminiscent of searches for Polycomb response elements in mammalian gene
promoters (Bauer et al., 2015)
The cancer susceptibility of Rb1S/S mice suggests a role for pRB-EZH2 in genome
maintenance and tumor suppression. This begs the question of how this mechanism
functions endogenously, particularly since up regulation of repeat sequences in the spleen
appeared quite variable. We note that elevated repetitive elements are detectable in
splenocytes from cancer prone Tlr3, Tlr7, and Tlr9 triple deficient mice (Yu et al., 2012),
even though chromatin dependent repression mechanisms are wild type. This implies that
immune surveillance acts to eliminate wild type cells that sporadically express repetitive
elements on an ongoing basis, even if their repressive mechanisms are normal. This may
explain the high degree of variability in repeat expression found in cells deficient for
DNA methylation or histone methylation dependent repressive mechanisms (Howard et
al., 2008; Muotri et al., 2010; Wylie et al., 2016). In this way, splenocytes of Rb1S/S mice
may be poised to over express repeats, but are eliminated by immune detection
mechanisms, preventing their accumulation and consistent detection of repeat expression.
It is difficult to conclude that repeat expression alone causes cancer in Rb1S/S
mice. However, there are a number of reasons to expect that a pRB-E2F1-EZH2 complex
has cancer relevant properties. First, the preference for lymphomas and age of onset in
Rb1S/S mice phenotypically parallels E2f1-/- mice (Yamasaki et al., 1996). Missense
alleles in human RB1 are rare, so it is not surprising that the Rb1S allele is absent from
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cancer genome datasets. However, a low penetrance RB1 family has been reported to
possess exon 24 and 25 deletions (Bremner et al., 1997) that eliminate pRB’s unique
binding domain for E2F1(Cecchini and Dick, 2011; Julian et al., 2008). Similarly,
multiple instances of D295 substitutions in DP1 (Munro et al., 2014) indicate that the
unique contact point for E2F1/DP1 with pRB is directly targeted in human cancers.
Lastly, other Rb1 targeted strains that compromise E2F transcriptional control at
canonical cell cycle target genes, such as Rb1G/G (Cecchini et al., 2014), or that are prone
to unstable genomes related to defective chromatin condensation, as in Rb1L/L and
Rb1NF/NF mice (Coschi et al., 2010; Vormer et al., 2014), are not spontaneously cancer
prone. Since only Rb1S/S cells misexpress repeat sequences among these genotypes, and
repeat expression is most pronounced in the cancer prone tissue of Rb1S/S mice, these data
point to a very strong correlation between defective pRB-EZH2 repeat suppression and
cancer incidence.
Likely the most significant implication for our work is the relationship between
RB1 status and the effects of new EZH2 inhibitors. We anticipate that EZH2 inhibitors
will cause widespread derepression of repetitive sequences in pRB positive cancers as
reported for inhibitors of DNA methylation (Chiappinelli et al., 2015; Roulois et al.,
2015), and this may offer a new pathway to sensitize tumors to immunotherapy.
Furthermore, our work suggests EZH2 inhibitors may have activity as anti-viral agents as
they may awaken latent viral genomes. This manuscript reveals an exciting new
connection between a canonical tumor suppressor and heterochromatin formation that
further supports repetitive element silencing as a cancer relevant process.
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Chapter 3

3

Disruption of CDK-resistant chromatin association by
pRB causes DNA damage, mitotic errors, and reduces
Condensin II recruitment
3.1

Abstract

Organization of chromatin structure is indispensible to the maintenance of genome
integrity. The retinoblastoma tumor suppressor protein (pRB) mediates both
transcriptional repression and chromatin organization, but the independent contributions
of these functions have been difficult to study. Here, we utilize a synthetic Rb1 mutant
allele (F832A) that maintains pRB association at cell cycle gene promoters, but disrupts a
cyclin-dependent kinase (CDK)-resistant interaction with E2F1 to reduce occupancy of
pRB on intergenic chromatin. Reduced pRB chromatin association increases spontaneous
γH2AX deposition and aneuploidy. Our data indicates that the CDK-resistant pRB-E2F1
scaffold recruits Condensin II to major satellite repeats to stabilize chromatin structure in
interphase and mitosis. In its absence, pericentromeric major satellite repeats are enriched
with γH2AX, but LINE and ERV repeats remain free of this DNA damage marker. This
suggests that DNA damage phenotypes in Rb1 F832A mutant cells are mechanistically
distinct from silencing of repetitive sequence expression.

3.2

Introduction

Regulated alterations in chromatin structure during the cell cycle ensure coordination
of transcription, DNA replication, and segregation of chromosomes in mitosis.
Perturbations to broad mechanisms of chromatin organization that disrupt the careful
coordination of these processes are often observed in concert with genome instability
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(Papamichos-Chronakis and Peterson, 2013). This state of instability, characterized by
persistent DNA damage, often precedes tumorigenesis (Jackson and Bartek, 2009). In this
regard, it is not surprising that genes encoding broad organizers of chromatin structure
are often classified as tumor suppressors.
In human cancer, a frequent target for disruption or misregulation is the
retinoblastoma protein (pRB) (Dyson, 2016). Primary fibroblasts deficient for pRB
exhibit relaxed chromatin structure (Herrera et al., 1996), along with replication defects
and reduced chromatin compaction in prophase and chromosome segregation errors
(Coschi et al., 2014; Coschi et al., 2010; Longworth et al., 2008; Manning et al., 2010;
Manning et al., 2014). These changes are often accompanied by manifestations of
genome instability, such as aneuploidy and widespread DNA damage (Coschi et al.,
2014; Manning et al., 2014; van Harn et al., 2010). However, since pRB exerts
transcriptional control over S- and M- phase cell cycle targets through E2Fs (Hernando et
al., 2004; Schvartzman et al., 2011), genetic models of pRB deficiency may not
distinguish the mechanistic contributions of pRB chromatin regulation from pRB-E2F
transcriptional control in the maintenance of genome integrity. Thus, the ability to
determine contributions of pRB chromatin organization to maintenance of genome
stability requires specific loss-of-function models that maintain E2F transcriptional
control and cell cycle regulation.
To regulate chromatin structure, pRB serves as a scaffold for a number of regulatory
complexes that methylate DNA, modify histone tails, or mediate topological remodeling
of nucleosomes (Longworth and Dyson, 2010). DNA-binding proteins, such as
transcription factors, mediate region-specific pRB-chromatin association (Talluri and
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Dick, 2012). This recruitment is predominantly mediated by E2F transcription factors.
However, pRB-E2F complexes dissociate at the G1-S transition in response to cyclindependent kinase (CDK) phosphorylation. Recent evidence indicates that pRB uses an
alternate CDK-resistant interaction with E2F1 to associate with repetitive elements
(Calbo et al., 2002; Cecchini and Dick, 2011; Coschi et al., 2014; Ianari et al., 2009;
Ishak et al., 2016). Germline disruption of this interaction abrogates EZH2-mediated
facultative heterochromatinization at repetitive elements in concert with repeat
misexpression and lymphomagenesis in mice (Ishak et al., 2016). The cancer
susceptibility observed upon loss of CDK-resistant pRB-chromatin association merits
investigation into whether this pRB-E2F1 interaction might underlie other pRBdependent activities that impact genome integrity.
Here, we report that disruption of pRB’s unique interaction with E2F1 causes the
accumulation of γH2AX foci, aneuploidy, increased RPA phosphorylation, and mitotic
defects. Importantly, E2F target genes involved in DNA replication and mitosis remain at
normal expression levels. We demonstrate that cells bearing an F832A mutation in Rb1
(Rb1S) exhibit impaired chromatin recruitment of the Condensin II complex specifically
at genomic locations where γH2AX accumulates. This mechanism further suggests that
chromatin organization is an indispensible facet of pRB-mediated tumor suppression.

3.3
3.3.1

Experimental Procedures
Cell culture

Gene targeted mouse strains bearing a null allele of Rb1 (Rb1tm1Tyj) and an F832A point
mutation to disrupt pRB’s unique interaction with E2F1 (Rb1S, or Rb1tm3Fad) have been
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previously described (Ishak et al., 2016; Jacks et al., 1992). Primary murine embryonic
fibroblasts (MEFs) were isolated and cultured from E13.5 embryos of the desired
genotypes according to established procedures (Thwaites et al., 2016). All experiments
were performed on passage 4 (P4) cells.

3.3.2

Fluorescence microscopy

Immunofluorescence was conducted as previously described (Coschi et al., 2014).
Briefly, 2.5x105 MEFs were seeded per confocal dish, incubated 24h, washed 3x for 5
minutes in 1x PBS, fixed by incubation with 4% paraformaldehyde in 1x PBS for 10
minutes at room temperature, then washed and stored at 4°C. To immunostain, cells were
permeabilized for 10 minutes with 0.3% Triton X-1000 in 1xPBS (PBS-T), blocked for 1
hour at room temperature with 5% goat serum in PBS-T, incubated one hour with mouse
anti-Phospho histone H2A.X Ser139 (05-636, Millipore) diluted 1:400 in PBS-T, washed,
and incubated one hour in goat anti-mouse Alexa Fluor 594 secondary antibody diluted
1:800 in PBS-T. Cells were washed 3x for 5 minutes with PBS-T, then incubated 5
minutes with DAPI in PBS-T. Stained MEFs were washed 3x with PBS-T, twice with 1x
PBS, then mounted with a coverslip using SlowFade® Gold antifade reagent (S36937,
Life Technologies). Fluorescence was visualized using an Olympus Fluoview FV1000
confocal microscope system, with images compiled using Olympus Fluoview FV1000
Viewer. γH2AX foci were quantified using the focinator program (Oeck et al., 2015) with
fixed thresholds and parameters maintained across all groups in a given experiment.
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3.3.3

Flow cytometry

Asynchronous or serum starved MEFs were ethanol-fixed, stained with propidium iodide,
treated with RNase, strained, and analyzed by flow cytometry on a Beckman-Coulter
EPICS XL-MCL (Cecchini et al., 2012).

3.3.4

Detection of RNA and protein levels

RNA levels were determined by Affymetrix Mouse Gene 1.0 Array as previously
described using rRNA-depleted total RNA from serum starved P4 MEFs (Cecchini et al.,
2014) (Ishak et al., 2016). Log2 values of mutant/wild-type expression determined with
Partek Genomics Suite were plotted as heat maps using matrix to PNG at
chibi.ubc.ca/matrix. Array CEL files are available at GSE85640 and GSE54924. To
assess protein levels, whole-cell lysates and chromatin fractions were generated as
previously described (Ishak et al., 2016), resolved by SDS-PAGE, and immunoblotted
using the following antibodies: RPA32 (A300-244A, Bethyl labs), RPA32 pSer33 (A300246A, Bethyl labs), H3, (ab1791, Abcam), Actin (A2066, Sigma), PCNA (F-2 Santa
Cruz), Mcm3 (4012S, Cell Signaling), Mcm7 (H-5, Santa Cruz), BubR1 (C-20, Santa
Cruz), Cdk1 (ab7953 abcam), Mad2 (C-19, Santa Cruz), CAP-D3 (Coschi et al., 2010),
SMC2 (Coschi et al., 2014).

3.3.5

Chromatin immunoprecipitation and ChIP-seq analysis

Chromatin immunoprecipitation experiments and analyses were conducted as previously
described (Ishak et al., 2016). Briefly, cross-linked chromatin fragments were pre-cleared
with protein G Dynabeads for immunoprecipitation with ChIP antibodies. Cross-links
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were reversed at 65°C followed by DNA isolation. For ChIP-reChIP experiments,
crosslinks were maintained following the first immunoprecipitation. Protein-DNA
complexes were eluted, and subjected to a second immunoprecipitation with a different
antibody. DNA was isolated as described for single-IP ChIP. deepTools was used to
generate heat maps depicting ChIP-seq read enrichment at wild-type peak locations.
bamCompare was used to normalize ChIP to input reads, then computeMatrix was used
to determine read enrichment at wild-type repeat peak intersects with the mm9
RepeatMasker index from UCSC Table Browser. heatMapper was used to plot
enrichment per peak location (Ramirez et al., 2014). Reads are available at GSE85640.
ChIP antibodies used were anti-phospho histone H2A.X Ser139 (07-164, Millipore), antiCAP-D3 (Coschi et al., 2010), and a previously described cocktail of pRB antibodies
(Cecchini et al., 2014). ChIP-qPCR primer sources have been previously described
(Cecchini 2014, Ishak 2016 references). Sequences 5- to 3' are as follows: PCNA_E2F_F
CAGAGTAAGCTGTACCAAGGAGAC, PCNA_E2F_R
CGTTCCTCTTAGAGTAGCTCTCATC, PCNA_-2kb_F
CATCAGTGAATACGTCTCTGTTCCA, PCNA_-2kb_R
CTGCTTCTCAGTTGTTTTAGGAAGG, Maj_F
GACGACTTGAAAAATGACGAAATC, Maj_R
CATATTCCAGGTCCTTCAGTGTGC, L1 5' UTR_F
CTGCCTTGCAAGAAGAGAGC, L1 5' UTR_R AGTGCTGCGTTCTGATGATG, IAP
LTR_F CTGACAGCTGTGTTCTAAGTGGTAAACAAA, IAP LTR_R
AGAACACCACAGACCAGAATCTTCTGC
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3.3.6

Video Microscopy

Video microscopy was conducted as previously described (Coschi et al., 2010). Briefly,
MEFs infected with ecotropic retroviruses carrying pBABE-H2B-GFP packaged in
Bosc23 cells were plated into glass-bottom tissue culture dishes in phenol-free DMEM
with 5% FBS, penicillin, streptomycin, and glutamine. Cells were maintained at 37°C
with 5% CO2 as phase-contrast and fluorescent images were captured every 3 minutes for
15 hours by a DMI 6000b Leica microscope. Images were assembled into movies and
analyzed for mitotic errors.

3.4
3.4.1

Results
The Rb1S mutation causes defects in genome integrity

To assess the contribution of pRB-E2F1 interactions in chromatin association and its
effects on genome stability, we utilized a previously described mutation (F832A, called
Rb1S) that disrupts pRB’s unique C-terminal interaction with the E2F1 marked box
domain (Cecchini and Dick, 2011; Coschi et al., 2014; Ishak et al., 2016). ChIP-sequence
of pRB from wild type and Rb1S/S cells was analyzed. Alignment of pRB ChIP-seq reads
reveals locations of pRB enrichment within repetitive elements throughout the genome
and these are lost in ChIP-seq using pRBS (Figure 3.1A). Strikingly, this pattern of repeat
occupancy by pRB is relatively preserved under proliferating conditions. In contrast, pRB
ChIP-qPCR demonstrates that pRBS retains occupancy at cell cycle and E2F regulated
promoters, such as Pcna, at levels comparable to that of wild-type pRB (Figure 3.1B)
(Ishak et al., 2016). Therefore, in contrast to previous models of pRB-deficiency,
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Figure 3.1: Disruption of pRB association with repetitive sequences.
(A) Heat maps display scaled pRB ChIP-seq read build ups. Wild-type pRB read build
ups are shown for mm9 RepeatMasker index locations. Each row contains ± 0.5 kb of
flanking sequence surrounding the scaled reads. Intensity scales on right indicate the
magnitude of read enrichment over input control. Heat maps of Rb1S/S mutant ChIP-seq
reads display occupancy at the analogous wild type positions under arrested and
proliferating conditions. (B) pRB ChIP-qPCR analyzing amplicons at the Pcna
transcriptional start site (TSS) and 2 kb 5' of Pcna. Error bars indicate one standard
deviation from the mean, and an asterisk represents a significant difference from wild
type (n = 3, P≤0.05 by t-test).
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the Rb1S mutation permits assessment of post-G1 pRB-chromatin regulatory activities
independent of E2F cell cycle gene association and regulation.
We investigated a number of broad measures of genome integrity in Rb1S/S MEFs
relative to controls. Since Rb1-/- cells exhibit aneuploidy with increasing rounds of cell
division (Srinivasan et al., 2007), we sought to determine whether loss of pRB-chromatin
association at non-cell cycle genes could cause a similar effect. To assess cellular DNA
content, proliferating and serum-starved MEFs were stained with propidium iodide and
analyzed by flow cytometry. DNA content greater than the 4N peak was quantified to
determine the proportion of aneuploid cells. In accordance with previous reports, Rb1-/MEFs exhibit significantly elevated levels of >4N DNA. Intriguingly, Rb1S/S MEFs also
exhibit increased levels of >4N DNA relative to wild-type MEFs under arrested and
proliferating growth conditions, albeit at levels less than those of Rb1-/- MEFs (Figure
3.2A).
Another broad manifestation of genome instability observed upon pRB loss is the
emergence of γH2AX foci in fluorescence microscopy experiments. Immunofluorescence
revealed increased γH2AX foci in proliferating Rb1S/S MEF cultures comparable in
magnitude to Rb1-/- MEFs, with approximately 10% of nuclei displaying 5 or more foci
(Figure 3.2B and 3.2C). Increased γH2AX foci together with elevated >4N DNA content
in Rb1S/S cells suggests pRB-E2F1 complexes might mediate post-G1 functions. Post-G1,
pRB reduces DNA damage through mitigation of replication stress via mechanisms that
remain poorly understood (Bester et al., 2011; Coschi et al., 2014; Manning et al., 2014).
To explore the effects of reduced pRB chromatin association on replication, we assessed
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Figure 3.2: Loss of genome integrity in Rb1S/S mutant cells.
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Figure 3.2: Loss of genome integrity in Rb1S/S mutant cells.
(A) Cells were stained with propidium iodide and analyzed by flow cytometry for DNA
content. The histogram shows gates to demarcate cells with >4N DNA content. 4N DNA
content was determined for the indicated genotypes of cells. Error bars indicate one
standard deviation from the mean, and an asterisk represents a significant difference from
wild type compared within the same growth condition (n = 3, P≤0.05 by t-test). (B)
Immunofluorescence microscopy of proliferating MEFs stained for γH2AX (red) and
DAPI (blue). White boxes indicate regions shown at increased magnification within the
inset. Scale bars indicate relative magnification. (C) The number of γH2AX foci per
nucleus was quantified and compared among three biological replicates per genotype
using a χ2 test (Rb1+/+ n = 1054, Rb1S/S n = 744, Rb1-/- n = 602 total nuclei analyzed). (D)
Western blots show RPA32 pSer33 levels for the indicated genotypes from arrested and
proliferating MEFs. The Actin blot serves as a loading control. (E) RPA32 pSer33 and
RPA32 western blots of chromatin fractions from proliferating MEFs. Histone H3 blot
indicates loading.
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relative phosphorylation levels of the single-strand DNA binding protein RPA. Western
blots of whole cell extracts reveal increased levels of RPA32 pS33 under proliferating
conditions relative to arrested wild-type MEFs. This proliferation-dependent RPA32
pS33 increase appears further elevated in Rb1S/S MEFs relative to control cells (Figure
3.2D). Strikingly, western blots of chromatin fractions revealed that the elevated RPA32
pS33 in mutant MEFs can be detected on chromatin at levels comparable to that of Rb1-/MEFs (Figure 3.2E).
In pRB deficient cells, misregulation of E2F transcriptional control of DNA
replication components contributes to aneuploidy (Srinivasan et al., 2007). However, in
accordance with pRBS association with cell cycle promoters in ChIP experiments,
microarray analysis revealed normal regulation of E2F targets involved in DNA
replication in arrested Rb1S/S MEFs (Figure 3.3A). In contrast, Rb1-/- MEFs exhibited
deregulation of DNA replication components under the same culture conditions (Figure
3.3A). Beyond mRNA levels, western blots of whole cell extracts confirmed expression
levels of DNA replication components in Rb1S/S MEFs paralleled those in wild-type
MEFs under both arrested and proliferating conditions, and contrasted with the
pronounced misregulation evident upon complete loss of pRB expression (Figure 3.3B).
Collectively, these observations suggest that reduced pRB-chromatin association
under proliferating growth conditions increases the frequency of events that can
compromise genome integrity. Expression analysis suggests that these effects in Rb1S/S
MEFs are independent of E2F transcriptional control of DNA replication genes.
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Figure 3.3: Normal expression of DNA replication targets of pRB-E2F.
(A) Expression microarrays were performed with RNA from serum-starved MEFs of the
indicated genotypes and wild type controls (n = 3). For each gene listed, corresponding
log2 values of each mutant replicate vs. wild type is shown as a heat map. (B) Western
blots indicate PCNA, Mcm3, and Mcm7 levels detected in whole-cell extracts from
arrested and proliferating MEFs. The Actin blot serves as a loading control.
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3.4.2

Rb1S mutant cells exhibit defects in mitosis.

Beyond replication, pRB maintains proper chromosome segregation through
coordination of multiple mitotic processes such as the regulation of E2F-activated spindle
assembly checkpoint targets, and regulation of chromosome condensation (Manning and
Dyson, 2012). We investigated whether the Rb1S mutation affected mitosis. To visualize
mitotic progression, wild-type and mutant MEFs were transduced with GFP-tagged H2B
using viral delivery, and subjected them to live-cell video microscopy. Analysis of Rb1S/S
cells revealed a marked defect in chromosome condensation apparent in prophase that
frequently impeded chromosome congression at metaphase (Figure 3.4A and 3.4B). We
next analyzed mitotic chromosome segregation. Figure 3.4C shows examples of normal
mitotic stages and cell division observed by video microscopy in wild-type MEFs. These
microscopy experiments revealed numerous mitotic aberrations present in Rb1S/S MEFs
such as chromosome bridges in anaphase, partial segregation of chromosomes, as well as
missegregation of all chromosomes to one daughter, or failure of cytokinesis leading to
binucleated cells (Figure 3.4D and 3.4E). Ultimately, the majority of mitotic Rb1S/S MEFs
fail to faithfully segregate duplicated chromosomes to their daughter cells, while over
90% of wild-type MEFs displayed proper mitotic progression in this assay (Figure 3.4E).
Mitotic errors such as lagging chromosomes and missegregation events contribute to
the generation of micronuclei (Holland and Cleveland, 2012). To determine whether
mitotic errors in Rb1S/S cells were associated with the accumulation of micronuclei, MEFs
were fixed and stained with DAPI for fluorescence-based visualization. Quantification of
micronuclei revealed a significant increase in Rb1S/S cells relative to wild type (Figure
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Figure 3.4: Defective mitosis in Rb1S/S mutant cells.
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Figure 3.4: Defective mitosis in Rb1S/S mutant cells.
Mitosis was investigated by video microscopy experiments using MEFs transduced with
H2B-GFP (Rb1+/+ n = 19, Rb1S/S n = 15). (A) Merged images of phase-contrast and GFP
channels display examples of chromosome condensation in prophase for indicated
genotypes. (B) Quantitation of the frequency of condensation errors observed in wild
type and Rb1S/S MEFs. (C) Merged images of phase-contrast and GFP channels display
examples of normal mitotic stages observed in wild type cells are shown. (D) Merged
images of phase-contrast and GFP channels to demonstrate examples of defective
anaphase and cytokinesis observed by video microscopy. (E) Quantitation of segregation
events observed in wild type and Rb1S/S MEFs. (F) Fluorescence microscopy of
proliferating MEFs stained with DAPI (blue). White arrows demark examples of
micronuclei while scale bars indicate relative magnification. (G) Quantitation of
micronuclei frequency visualized by immunofluorescence microscopy. Error bars
indicate one standard deviation from the mean, and an asterisk represents a significant
difference from wild type (P≤0.05 by t-test, n = 3).
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3.4F and 3.4G). However, the increase observed in mutant cells does not exceed the
magnitude of micronuclei present in Rb1-/- cells (Figure 3.4G).
We next assessed whether misregulation of E2F mitotic target gene expression might
underlie the mitotic errors observed upon reduction of pRB-chromatin association. Akin
to DNA replication components, microarray analysis revealed normal expression of E2F
mitotic checkpoint targets in Rb1S/S MEFs that contrasted with the misexpression
observed in Rb1-/- MEFs (Figure 3.5A). Western blots of whole cell extracts confirmed
that expression levels of mitotic checkpoint proteins in Rb1S/S MEFs resembled
expression levels observed in wild-type fibroblasts. Accordingly, Rb1-/- cells exhibit
misexpression of E2F mitotic checkpoint targets at the protein level (Figure 3.5B).
Overall, lack of mitotic checkpoint misexpression in the presence of mitotic errors
suggests that pRB-chromatin association facilitates mitotic progression independently of
E2F transcriptional control.

3.4.3

pRB-E2F1 recruits Condensin II to major satellites to
mitigate DNA damage.
In light of the post-G1 defects apparent upon diminished pRBS chromatin

association, we sought to identify a pRB-dependent mechanism that could link increased
γH2AX, increased RPA32 pS33, and mitotic defects observed in Rb1S/S cells. Since pRB
serves as a recruitment factor for numerous chromatin regulators including Condensin II
(Coschi et al., 2014; Coschi et al., 2010; Longworth et al., 2008), we investigated its
recruitment to sites of γH2AX deposition. First, to determine whether Condensin II
exhibited sensitivity to diminished pRB-chromatin association, we assessed the
expression of Condensin II subunits. Western blots of whole cell extracts from arrested
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Figure 3.5: Normal expression of mitotic pRB-E2F target genes.
(A) Expression microarrays were performed with RNA from serum-starved MEFs of the
indicated genotypes and wild type controls (n = 3). For each gene listed, corresponding
log2 values of each mutant replicate vs. wild type is shown as a heat map. (B) Western
blots indicate BubR1, Mad2, and Cdk1 levels detected in whole-cell extracts from
proliferating MEFs. The Actin blot serves as a loading control.
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and proliferating MEFs revealed no differences in CAP-D3 and SMC2 expression in
mutant cells relative to wild type controls (Figure 3.6A). We next assessed whether the
Rb1S mutation affected Condensin II recruitment to chromatin. Western blots of
chromatin fractions revealed that relative to the arrested state, both CAP-D3 and SMC2
exhibited increased chromatin loading in proliferating wild-type MEFs. Notably, this
proliferation-dependent increase in Condensin II chromatin loading is diminished in
Rb1S/S cells (Figure 3.6B). We then used ChIP-reChIP to determine whether reduced
Condensin II loading on chromatin in mutant cells was due to a direct pRB-mediated
recruitment mechanism. ChIP for CAP-D3 followed by ChIP for pRB confirms that
CAP-D3 localizes with pRB to pericentric major satellite repeats in wild type MEFs.
pRB-CAP-D3 co-recruitment is significantly reduced in Rb1S/S MEFs, consistent with the
global reduction of Condensin II loading observed in chromatin fractions (Figure 3.4C).
Condensin II-mediated regulation of replication and chromosome condensation
requires chromatin loading. We hypothesized that genomic locations of pRB-dependent
Condensin II association, such as pericentric repeats, would be particularly sensitive to
accumulation of γH2AX upon reduction of Condensin II recruitment. ChIP-qPCR
demonstrates a relative increase in γH2AX at major satellite repeats in proliferating
Rb1S/S MEFs, while γH2AX levels in wild-type MEFs do not exceed background levels
(Figures 3.6D). By comparison, γH2AX ChIP-qPCR experiments demonstrated that
DNA damage is not increased at LINE1 or endogenous retroviral repeats in Rb1S/S cells
(Figure 3.6E and 3.6F). This indicates that only specific genomic locations accumulate
γH2AX in response to the Rb1S mutation rather than all repeat locations occupied and
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Figure 3.6: Recruitment of CAP-D3 by pRB mitigates DNA damage at
pericentromeric major satellite repeats.
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Figure 3.6: Recruitment of CAP-D3 by pRB mitigates DNA damage at
pericentromeric major satellite repeats.
(A) CAP-D3 and SMC2 levels were detected by western blotting whole-cell extracts
from arrested and proliferating MEFs. The Actin blot serves as a loading control. (B)
CAP-D3 and SMC2 western blots of chromatin fractions. Coomassie-stained histones are
used as a loading control. (C) CAP-D3-pRB ChIP-reChIP was performed using
chromatin from proliferating MEFs and occupancy was quantified at pericentromeric
major satellite repeats by qPCR. Error bars indicate one standard deviation from the
mean, and an asterisk represents a significant difference from wild type (n = 3, P≤0.05 by
t-test). (D) γH2AX ChIP-qPCR was performed using chromatin from proliferating MEFs
and quantified at pericentromeric major satellite repeats and normalized to IgG ChIP
performed in parallel from same chromatin preparation. (E and F) γH2AX ChIP-qPCR as
in D except occupancy was quantitated at L1 5' UTRs and IAP LTRs.
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regulated by pRB. Overall, site-specific γH2AX accumulation at locations of pRBCondensin II loss in Rb1S/S MEFs suggests that the CDK-resistant pRB-E2F1 complex
mediates Condensin II recruitment to pericentromeric repeats to support genome
integrity. Loss of this recruitment event is associated with the onset of DNA damage and
mitotic errors that are prevalent in Rb1S/S MEFs, and the contributions of this mechanism
to cancer susceptibility in Rb1S/S mice is likely significant.

3.5

Discussion

The original null alleles of Rb1 in mice revealed that it was indispensable to the
maintenance of genome integrity (Zheng et al., 2002). However, deregulation of E2F cell
cycle targets concurrent with loss of genome stability hindered the ability to assess
whether pRB could maintain genome integrity independent of E2F transcriptional
control. Here, we utilized a synthetic Rb1 mutant allele that maintains pRB association at
E2F cell cycle targets, but reduces overall pRB-chromatin association at intergenic
regions (Ishak et al., 2016). We demonstrate that cells from these mice possess inherently
unstable genomes characterized by markers of DNA damage, replication abnormalities,
and aneuploidy.
Elevated RPA32 pS33 in Rb1S/S chromatin is suggestive of DNA replication defects.
pRB-E2F1-dependent Condensin II recruitment prevents many features that are
characteristic of ‘under replication’ of pericentric repeats (Coschi et al., 2014; Harrigan et
al., 2011; Lukas et al., 2011). It remains to be explored whether the pRB-E2F1 scaffold
underlies other pRB interactions with replication components that may also contribute to
spontaneous DNA damage. pRB restricts DNA replication initiation and progression
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through its interaction with Mcm7 and its ability to suppress DNA polymerase α and Ctf4
recruitment to replisomes (Borysov et al., 2015). It has also been shown that pRB
associates with Orc1 at replication origins (Avni et al., 2003; Mendoza-Maldonado et al.,
2010). Finally, pRB can displace PCNA to halt progression of the replication fork
(Braden et al., 2006). If the pRB-E2F1 scaffold mediates these interactions, it is possible
that they also contribute to RPA32 pS33 and γH2AX at pericentric repeats.
We note a significant failure of Rb1S/S cells to condense chromosomes that precedes
numerous chromosome segregation defects. These defects parallel mitotic errors
observed in other models that are deficient for pRB-Condensin II recruitment to
chromatin (Coschi et al., 2010; Longworth et al., 2008; Manning et al., 2010).
Collectively, these data suggest that pRB-E2F1 forms a scaffold to permit Condensin II
interaction with the pRB LxCxE binding cleft. Despite characterization of chromatin
recruitment, mechanistic details of pRB-Condensin II association remain poorly
understood. However, these phenotypes and the ensuing lymphoma in Rb1S/S mice has
intriguing similarities to recent studies examining a hypomorphic CAP-H2 mutant mouse
strain (called Nessy) (Woodward et al., 2016), as well as lymphomas from E2f1-/- mice
(Yamasaki et al., 1996). E2f1-/- mice frequently succumb to follicular B-lymphomas
evident in the mesenteric lymph node and this is a common finding in Rb1S/S mice (Ishak
et al., 2016; Yamasaki et al., 1996). Nessy, or Caph2I15N mutant mice, have lineagespecific delayed anaphase entry that manifests as aneuploid CD4+/lo;CD8+;CD71+ thymic
T-cells that develop into lymphomas in adult animals (Woodward et al., 2016). It will be
interesting to understand the subtle differences in tissue tropism between the Rb1S/S and
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Nessy mice, although other pRB-E2F1 containing complexes recruited to chromatin
likely underlie some of these differences.
Our observations contribute to a growing body of literature that challenges
classification of pRB as ‘inactive’ beyond entry into S-phase. In addition to Condensin II,
the pRB-E2F1 scaffold also recruits EZH2 to repetitive elements in cycling cells (Ishak et
al., 2016). We envision that disruption of both complexes likely contributes to the cancer
phenotype in Rb1S/S mice. First, loss of Condensin II recruitment and instability
phenotypes are found in Rb1 mutant mice with defective LxCxE interactions (Rb1L), but
this defect is insufficient to trigger cancer on its own (Coschi et al., 2014). In this study
we show that instability phenotypes found in Rb1S/S cells are most attributable to defects
in Condensin II recruitment as γH2AX accumulates preferentially in pRB-E2F1Condensin II locations, yet Rb1S/S mice are cancer prone. An important difference
between Rb1S/S and Rb1L/L mutant mice is repeat misexpression that predominantly
occurs in the spleens of Rb1S/S mice where the majority of tumors arise. Based on this
reasoning, we expect that loss of both pRB-E2F1-Condensin II and pRB-E2F1-EZH2
complexes caused by the F832A mutation are both necessary to cause the cancer
phenotype observed in Rb1S/S mice. Collectively, this body of work further emphasizes
the multifunctionality of pRB and how its disparate activities work together to underlie
its tumor suppressor role.

3.6
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Chapter 4

4

Disruption of the CDK-resistant pRB-E2F1 scaffold upregulates L1 ORF2p, interferon response genes, and shifts
tumor spectrum of Trp53-/- mice
4.1

Introduction

Misexpression of endogenous repetitive elements threatens the stability of the host
genome through numerous means. To prevent such deleterious effects, host genomes
employ epigenetic silencing mechanisms to repress repetitive element activity(Slotkin
and Martienssen, 2007). Perturbance of these mechanisms invokes an additional layer of
defenses in which endosomal toll-like receptors (TLRs) and cytosolic RIG-I-like
receptors (RLRs) detect nucleic acids of foreign origin to initiate an interferon (IFN)
response that culls affected cell populations (Shen et al., 2015; Young et al., 2012; Yu et
al., 2012). While this cascade is generally utilized upon ectopic viral detection, specific
effectors distinguish an endogenous retrovirus (ERV)-specific TLR response. TLR7
ensures production of ERV-specific antibodies, while TLR3 and TLR9 modulate ERV
antibody response to propagate a type I IFN response. Mice deficient for these three
TLRs succumb to T-cell acute lymphoblastic leukemia (T-ALL) that bear novel ERV reintegrations (Yu et al., 2012).
Studies using epigenetic modifiers have revealed the effect of redundancy on
induction of the ERV-specific innate immune response. Observations of repetitive
sequence resurrection following radiation or chemotherapy first suggested that genomic
insults could suffice to disrupt repetitive sequence silencing (Vabret et al., 2016).
Subsequent investigations with epigenetic inhibitors, such as inhibitors of histone de-
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acetylases (HDACs) or DNA methyltransferases (DNMTs), identified redundant and
non-redundant effectors of repetitive sequence silencing. It became clear that targeted
disruption of these effectors could activate the ERV-specific innate immune response in a
dose-dependent manner (Chiappinelli et al., 2015; Roulois et al., 2015; Saito et al., 2016).
More specifically, alleviation of non-redundant silencing mechanisms enhanced the
interferon response (Desai et al., 2017; Leonova et al., 2013). While this IFN response
initially serves as a negative selection pressure, constitutive IFN activation becomes
antagonistic towards this end, sustaining cell populations that harbour nucleic acids of
foreign origin (Vabret et al., 2016). Despite extensive characterization, the mechanisms
by which epigenetic effectors target mutually exclusive repeats, and the biological
contexts in which they are perturbed to activate the IFN response remain poorly
understood.
Recent evidence suggests that common inactivating events in cancer may disrupt
chromatin organization at repetitive sequences (Levine et al., 2016). The p53 tumor
suppressor protein suppresses retrotransposon expression and transposition through
H3K9me3 deposition (Botcheva and McCorkle, 2014; Leonova et al., 2013; Wylie et al.,
2015). Recent discovery of pRB-EZH2-mediated H3K27me3 deposition at repetitive
elements and specific pRB-Condensin II-mediated mitigation of γH2AX accumulation at
major satellites merits investigation into the effects of alleviating multiple tumorsuppressor based mechanisms of chromatin-organization at repetitive sequences (Ishak et
al., 2016). Notably, it remains unknown whether pRB-mediated chromatin organization
at repeats presents an opportunity to enhance the immune response through drug-induced
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viral mimicry (Roulois et al., 2015). If so, pRB functional status may predict efficacy of
clinically relevant epigenetic modulators.
In this study, we investigate whether disruption of pRB-EZH2-mediated silencing
through acute epigenetic modulation can suffice to de-repress repetitive elements. We
investigate whether cells deficient for this silencing paradigm exhibit evidence of
transposition, or evidence of ERV-specific innate immune responses. Finally, we explore
the effects of disrupting the CDK-resistant pRB-E2F1 scaffold in a Trp53-/- background.

4.2
4.2.1

Experimental Procedures
Cell culture and mouse colonies

Mouse embryonic fibroblasts (MEFs) were generated from E13.5 embryos using standard
procedures. Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with L-glutamine (2mM), streptomycin (50μg/mL), penicillin (50U/mL),
and 10% fetal bovine serum, incubated at 37°C with 5% CO2. Generation and
characterization of Rb1S/S mice has been described previously. To ablate p53 expression,
Rb1S/S mice were crossed into a Trp53−/− background in which Trp53 exons 2-7 are
substituted for a Neomycin cassette. The Trp53−/− mice were obtained from The Jackson
Laboratory. All animals were housed, handled, and analyzed as approved by the
Canadian Council on Animal Care.

4.2.2

Determination of protein and RNA expression

Chromatin fractions whole cell extracts were prepared as previously described (Ishak et
al., 2016). Antibodies used for Western blots are as follows: Ezh2 (D2C9; Cell
Signaling), H3K27me3 (07-449; Millipore), H3K9Ac (06-942; Millipore), H3 (ab1791;
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abcam), L1 ORF2p (M-300; Santa Cruz), tubulin (11H10; Cell Signaling), Actin (A2066;
SIGMA). RNA was prepared in TRIzol as previously described. Primers used are as
follows: Maj_F: GACGACTTGAAAAATGACGAAATC, Maj_R:
CATATTCCAGGTCCTTCAGTGTGC, L1 5' UTR_F:
CTGCCTTGCAAGAAGAGAGC, L1 5' UTR_R: AGTGCTGCGTTCTGATGATG, IAP
LTR_F: CTGACAGCTGTGTTCTAAGTGGTAAACAAA, IAP LTR_R:
AGAACACCACAGACCAGAATCTTCTGC.

4.2.3

EZH2 inhibition

In vivo based EZH2 inhibition was performed based upon methods modified from
Beguelin et. al (2013). Briefly, mice received daily treatments of 150mg/kg/day of
GSK343 or vehicle (Captisol) through 100μl intraperitoneal injections for 7 consecutive
days. Splenocytes were harvested on day 8 for RNA extraction using TRIzol reagent.
RNA was reverse transcribed and used for qRT-PCR.
To inhibit EZH2 in MEFs, asynchronously growing P4 MEFs at 50% confluency were
treated with GSK343 or vehicle (DMSO) with treatment volumes of 0.1% of total media
volume. For the 96-hour treatment course, 10 μM were treatments were administered
every 12 hours. H3K27me3 blots were performed from chromatin fractions of treated
cells. For the 48-hour treatment course, treatments of 2.5μM or 5μM were administered
once every 24 hours. L1 ORF2 blots were performed from whole cell extract of treated
cells. GSK343 was stored at a stock concentration of 10mM in DMSO at -20°C protected
from light.
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4.2.4

Retrotransposition Assay

P3 MEFs seeded at 2x105 cells / well in a 6-well dish were co-transfected with 1μg of an
eGFP-expressing L1 reporter plasmid along with 1μg of a Crimson-expressing plasmid.
24h post-transfection, cells were split 1:3 into 6-well dishes. Three wells per
experimental group were harvested 72h post transfection for live-cell flow cytometry to
measure Crimson (+) cells as a measure of transfection efficiency. To test TSA sensitive
de-repression, MEFs were treated with 2.5μM TSA or vehicle (DMSO) 6d posttransfection. 7d post-transfection, live-cell flow cytometry was conducted to measure
eGFP expression as a measure of retrotransposition using a FACSCalibur. Analysis was
conducted using FlowJo software. Live cells were gated, and analyzed for Crimson (+)
and eGFP (+) signal. Analysis of H2B-GFP-transduced MEFs were used to gate eGFP
positive cells. Background signal from untransfected controls was subtracted from all
samples, and eGFP signal was normalized to Crimson (+) signal. The following plasmids
were used in this study: cep99-gfp-L1SM (gift from Boeke lab, NYU), cep99-gfp-TGF21
(gift from Moran lab, U-M), pEF.myc.ER-E2-Crimson (Addgene), and pBABE-H2BGFP (Dick lab). See Appendix E for plasmid descriptions.

4.2.5

Expression Microarray

RNA levels were determined by Affymetrix Mouse Gene 1.0 Array as previously
described (Ishak et al., 2016). Average RMA expression values of all three replicates per
genotype were log2 transformed for an ANOVA analysis to determine significant
expression changes of 1.5 fold or greater with a p value of 0.05 or less in mutant cells
relative to wild-type cells. GeneOntology (GO) analysis on this list of genes yielded GO
enrichment scores that were plotted for the top 5 enriched categories. Annotations were
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derived from Affymetrix MoGene-1 0-st-v1 Transcript Cluster Annotations, CSV,
Release 32.

4.2.6

CD4 CD8 thymocyte quantification

To determine distribution of immature and mature thymocyte populations, thymocytes
from 4-6 week old mice were isolated from freshly sacrificed mice, and mashed through
a 40μm sterile cell strainer in a 10cm dish containing 3-4ml of media. Cells were then
isolated, pelleted at 4°C, and incubated 5 minutes in 1x RBC lysis buffer (0.15M NH4 Cl,
10mM KHCO3 , 0.1mM EDTA) to lyse erythrocytes. Thymocytes were washed twice in
1x PBS, then labeled with fluorescein-conjugated α-CD8, R-phycoerythrin-conjugated αCD4, 7-AAD, and subjected to flow cytometry analysis to compare thymocyte
maturation stage according to expression of CD4 and CD8 surface antigens. Percent
viability was measured as proportion of total cells within the ‘live’ gate of count versus
7-AAD plots. CD4 CD8 status was quantified as proportion of total viable cells per
quadrant, and then plotted as an average of the same quantification for three animals per
genotype. Error bars indicate +/- 1 standard deviation.

4.3
4.3.1

Results
Disruption of the CDK-resistant pRB-E2F1 interaction
deregulates L1 ORF2p expression

We sought to identify whether disruption of certain pRB interaction surfaces
could permit expression of factors required for endogenous retrotransposition. Western
blots of whole cell extracts from proliferating MEFs demonstrate L1 ORF2p
misregulation is specific to the Rb1S/S mutant, and not sensitive to disruption of pRB-E2F
small pocket interactions in Rb1G/G cells, or disruption pRB LxCxE binding cleft

153

interactions in Rb1L/L cells (Figure 4.1A). This complements previous microarray-based
analysis of repetitive element transcript levels across Rb1 synthetic mutant genotypes
(Ishak et al., 2016). Importantly, since both the Rb1S/S and Rb1L/L mutants perturb
Condensin II recruitment to pericentric satellites, this corroborates attribution of pRBmediated repeat silencing to EZH2 recruitment rather than interactions with Condensin II.

4.3.2

GSK343 treatment de-represses repetitive elements in
MEFs
We sought to determine whether epigenetic modulation could perturb pRB-

mediated facultative heterochromatinization of repetitive sequences. Since pRB-mediated
silencing is specific to EZH2 recruitment, chemical inhibitors of EZH2 function may
recapitulate repetitive element deregulation observed in Rb1S/S cells. Western blots of
chromatin fractions reveal reduced H3K27me3 levels following GSK343 treatment of P4
MEFs every 12 hours for 96 hours (Figure 4.2A). Upon confirmation of activity, GSK343
treatments were modified to identify minimal doses that sufficed to de-repress repeats
silenced by H3K27me3 in MEFs. Increasing doses of GSK343 produced modest
increases in L1 ORF2p levels in proliferating MEFs, with no overt fluctuations in
H3K27me3 levels as measured by western blots (Figures 4.2B and 4.2C).

4.3.3

GSK343 treatment de-represses repetitive elements in
splenocytes
Ablation of epigenetic writers results in differential effects on repetitive element

silencing based on cell type and developmental stage (Rowe and Trono, 2011).
Disruption of pRB-EZH2-mediated silencing resulted in pronounced deregulation of
repetitive elements in adult Rb1S/S splenoctyes. To determine whether targeted EZH2
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Figure 4.1: Disruption of the CDK-resistant pRB-E2F1 interaction de-represses L1
ORF2p.
(A) Western blots of whole cell extract from asynchronous P4 MEFs of the indicated
genotypes demonstrate expression levels of L1 ORF2p, and tubulin as a loading control.
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Figure 4.2: GSK343 inhibition of EZH2 de-represses repetitive elements in MEFs.
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Figure 4.2: GSK343 inhibition of EZH2 de-represses repetitive elements in MEFs.
(A) Western blot for H3K27me3 from chromatin fractions of asynchronous P4 MEFs
treated every 12 hours with 10 μM of GSK343 or DMSO vehicle for 96 hours total.
Coomassie-stained histones serve as a loading control, and chromatin from Ezh2-/- MEFs
serves as a control for antibody specificity. (B) Western blot for L1 ORF2p, EZH2, and
Actin as a loading control from whole cell extracts of asynchronous P4 MEFs treated
every 24 hours with with indicated concentrations of GSK343 or DMSO vehicle for 48
hours total. (C) Extracts from (B) blotted for H3K27me3 and Actin along with extract
from Ezh2-/- MEFs to serve as a control for antibody specificity.
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inhibition could recapitulate this effect, wild-type mice received daily treatments of
150mg/kg/day of GSK343 or vehicle through intraperitoneal injections for 7 consecutive
days. Splenocytes were harvested on day 8 for RNA extraction (Figure 4.3A). Strikingly,
while overt tissue morphology remained unchanged, qRT-PCR revealed elevated levels
of major satellites, 5' L1 UTR, and the IAP LTR in splenocytes from GSK343 treated
mice only (Figures 4.3B and 4.3C). This demonstrates that acute EZH2 inhibition derepresses repetitive elements in splenocytes.

4.3.4

The CDK-resistant pRB-E2F1 complex suppresses
retrotransposition of LINE1 reporters

Amongst the repetitive element families silenced by pRB-EZH2 recruitment, a
subset contain members that retain the potential to mobilize throughout the genome.
Detection of L1 ORF2p suggests that the components required for endogenous
retrotranspiosition are present in Rb1S/S cells. To assess retrotransposition in cells
deficient for pRB-EZH2 recruitment, we used a previously described assay in which a
plasmid borne LINE1 element contains an eGFP reporter in the antisense orientation
interrupted by an intron (Figure 4.4A) (Garcia-Perez et al., 2010). Only following
expression, splicing, and retrotransposition can eGFP be expressed, thus serving as a read
out for bona fide mobility of the reporter. Both a naturally occurring LINE1 (L1 Gf) and
a synthetic version (L1 SM) exhibited elevated retrotransposition in Rb1S/S MEFs relative
to wild-type cells (Figure 4.4B). In addition to retrotransposition, we also used this assay
to analyze silencing of retroelements. Treatment of cells with Trichostatin A (TSA)
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Figure 4.3: GSK343 inhibition of EZH2 de-represses repetitive elements in
splenocytes.
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Figure 4.3: GSK343 inhibition of EZH2 de-represses repetitive elements in
splenocytes.
(A) Treatment scheme illustrates that 6-8 week-old wild-type mice received daily
treatments of 150mg/kg/day of GSK343 or volume-matched vehicle for 7 consecutive
days. Splenocytes were harvested on day 8. (B) Overt morphology of splenocytes upon
necropsy. (C) Heat map of repeat element expression in spleens of treated mice
quantified by qRT-PCR. Log2 ratio of expression is displayed relative to the average of
all vehicle-treated mice.
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Figure 4.4: pRB suppresses retrotransposition.
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Figure 4.4: pRB suppresses retrotransposition.
(A) Retrotransposition assay schematic. LINE1 reporters encode an anti-sense CMVeGFP marker in the 3'UTR interrupted by an intron in the sense direction. Upon genomic
integration, expression, intron splicing, and re-integration, the sense CMV-eGFP is
expressed. (B) Percent eGFP positive MEFs per genotype determined by flow cytometry
normalized to co-transfected Crimson expression plasmid to provide an unconditionally
expressed marker of transfection efficiency. Reporters used encoded endogenous L1 (L1
Gf), and a synthetic L1 (L1 SM) with modified ORFs for optimized expression. Signal
measured by live cell flow cytometry. (C) Whole cell extract WB of H3K9Ac, and H3
from MEFs treated 24h with 2.5 μM TSA or DMSO vehicle. (D) Retrotransposition
assay conducted with DMSO vehicle or 2.5 μM TSA treatment 24h prior to live cell flow
cytometry. Percent eGFP positive cells were expressed as fold change relative to vehicle
control for each genotype and reporter. Error bars indicate one standard deviation from
the mean, an asterisk represents a significant difference from wild type or untreated
control (P≤0.05 using a t-test).
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inhibits HDAC activity to increase histone acetylation as detected by western blot of
H3K9Ac (Figure 4.4C). TSA treatment of reporter-transduced wild type and Rb1S/S
fibroblasts elevated the abundance of eGFP positive wild type cells, but not Rb1S/S
mutants (Figure 4.4D). This suggests that retrotransposon expression is fully de-repressed
in Rb1S/S cells such that TSA dependent de-repression can no longer lead to higher levels
of eGFP reporter transposition. Considered together with the elevated levels of
retrotransposon reporter events that take place in Rb1S/S MEFs, there is a strong
likelihood that loss of pRB-EZH2 occupancy and repression of repetitive sequences may
be associated with endogenous transposition of mobile repetitive elements.

4.3.5

Disruption of the CDK-resistant pRB-E2F1 interaction
activates innate immune components
Cells with perturbed silencing of repetitive sequences exhibit activation of the

innate immune response (Roers et al., 2016). To determine transcriptional responses
associated with loss of pRB-mediated repetitive element silencing, expression
microarrays of arrested Rb1S/S MEFs were analyzed (Ishak et al., 2016). Average RMA
expression values of all three replicates per genotype were log transformed for an
ANOVA analysis to determine significant expression changes of 1.5 fold or greater with
a p value of 0.05 or less in mutant cells relative to wild-type cells. GeneOntology (GO)
analysis conducted on this list of genes revealed that 3 of the top 5 GO enrichment scores
corresponded to categories that were specific to immune responses (Figure 4.5A).
Up-regulated immune targets from this list were curated into tables based upon
sensory or responsive roles in the immune response. Analysis of up-regulated sensory
components revealed up-regulation of toll like receptors, C-type lectins, and Ig
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Figure 4.5: Upregulation of innate immune components upon loss of the CDKresistant pRB-E2F1 interaction
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Figure 4.5: Upregulation of innate immune components upon loss of the CDKresistant pRB-E2F1 interaction.
(A) Average Affymetrix Mouse Gene 1.0 Array RMA expression values of all three
replicates per genotype were log2 transformed for an ANOVA analysis to determine
significant expression changes of 1.5 fold or greater with a p value of 0.05 or less in
mutant cells relative to wild-type cells. GeneOntology (GO) analysis on this list of genes
yielded GO enrichment scores that were plotted for the top 5 enriched categories. (B)
Annotations of immune targets from this list were derived from Affymetrix MoGene-1 0st-v1 Transcript Cluster Annotations, CSV, Release 32 and plotted as tables according to
‘sensory’ functions. (C) Same analysis as (B) with ‘response’ components listed.
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components, in addition to surface markers associated with immune cells (Figure 4.5B).
Amongst responsive components, Trim proteins exhibited the most pronounced upregulation, accompanied by other IFN and IL-stimulated cytokines (Figure 4.5C).
Interestingly, components of the complement system downstream of antigen recognition
were also enriched. Finally, components involved in immunogenic cytotoxicity were also
up-regulated. Collectively, this suggests that nucleic acid sensory receptors and IFN
stimulated cytokines are active in cells with disrupted pRB-EZH2-mediated repeat
silencing.

4.3.6

Disruption of the CDK-resistant pRB-E2F1 interaction does
not alter thymocyte maturation
Studies in embryonic stem cells demonstrate that p53, like pRB, mediates

genome-wide chromatin organization. Specifically, p53 mediates H3K9me3-dependent
silencing of repetitive sequences (Wylie et al., 2015). We sought to determine the effects
of disrupting multiple tumor suppressor-based chromatin-organizing mechanisms. Trp53/-

mice predominantly succumb to thymic lymphomas (Jacks et al., 1994). However, the

roles of E2F1 in thymocyte apoptosis may present a potential confounding variable to
any alterations in tumor phenotypes.
E2f1-/- thymocytes exhibit attenuated apoptosis during negative selection as
measured by CD4/CD8 surface markers (Field et al., 1996). As thymocytes mature, they
progress sequentially from CD4/CD8 double negative, to double positive, and finally
single positive status following selection. Elevated levels of single-positive E2f1-/thymocytes underscore the role of E2F1 as a pro-apoptotic transcription factor, and
complement their resistance to etoposide-induced apoptosis (Field et al., 1996; Lin et al.,
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2001). If pRB represses E2F1-induced apoptosis through the CDK-resistant interaction,
then Rb1S/S thymocytes may exhibit increased sensitivity to pro-apoptotic stimuli, and
thus, delay or ablate onset of thymic lymphomas within a Trp53-/- background.
To assess potential alterations in thymocyte negative selection, freshly harvested
thymocytes from 4-6 week old wild-type and Rb1S/S mice were stained for CD4/CD8 to
measure thymocyte proportions per maturation stage, and 7-AAD to measure thymocyte
viability. No significant differences in total viability or thymocyte maturation were noted
from this analysis, suggesting that any potential differences in thymic lymphoma
development within a Trp53-/- background could not be attributed to intrinsic
developmental alterations (Figures 4.6A, 4.6B and 4.6C).

4.3.7

Disruption of the CDK-resistant pRB-E2F1 complex
decreases tumor-free survival of Trp53-/- mice.

Since TP53 inactivating mutations often accompany RB1 inactivation in human
cancers, Trp53-/- mice were crossed with Rb1S mice, and offspring were aged until animal
protocol endpoints, upon which they were subjected to necropsies with portions of
samples fixed for histological analysis, and the remaining sample portions frozen. Within
a Trp53-/- background, Rb1S/S mice all succumb to tumors with decreased tumor latency
relative to Rb1+/+ controls (p = 0.032) (Figure 4.7A). Consistent with previous studies,
Rb1+/+; Trp53-/- mice predominantly succumb to thymic lymphomas or sarcomas (Figure
4.4B) (Jacks et al., 1994). A subset of Rb1S/S; Trp53-/- mice presented with lymphomas in
the spleen, or axial lymph nodes, or mesenteric lymph nodes (Figures 4.7B and 4.7C).
Beyond lymphomas and sarcomas, a lung adenocarcinoma and a malignant papillary
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Figure 4.6: Disruption of the CDK-resistant pRB-E2F1 interaction does not alter
thymocyte maturation.
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Figure 4.6: Disruption of the CDK-resistant pRB-E2F1 interaction does not alter
thymocyte maturation.
A) Freshly harvested thymocytes from 4-6 week-old mice were stained and subjected to
live-cell flow cytometry analysis. Percent viability was measured as proportion of total
thymocytes within the ‘live’ gate of count versus 7-AAD plots. (B) Representative CD4
versus CD8 histograms demonstrate gating used to determine positive or negative signal
by flow cytometry. (C) Proportion of total viable cells per quadrant plotted as an average
of the same quantification for three animals per genotype. Error bars indicate +/- 1
standard deviation.
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Figure 4.7: Disruption of the CDK-resistant pRB-E2F1 interaction accelerates onset
of tumorigenesis in a Trp53−/− background.
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Figure 4.7: Disruption of the CDK-resistant pRB-E2F1 interaction accelerates onset
of tumorigenesis in a Trp53−/− background.
(A) Overall tumor-free survival plotted for Rb1+/+; Trp53-/- (n = 18) and Rb1S/S; Trp53-/mice (n = 13) as Kaplan-Meier curves with log rank test p-value indicated. (B) Table
indicates occurrence per tumor type (C) H&E-stained sections exhibit histological
characteristics specific to tumor type. Scale is indicated per image. For F132, a white box
within an image at a lower magnification indicates the relative location of the adjacent
image.
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growth from the vas deferens were present amongst the Rb1S/S; Trp53-/- cohort (Figures
4.7B and 4.7C).
Since different tumor types confer different latencies to animal protocol endpoints,
latency was compared amongst control and mutant animals that succumbed to thymic
lymphomas. Rb1S/S; Trp53-/- mice that succumbed to thymic lymphomas exhibited a
significantly reduced tumor latency relative to Rb1+/+; Trp53-/- mice that developed
thymic lymphomas (p = 0.023) (Figure 4.8A). No differences in overt morphology of
thymic lymphomas were noted upon necropsy between cohorts. Mitotic cells were readily
apparent upon histological analysis that revealed no pathological differences between
thymic lymphomas of compound mutants versus single mutants (Figure 8B).

4.4

Discussion

This chapter explores a number of focused questions to initiate investigations of
how the pRB-E2F1 scaffold may be exploited for therapeutic purposes, and how it may
contribute to tumorigenesis in combination with p53 ablation. With respect to therapeutic
exploitation, we explore whether a clinically relevant epigenetic modulator can alleviate
H3K27me3-based repetitive element silencing. Intraperitoneal injections of the EZH2
inhibitor GSK343 sufficed to de-repress repetitive sequences in splenocytes. Deregulation was uniform for all drug treated animals at time of harvesting. In contrast, the
response of aged-matched animals is less likely to be synchronized after 6-8 weeks of
immune-induced negative selection (Ishak et al., 2016).
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Figure 4.8: Disruption of the CDK-resistant pRB-E2F1 interaction accelerates onset
of thymic lymphomas in a Trp53−/− background.
(A) Tumor-free survival of mice that succumbed to thymic lymphomas plotted for
Rb1+/+; Trp53-/- (n = 13) and Rb1S/S; Trp53-/- mice (n = 8) as Kaplan-Meier curves with
log rank test p-value indicated. (B) Representative images of thymic lymphomas upon
necropsy accompanied by corresponding H&E stained sections. Scale bar indicates 100
μm.
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Disruption of repeat-silencing mechanisms may also permit retrotransposition of
elements that retain the ability to transpose autonomously. Discovery of L1 ORF2p
expression in Rb1S/S MEFs suggests that the machinery required for endogenous
retrotransposition is present in Rb1S/S cells. Further exploration of L1 ORF2p expression
in tissues of adult Rb1S/S mice may reveal tissue-specific differences in any potential
endogenous retrotransposition. Here, a transfection-based eGFP LINE reporter assay was
used to assess whether pRB-EZH2-mediated silencing suppressed expression and
retrotransposition in wild-type and Rb1S/S MEFs. Reporter retroransposition is silenced in
a pRB-dependent manner. Whole genome sequencing will be required to determine
whether endogenous LINE retrotransposition can be observed upon alleviation of pRBrepeat association in both experimental models, and human cancers. If so, LINE
retrotransposition may be common to cancers with inactivated pRB.
Constitutive disruption of repeat silencing induces an innate immune response that
begins with stimulation of endosomal toll-like receptors (TLRs) or cytosolic RIG-I_like
receptors that initiate an interferon (IFN) response. Expression microarray analysis of
Rb1S/S MEFs suggests that such a response may occur in upon disruption of pRB-EZH2mediated repeat silencing. Upon detection of repetitive transcripts, TLR7 ensures
production of ERV-specific antibodies. Indeed TLR7 and immunoglobin components
were amongst the most up-regulated sensory components in mutant MEFs. Downstream
of receptor stimulation, TRIM proteins propagate the response to ensure that a host of
IFN-stimulated cytokines can respond and induce cytotoxicity to cull the cells if required.
Transcriptional targets associated with the immune response in Rb1S/S MEFs suggest that
this response may be active upon disruption of this silencing paradigm. Accordingly, we
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previously report IFN activation in splenocytes of adult Rb1S/S MEFs (Ishak et al., 2016).
However, assessing such signatures in multiple tissues of GSK343-treated adult mice
may reveal additional cell types that may invoke such a response upon disruption of pRBEZH2-mediated heterochromatinization.
Investigation of p53-deficient cells first revealed that retrotransposition and innate
immune responses were sensitive to tumor suppressor-mediated repeat silencing
(Leonova et al., 2013; Wylie et al., 2015). Identification of pRB-mediated H3K27me3
deposition at repeats suggested that combinatorial inactivation of both pRB and p53 may
exacerbate overall heterochromatinization defects relative to those observed upon
inactivation of either tumor suppressor in isolation. To assess whether this was the case,
Rb1S/S mice were crossed into a Trp53-/- background and aged until animal protocol
endpoints. Upon necropsy, Rb1S/S; Trp53-/- mice presented with a slightly more varied
tumor spectrum and an overall decreased tumor latency relative to Rb1+/+; Trp53-/- mice.
Trp53-/- mice predominantly succumb to thymic lymphomas. Compound mutants that
developed thymic lymphomas exhibited a significantly reduced latency relative to
Rb1+/+; Trp53-/- mice. While Rb1S/S; Trp53-/-displayed an increase in lymphomas beyond
the thymus, Rb1L/L; Trp53-/- display an increase in sarcoma incidence. This further
distinguishes additional factors that contribute to genome instability in Rb1S/S mice
beyond disruption of Condensin II-mediated mitotic instability observed in Rb1L/L mice.
Mechanistic underpinnings of reduced latency may provide insight into yet-unidentified
factors that govern tumor evolution in human cancers that lack both pRB and p53.
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Chapter 5

5

Discussion
5.1

Summary of findings

My thesis investigates mechanistic links between genome integrity and pRBmediated recruitment of chromatin organizing proteins to repetitive DNA sequences. The
work here suggests that the CDK-resistant interaction between the pRB C-terminus and
the E2F1 marked box domain establishes a scaffold that facilitates recruitment of
multiple chromatin-organizing proteins to repetitive sequences across the genome
throughout the cell cycle. The onset of lymphomagenesis evident upon disruption of this
pRB-E2F1 interaction suggests that the activities of this complex constitute a previously
unappreciated facet of pRB-mediated tumor suppression.
My work in chapter two identifies the enhancer-of-zeste-homoglogue 2 (EZH2)
histone methyl transferase as one such chromatin-modifying protein recruited through
this pRB-E2F1 complex. pRB-E2F1 recruit EZH2 to deposit H3K27me3 and silence
repetitive elements. Germline disruption of this interaction results in pronounced
misexpression of repetitive elements in splenocytes, and lymphomas that arise in the
spleen, mesenteric and axial lymph nodes.
In chapter 3, the CDK-resistant scaffold is investigated as a biochemical
mechanism that underlies previous observations of pRB-mediated Condensin II
recruitment to pericentric heterochromatin. A portion of my investigation into this
question was published in Cancer Discovery and it is appended to this thesis. I will
consider its implications while discussing findings from chapter 3. Chapter 3
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demonstrates that disruption of the CDK-resistant pRB-E2F1 interaction coincides with
increased γH2AX, aneuploidy, ppRPA32, and mitotic errors. While these functions are
known to be associated with perturbed Condensin II recruitment, chromatin
immunoprecipitation experiments demonstrate that γH2AX appears to be limited to
regions co-occupied by pRB-Condensin II and not regions exclusively occupied by pRBEZH2.
In chapter 4, I explore whether functions of the pRB-E2F1 scaffold provide an
opportunity for therapeutic exploitation, and whether these properties direct disease
outcomes in combination with other cancer-relevant events that deregulate repetitive
elements. My work demonstrates that the EZH2 inhibitor GSK343 derepresses repetitive
elements in MEFs and in splenocytes. While acute derepression may be therapeutic,
constitutive derepression may permit retrotransposition as determined using LINE
reporter assays. Furthermore, disruption of this silencing paradigm through the Rb1S
mutation in concert with ablation of p53 expression decreases latency of thymic
lymphomas, and increases diversity of tumor spectrum.
Collectively, my work provides a mechanistic link between tumor suppressor
inactivation and repetitive element misregulation in cancer. Specifically, cell cycle
independent pRB-chromatin association at repetitive regions maintains genome stability
through facultative heterochromatinization of repetitive sequences, and recruitment of
chromatin-condensing proteins required for fidelity of DNA replication and mitosis.
Discovery of this recruitment mechanism suggests a previously unidentified means of
therapeutic exploitation of pRB-positive cancers through the use of EZH2 inhibitors.
Upon review of the implications of this work, it is apparent that the investigation into the
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Figure 5.1: The CDK-resistant pRB-E2F1 scaffold recruits chromatin-organizing
complexes to repetitive sequences.
The above model of post-G1 pRB-chromatin association depicts CDK-phosphorylated
pRB, however whether CDK-phosphorylated pRB associates with repetitive elements
endogenously remains to be investigated. The top half of the panel portrays pRB-E2F1Condensin II complexes at major satellites (MaSat). Loss of this recruitment in Rb1S/S
mutant cells coincides with increased γH2AX depicted specifically at major satellites, but
not at other repetitive elements that are insensitive to loss of pRB-Condensin II
interactions alone. Whether these regions account for increases in ppRPA32 remains to
be explored. In addition, pRB-E2F1-EZH2 complexes are illustrated at both a major
satellite and a LINE1 element to emphasize the increased repertoire of repetitive
sequences occupied by this complex. Loss of pRB-dependent EZH2 recruitment
coincides with loss of repressive H3K27me3 and transcriptional activation of both
interspersed and tandem repetitive elements that include major satellites, IAP endogenous
retroviruses, and LINE1 elements. Post-G1, pRB-E2F1 occupy repetitive sequences
while pRB dissociates from E2Fs at cell cycle genes such as Mcm3 illustrated above.
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properties of the pRB-E2F1 scaffold may illuminate answers to long-standing questions
in the repetitive element field regarding recruitment of epigenetic effectors to repetitive
sequences, host-directed alleviation of repetitive element silencing, and misregulation of
silencing associated with mitotic defects and the onset of tumorigenesis.

5.2
The CDK-resistant pRB-E2F1 scaffold recruits
multiple complexes to repetitive sequences.
The use of discrete pRB synthetic mutants has permitted elucidation of two
distinct pRB-E2F1 complexes. The CDK-resistant pRB-E2F1 scaffold mediates EZH2
recruitment and H3K27me3 deposition at repetitive sequences throughout the genome. In
contrast, pRB-E2F1-Condensin II complexes occupy and act upon major satellite
sequences, but are not functionally relevant at the L1 5'UTR or IAP LTR. Curiously,
disruption of the pRB-E2F1 scaffold resulted in γH2AX accumulation at repeats
regulated by pRB-Condensin II, but not pRB-EZH2 exclusively. The attribution of
repetitive element silencing to EZH2 recruitment appears consistent with another
synthetic pRB mutant model that is defective for Condensin II recruitment, but does not
exhibit deregulation of repetitive sequences. Proliferating Rb1L/L MEFs exhibit reduced
H4K20me3 at pericentric repeats, and reduced H3K9me3 at cell cycle promoters upon
senescence induction, consistent with defective recruitment of HMTs that establish
constitutive heterochromatin marks (Isaac et al., 2006; Talluri et al., 2010). In contrast,
H3K27me3 levels remain unperturbed at these sites and at Hox genes, consistent with
proper H3K27me3 levels maintained at Hox genes in Rb1S/S cells (Talluri et al., 2010).
This suggests that H3K27me3 deposition at these regions is likely pRB-independent.
Curiously, the D.melanogaster CAP-D3 subunit that interacts with the D.melanogaster
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pRB orthologue Rbf restricts transposon activity (Schuster et al., 2013). This suggests
that Condensin II may participate in transposon silencing in mammals, however the
means by which this may occur remains unknown, but is likely independent of pRB.
These observations give rise to questions regarding the biochemical properties
that distinguish either complex. With respect to assembly, functional expression and
epigenetic outputs suggest that pRB-dependent EZH2 recruitment must be independent of
the LxCxE binding cleft. Since nuclear extract pulldowns with recombinant GST-RBLPL
exhibit reduced binding to the PRC2 subunit RbAp46, this suggests RbAp46 may not
participate in recruitment of EZH2 by pRB (Isaac et al., 2006). Alternatively, RbAp46
may be required for non-PcG HDAC complex recruitment by pRB through the LxCxE
binding cleft. Endogenous immunoprecipitations in previous data chapters assess proteinprotein interactions or genome occupancy but cannot distinguish whether pRB-mediated
EZH2 recruitment is direct or indirect. Furthermore, a minimal region required for this
recruitment has yet to be mapped on pRB.
While Condensin II association with pRB has been characterized as LxCxEdependent, many of the same questions that exist for EZH2 recruitment exist for
Condensin II recruitment. Despite extensive characterization, it remains unknown
whether interactions between pRB and certain Condensin II subunits are direct or
indirect, and which subunits are essential for this interaction. Evidence of a highermigrating CAP-D3 band that associates with pRB suggests modifications to Condensin II
subunits, such as CAP-D3 phosphorylation, may facilitate interaction with pRB. Finally,
properties that determine whether pRB-E2F1 will recruit Condensin II or EZH2 remain
unknown. Biochemical experiments are required to determine whether this recruitment is
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competitive, and whether additional co-factors or post-translational modifications are
required to mediate this interaction. Development of pRB synthetic mutants that disrupt
EZH2 recruitment and preserve LxCxE interactions will facilitate this endeavor.

5.3
Do E2F-consensus motifs underlie pRB-E2F1
recruitment to repetitive elements?
Occupancy of the CDK-resistant pRB-E2F1 scaffold at a diverse repertoire of
repetitive elements begs the question of the molecular basis that underlies repetitive
sequence recruitment. Repetitive elements must be recognized by chromatin modifying
complexes in order to be silenced, or by transcription factors to serve as alternative
promoters or enhancers throughout the host genome. However, mechanisms of repetitive
sequence recognition remain poorly understood. Classic mechanisms of promotertranscription factor dynamics predominantly involve the recognition of a conserved DNA
motif or element within the promoter. There is some evidence to suggest that recognition
of DNA sequences serves as the recruitment mechanism for a subset of proteins that bind
repeats.
For example, retrotransposition assays that utilize fragments of IAPs demonstrate that
the presence of the 5'UTR or a 160bp region from the gag-encoding ORF suffice to
silence the reporter (Sadic et al., 2015). Certain members of the Krüppel-associated box
zinc-finger proteins (KRAB-ZFPs) recognize these sequences within the 5'UTR and gag
regions (Wolf and Goff, 2009). KRAB-ZFPs harbor varying numbers of zinc finger
motifs to confer DNA binding specificity. Divergence amongst these motifs are believed
to underlie extensive occupancy of a diverse repertoire of repeats by Cys2-His2 zinc
finger (C2H2-ZF) transcription factors that include the KRAB-ZFP members (Najafabadi
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et al., 2015). These associations are often found within heterochromatinized repeats, and
corroborate mechanistic investigations that conclude KRAB-ZFPs bind TRIM28 and
SETDB1 to mediate H3K9me3 of certain repetitive elements (Schmitges et al., 2016).
It appears that other DNA-binding motifs commonly found within transcription
factors suffice to mediate sequence-based recognition of repetitive sequences. For
example, a partial consensus motif within major satellite subrepeat 2 recognized by the
homeodomain of Pax3 is required for Pax3 recruitment and deposition of H3K9me3 and
H4K20me3 at pericentric satellites (Bulut-Karslioglu et al., 2012). The p53 transcription
factor also associates with repetitive sequences. p53 recognizes DNA as a tetramer in
which a DNA binding domain within its ‘core’ region associates with p53 recognition
elements (Demir et al., 2017). p53 recognition elements in human ERV LTRs and L1
5'UTRs appear to be mediate p53 recognition (Harris et al., 2009). Paradoxically, in vitro
reporter assays suggest p53 association with these elements activates transcription, while
in vivo NGS profiles suggest p53 association establishes repressive heterochromatin at
these elements (Wylie et al., 2016).
Investigation of E2F-based mechanisms of DNA recognition provide insights into
how an E2F might recruit pocket proteins to repetitive sequences. E2F/DP heterodimers
were discovered to recognize and bind the canonical E2F motif 5'TTTC[CG]CGC-3'
(Boeuf et al., 1990; Kovesdi et al., 1987; Yee et al., 1987). More recent work suggests
that these heterodimers along with atypical E2Fs bind the core sequence 5'-GGCGGG-3'
(Jolma et al., 2013). Crystal structures of E2F4/DP2 fragments bound to DNA suggest
that a winged-helix fold adopted by the DNA-binding domains of both transcription
factors mediates this recognition (Zheng et al., 1999). Subsequent investigations of
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atypical E2Fs reveal that the two DNA binding domains of E2F8 adopt an analogous
structure upon DNA binding (Morgunova et al., 2015).
Identification of L1 ORF2p expression in MEFs deficient for all three pocket proteins
first prompted investigation of E2F recognition of mammalian LINE elements.
Investigation of the human L1RP 5'UTR and the murine L1Md-A2 5'UTR identified a
stretch of GGCG and CGCG respectively within either 5'UTR. These sequences were
considered homologous to the E2F core recognition sequence 5'-GGCGGG-3', and were
attributed as the basis of E2F recruitment to these UTRs. ChIP for E2F1 yielded
occupancy above IgG background levels when quantified using primers that produced an
amplicon >100bp that encompassed this sequence in the L1 5'UTR (Montoya-Durango et
al., 2009). However, loss-of-function approaches, such as mutagenesis of this site, were
never performed. Thus, the requirement of either sequence for E2F1 occupancy of the L1
5'UTR remains unknown.
In contrast to mammalian studies, investigations in plants conclude that the pRB-E2F
network is extensively governed by E2F consensus motifs that are enriched within
repetitive elements. Motif enrichment analysis of the Arabidopsis thaliana genome
indicates that 73% of all E2F recognition sequences (TTssCGssAA) intersect with
transposable elements, while overlap is 85% in Arabidopsis lyrata. This appears to
suggest extensive amplification of E2F recognition sequences through transposable
element activity. Notably, analysis of ChIP-seq profiles for histone tail marks reveal that
these E2F binding sites within transposable elements exhibit significant enrichment of
H3K27me1 (Henaff et al., 2014).
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Despite the parallels between these studies and our model of H3K27me3 deposition at
repeats through the pRB-E2F1 scaffold, the absence of E2F consensus sequences within
pericentric repeats suggests that pRB-E2F1 recognition must be more complex in
mammalian systems. Furthermore, the inability of E2F1 to associate with major satellites
independent of pRB binding strongly suggests that this association is likely conferred
through a structural motif, a post-translational modification, or an interaction with an
additional binding partner formed upon E2F1 binding to pRB (See appendix C) (Coschi
et al., 2014). This supports electrophoretic mobility shift assay experiments that
demonstrate E2F1 bound through the pRB-C-terminus exhibits reduced affinity for a
DNA probe that contains the E2F consensus motif (Dick and Dyson, 2003).
Finally, sequence-dependent pRB-repeat recruitment may be mediated through E2Findependent means. Recent studies in murine osteoblasts demonstrate that CDKphosphorylated pRB occupies the promoter regions of subtelomeric TERRA repeats.
Occupancy appears to be dependent on the presence of Retinoblastoma Control Elements
(RCEs) that facilitate pRB recruitment through the Sp1 transcription factor. Interestingly,
reporter assays demonstrate that pRB positively regulates TERRA expression. Since
TERRA forms DNA-RNA hybrids to maintain telomere length, this may be another
means by which pRB maintains genome stability (Gonzalez-Vasconcellos et al., 2017).
Direct roles of Sp1 in pRB-telomere requirement were not explored in this study (Kim et
al., 1992). Beyond E2F1 and Sp1, it remains unknown whether other transcription factors
may recruit pRB to repetitive sequences.
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5.4
pRB-E2F1 repeat-recruitment independent of E2F
consensus motifs?
Recruitment to sites of DNA damage suggests that pRB and E2F1 can be
recruited through sequence-independent means throughout the genome (Cook et al.,
2015; Vélez-Cruz et al., 2016). Recruitment to sites of DNA damage occurs through stepwise deposition of post-translational modifications that recruit additional epigenetic
‘writers’ that deposit new marks for recruitment of new effectors (Munro et al., 2012).
Likewise, heterochromatinization also follows a hierarchical modification and
recruitment scheme. At constitutively heterochromatinized regions, H3K9me3 is
recognized and bound by HP1. Following this event, SUV4-20H1/2 histone methyl
transferases catalyze H4K20me2/3 deposition at these regions (Saksouk et al., 2015). The
participation of EZH2 in pRB-mediated silencing of repetitive sequences suggests that
the pRB-E2F1 scaffold may adhere to the step-wise mechanisms of facultative
heterochromatinization that underlie target site recruitment.
Facultative heterochromatin is established through the activity of Polycomb group
(PcG) proteins. These proteins were first discovered in Drosophila melanogaster as
regulators of Hox gene expression, and thus, normal development. PcG recruitment in
D.melanogaster is mediated through sequence recognition of Polycomb response
elements (PREs) at target sites (Bauer et al., 2015). However, the lack of PREs that
predict polycomb binding in vertebrates suggests that vertebrate PcG recruitment is more
complex, and may involve targeting by different co-factors, adaptors, or transcription
factors that recognize histone or DNA modifications. PcG-mediated heterochromatin is
established through two multi-subunit complexes. Polycomb Repressor Complex 2

187

methylates lysine 27 of histone H3, while Polycomb Repressor Complex 1 ubiquitylates
lysine 119 of histone H2A. The interplay between these two activities has provided a
foundation to explore PcG recruitment mechanisms (Margueron and Reinberg, 2011).
Early models of PcG activity suggested that H3K27me3 deposition by EZH2 or
EZH1 of the PRC2 complex is recognized and bound by the PRC1 complex. Following
recruitment, the RING1A or RING1B ubiquitin E3 ligases of the PRC1 complex
ubiquitylate H2AK119 (Margueron et al., 2008). However, this model is challenged by
recent discoveries of PRC1-mediated H2AK119Ub1 that precedes and recruits PRC2 to
permit H3K27me3 deposition (Cooper et al., 2014). Following deposition, H3K27me3
recognition by EED permits PRC2-mediated H3K27me3 spreading independent of
nucleation mechanisms (van der Vlag and Otte, 1999). The interplay with PRC1 remains
unexplored in our model of pRB-mediated PRC2 recruitment to repetitive sequences.
PRC1-mediated ubiquitylation at repetitive sequences remains relatively unexplored.
However, if H2AK119Ub1 levels remain unperturbed at repetitive elements in Rb1S/S
MEFs, then E2F1-pRB-EZH2 recruitment may be mediated through recognition of
H2AK119Ub1. Conversely, reduced H2AK119Ub1 at repetitive elements in Rb1S/S MEFs
would suggest a model of PRC2-based recruitment of PRC1 to repetitive sequences.
PcG proteins also recognize modifications that neither PRC complex deposits. For
instance, the tudor domains of the substoichiometric PRC2 subunits PCL1, PCL2, and
PCL3 recognize and bind H3K36me3. In addition to histone methylation, enrichment of
CpG islands at regions of PcG occupancy suggests DNA methylation may recruit PcGs
as well (Entrevan et al., 2016). This presents another means by which pRB-E2Fs may
alter facultative heterochromatinization at repeats. Multiple E2Fs along with DP1 and
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pRB have been discovered in certain PRC1 complexes within human polycomb
interactome datasets (Hauri et al., 2016). If the GC-rich sequences at PcG-occupied CpG
islands are recognized as E2F ‘core’ sequences, then disruption of the CDK-resistant
pRB-E2F1 interaction may disrupt PRC1 recruitment in addition to PRC2 recruitment.
PcG recruitment dynamics may explain pRB-E2F1 recruitment to repetitive
sequences, but exclusion of pRB-Condensin II from the L1 5'UTR and IAP LTR suggest
that differential recruitment mechanisms act on different pRB-E2F1 complexes.
Comparison of genome wide occupancy patterns for PcG and Condensin components
will reveal the extent of this apparent mutually exclusive occupancy. If PcG components
direct E2F1-pRB-EZH2 recruitment, Condensin subunits may direct E2F1-pRBCondensin II recruitment. ESC ChIP-seq profiles for non-SMC subunits of Condensin II
suggest that Condensin II localizes to promoters and enhancers in addition to pericentric
repeats (Dowen et al., 2013). Analysis of occupancy profiles has yet to yield a cisregulatory motif that predicts Condensin association. Thus, in vivo recruitment of E2F1pRB-Condensin localization is likely mediated through additional mechanisms beyond
sequence recognition.

5.5
pRB-E2F1 functions may underlie phenotypes
associated with both regulated and unregulated
repetitive element reactivation
Repetitive elements are repressed through mechanisms that function cooperatively
to maintain silencing throughout fluctuations in developmental or cell cycle stage.
However, host genomes alleviate these mechanisms to permit repetitive element
activation under certain conditions. For example, under conditions of environmental
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stress, bursts of transposon activity serve as a means to increase genetic diversity within a
gene pool of individuals with low genetic diversity (Rowe and Trono, 2011). The means
by which stress signals propagate to epigenetic effectors that silence repeats remains
unknown. In this regard, effectors of the stress response should be surveyed as possible
candidates to dissociate the CDK-resistant pRB-E2F1 scaffold. Residues within the
minimal interaction C-terminal interaction domain on pRB or the marked-box domain of
E2F1 should be investigated for potential modifications imposed by stress response
effectors. The identified dissociation mechanism should then be investigated as a means
of pRB misregulation and repetitive element activation in human cancers.
Identification of how pRB-E2F1 recognizes repetitive sequences may also reveal
whether pRB functions may underlie chromosome segregation defects that recur
regardless of how repeat silencing is perturbed. Currently, the mechanisms that underlie
these errors remain unknown. However, if DNA or histone modifications mediate pRBCondensin II recruitment to pericentric heterochromatin, then cells with defective
constitutive heterochromatinization of repeats may exhibit reduced pRB-Condensin II
recruitment. Thus, pRB-Condensin II recruitment and mitotic regulation should be
investigated in cells that lack mutations in RB1 or Condensin subunits, but exhibit
repetitive element mis-expression along with mitotic defects.

5.6
Exploitation of pRB functions at repetitive
elements
Beyond epigenetic repression, the innate immune system serves as a form of
‘responsive’ repeat silencing (Vabret et al., 2016). This response is predominantly
characterized within the context of ectopic viral infection, in which nucleic acids of
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foreign origin are detected by endosomal toll-like receptors (TLRs) and cytosolic RIG-Ilike receptors that initiate an interferon (IFN) response (Shen et al., 2015; Young et al.,
2012; Yu et al., 2012).
Amongst endosomal pattern recognition receptors, TLR3, TLR7, TLR8, TLR9,
and TLR13 sense different nucleic acids that have been endocytosed or phagocytosed
(Vabret et al., 2016). TLR3 recognizes dsRNA, TLR7 and TLR8 generally recognize
ssRNA, while TLR9 recognizes bacterial and viral ssDNA with unmethylated CpG
regions(Jiménez-Dalmaroni et al., 2016). Specific endosomal receptors mediate the
endogenous retrovirus (ERV)-specific response. TLR7 ensures production of ERVspecific antibodies, while TLR3 and TLR9 modulate ERV antibody response to
propagate a type I IFN response. Mice deficient for TLR3, TLR7, and TLR9 succumb to
T-cell acute lymphoblastic leukemias (T-ALL) that bear novel ERV re-integrations (Yu
et al., 2012). Stimulation of these TLRs activates a type I IFN response that may result in
immunogenic cell death.
The cytosolic RIG-I-like receptors (RLRs) RIG-I, MDA5, and LGP2 also contribute
to nucleic acid sensory pathways that activate the innate immune response (Schlee and
Hartmann, 2016). Upon detection of dsRNA, these pattern recognition receptors activate
mitochondrial antiviral-signalling protein (MAVS) that induces nuclear localization of
IFN regulatory factor 7 (IRF7) to initiate a type III IFN response. This response acts upon
both ectopic and endogenous retroviruses. Following alleviation of DNA methylation at
repetitive elements, transcripts from de-repressed endogenous retroviruses stimulate RIGI and MDA5 that then signal through MAVS and IRF7 to a type III IFN response.
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Analogous to TLR-induced IFN responses, RLR-induced IFN responses may cause
immunogenic cell death (Roers et al., 2016).
The ability to induce immunogenic cell death upon activation of endogenous
retroviruses presents an emerging strategy that uses epigenetic modulation as an immune
enhancing therapy (Minn, 2015). This strategy, coined as ‘viral mimicry’, has been most
extensively characterized within the context of DNMT inhibition. In human and murine
cells, the FDA-approved DNMT inhibitor 5-aza-cytidine suffices to de-repress repetitive
elements which are detected by cytosolic RIG-I-like receptors that induce an interferon
response (Leonova et al., 2013). This response has been observed in human cells derived
from colorectal cancers, ovarian cancers, promyelocytic leukemia, hepatocellular
carcinomas, breast cancer, and in human intestinal tumor organoid models (Chiappinelli
et al., 2015; Desai et al., 2017; Liu et al., 2016; Roulois et al., 2015; Saito et al., 2016).
Characterization of viral mimicry has revealed that induction of the IFN response is
sensitive to a threshold of repetitive element misregulation. Cells that exhibit some
degree of repetitive element expression succumb to immunogenic cell death with
relatively lower doses of 5-aza-cytidine compared to cells with proper repression of
repetitive sequences. For example, p53-deficient cells and cancers exhibit increased
expression of repetitive elements, and increased sensitivity to lower doses of 5-azacytidine relative to p53-positive cells (Desai et al., 2017; Leonova et al., 2013). This is of
particular clinical significance upon consideration of emerging mechanisms of tumorsuppressor based silencing of repetitive elements that include ATRX-mediated H3.3
deposition in addition to p53-mediated H3K9me3 deposition (Sadic et al., 2015; Wylie et
al., 2015).
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Identification of pRB-EZH2-dependent facultative heterochromatinization suggests
that EZH2 inhibitors may be a yet-unidentified means of inducing viral mimicry. Indeed,
my work in chapter 4 demonstrates that EZH2 inhibition through GSK343 treatment
suffices to deregulate repetitive elements in wild-type MEFs and splenocytes. The next
steps may be to characterize whether an IFN response is induced, and if so, whether
induction is more efficient in cells with perturbed silencing of repetitive elements as a
result of combinatorial treatments with chemotherapy, radiation therapy, or DNMT
inhibitors. The observations from this work will determine whether tumor suppressor
status may predict efficacy of viral mimicry induced from epigenetic modulators.
Specifically, RB1-positive cancers may serve as ideal candidates for EZH2 inhibition.
In contrast to viral mimicry induced upon acute ablation of silencing, sustained
deregulation of repetitive elements promotes genome instability and proves advantageous
towards tumorigenesis. Independent of the mutagenic effects of endogenous
retrotransposition, constitutive IFN activation gradually becomes immunosuppressive,
and is associated with cancer cell resistance to chemotherapy and radiation therapy
(Kassiotis and Stoye, 2016). If tumor suppressor inactivation misregulates repetitive
elements, then the potentially mutagenic and immunosuppressive consequences may be
underappreciated drivers of clonal evolution and overall disease outcomes. To assess
whether this was the effect, Rb1S mice were crossed into a Trp53-/- background.
Decreased tumor latency and a modest increase in tumor spectrum in Rb1S/S;Trp53-/relative to Rb1+/+;Trp53-/- mice merit further investigation into whether a net increase in
repetitive element misregulation underlies potentially increased genome instability in
relevant cell-of-origin populations. The results of this work may suggest further
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investigations into whether transcriptional signatures of active repetitive elements and the
associated IFN response are a general property of all pRB-deficient human cancers.

5.7
Summary of pRB-E2F1 functions at repetitive
elements
In summary, the work presented in this thesis represents a significant contribution
towards the elucidation of pRB functions at repetitive regions of the genome. My
characterization of altered pRB-E2F1 recognition dynamics at major satellites presented
in appendix C initiated investigation into whether this altered recognition conferred
recruitment of the CDK-resistant pRB-E2F1 complex to other repetitive elements. This
investigation revealed that the pRB-E2F1 scaffold mediates recruitment of multiple
chromatin regulatory proteins to repetitive sequences throughout the genome. pRB
recruits EZH2 to deposit H3K27me3 to silence repetitive elements genome wide. In
addition to EZH2, pRB recruits Condensin II to major satellites to facilitate proper
replication and mitotic progression. Loss of the CDK-resistant pRB-E2F1 scaffold
precedes the onset of genome instability and lymphomagenesis.
This work also reveals new questions stated throughout this discussion that concern
distinguishing the biochemical properties of multiple complexes that utilize the CDKresistant pRB-E2F1 scaffold, and the recognition mechanism that underlies recruitment to
repetitive sequences. In addition to these questions, future work should continue from the
initial investigations presented in Chapter 4 that explore how loss of this regulatory
paradigm affects tumor outcomes in a Trp53-/- background, and whether the functions of
pRB at repetitive elements prove relevant towards predicting efficacy of EZH2 inhibition
in human cancers.
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Appendix D: List of primers used
Primer

Maj_F1
Maj_R1
IAP LTR_F
IAP LTR_R
L1 5' UTR_F
L1 5' UTR_R
L1 ORF1_F
L1 ORF1_R
L1 ORF2_F
L1 ORF2_R

Primer Sequence (5'-3')

Primer Use

Source

GACGACTTGAAAAATGACG
AAATC

qRT-PCR,
qPCR

(Martens et al.,
2005)

CATATTCCAGGTCCTTCAGT
GTGC

qRT-PCR,
qPCR

(Martens et al.,
2005)

TTGATAGTTGTGTTTTAAGT
GGTAAATAAA

qRT-PCR,
qPCR

(Martens et al.,
2005)

AAAACACCACAAACCAAAA
TCTTCTAC

qRT-PCR,
qPCR

(Martens et al.,
2005)

qRT-PCR,
CTGCCTTGCAAGAAGAGAGC qPCR

(Montoya-Durango
et al., 2009)

AGTGCTGCGTTCTGATGATG

qRT-PCR,
qPCR

(Montoya-Durango
et al., 2009)

AGATCTGGAACCATAGATG

qRT-PCR

(De Cecco et al.,
2013)

TTCTCATTGTGTCCTGGATT

qRT-PCR

(De Cecco et al.,
2013)

ACTTCCCAAATCTTAAA

qRT-PCR

(Puszyk et al.,
2013)

qRT-PCR

(Puszyk et al.,
2013)

AAAAGTCTGGTGTAATT

qRT-PCR

(Schneider et al.,
2008)

qRT-PCR

IFNα_R

TTCCTGGGTCAGAGGAGGTT
C

(Schneider et al.,
2008)

CTGGAGCAGCTGAATGGAA
AG

qRT-PCR

IFN-β1_F

(Schneider et al.,
2008)

qRT-PCR

IFN-β1_R

CTCCGTCATCTCCATAGGGA
TCT

(Schneider et al.,
2008)

β-act_9F

CTGGCTCCTAGCACCATGAA
GATC

IFNα_F

TGCAATGACCTCCATCAGCA

qRT-PCR

(Matsui et al.,
2010)
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β-act_5R

Ccne1_F1
Ccne1_R1
Ccna2_F1
Ccna2_R1
Rbl1_F
Rbl1_R
Cdt1_F1
Cdt1_R1
Mcm6_F1
Mcm6_R1
Mcm3_TSS_F
Mcm3_TSS_R
Mcm3_-2kb_F
Mcm3_-2kb_R

TGCTGATCCACATCTGCTGG

qRT-PCR

(Matsui et al.,
2010)

AGCGAGGATAGCAGTCAGC
C

qRT-PCR

(Pandit et al.,
2012)

GGTGGTCTGATTTTCCGAGG

qRT-PCR

(Pandit et al.,
2012)

CTTCTTCCTTTTCCCTTGGC

qRT-PCR

(Pandit et al.,
2012)

TTTCAGAGTCCCAGTGACCC

qRT-PCR

(Pandit et al.,
2012)

TTCCTGTGAAGAAGTTATAT
TCCCT

qRT-PCR

(Pandit et al.,
2012)

qRT-PCR

(Pandit et al.,
2012)

ACAGCCGGGCAAGATCCCCT qRT-PCR

(Pandit et al.,
2012)

GGCTCCCAACTTCCGTGCCC

qRT-PCR

(Pandit et al.,
2012)

CCTGTGAATAGGTTCAACGG
C

qRT-PCR

(Pandit et al.,
2012)

CATTTTCCTGAGGTGGAGCA
C

qRT-PCR

(Pandit et al.,
2012)

CTGTAGCGCTCATGGACAGA

ATCCAGGAAGTCCAAGTAGT
CTCTC
qPCR

(Cecchini et al.,
2014)

TTGAAGTGGTTAGCCAATCA
TAACG

qPCR

(Cecchini et al.,
2014)

GCCAAGGCAAAACAACAAT
TTCTAC

qPCR

(Cecchini et al.,
2014)

CTATCTCTTTGATTTTGGGTG qPCR
GCTG

(Cecchini et al.,
2014)

qPCR

(Cecchini et al.,
2014)

qPCR

(Cecchini et al.,

Gapdh_F

GAGCCAGGGACTCTCCTTTT

Gapdh_R

CTGCACCTGCTACAGTGCTC
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2014)

H19_ICR_d_F

CTGCAAACAATTCTGAAACT
GC

qPCR

(Kernohan et al.,
2010)

qPCR

(Kernohan et al.,
2010)

TCTGCTTTTAACAAGGCTCT
CC
TTGATAGTTGTGTTTTAAGT
GGTAAATAAA

Bisulfite

AAAACACCACAAACCAAAA
TCTTCTAC

Bisulfite

TTGTGTTTTAAGTGGTAAAT
AAATAATTTG

Bisulfite

IAP_R2

CAAAAAAAACACACAAACC
AAAAT

Bisulfite

L1_F1

AGAAGAGAGTTTGTTTGTAG
AGA

Bisulfite

L1_R1

ACACCTAAAATTCTCTCTTC
CA

Bisulfite

L1_F2

AGAAGAGAGTTTGTTTGTAG
AGA

Bisulfite

L1_R2

TCATTTCCATCACCTATTTAA
CT
Bisulfite

PCNA_E2F_F

CAGAGTAAGCTGTACCAAG
GAGAC

qRT-PCR

(Cecchini et al.,
2014)

PCNA_E2F_R

CGTTCCTCTTAGAGTAGCTC
TCATC

qRT-PCR

(Cecchini et al.,
2014)

PCNA_-2kb_F

CATCAGTGAATACGTCTCTG
TTCCA

qRT-PCR

(Cecchini et al.,
2014)

PCNA_-2kb_R

CTGCTTCTCAGTTGTTTTAGG
AAGG
qRT-PCR

H19_ICR_d_R
IAP_F1
IAP_R1
IAP_F2

(Lane et al., 2003)
(Lane et al., 2003)
(Lane et al., 2003)
(Lane et al., 2003)

this study
this study
this study
this study

(Cecchini et al.,
2014)
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Appendix E: List of plasmids used
Plasmid Name
cep99-gfp-L1SM
cep99-gfp-TGF21
pEF.myc.ER-E2Crimson
pBABE-H2B-GFP

Source
Jef Boeke
John Moran
Addgene

Description
full-length synthetic mouse LINE element (SM L1)
full-length endogenous L1
Crimson reporter

Fred Dick

pBSK-Rb25

Fred Dick

H2B-GFP Mammalian Expression vector,
Retroviral
Rb1S targeting vector encoding an F832A
substitution in Rb1 exon 24, and a floxed PGKneomycin cassette.

Appendix F: List of antibodies used
Antibody Target

Source

ChIP
(Ab:Chr)

C-15

pRb

Santa Cruz

5 μg : 80 μg

M-153

pRb

Santa Cruz

5 μg : 80 μg

M-136

pRb

S855

pRb

Hyb4.1

pRb

D2C9

Ezh2

Cell Signaling

D39F6

Suz12

Cell Signaling

1:1000

C-19

Hdac1

Santa Cruz

1:1000

06-942

H3K9Ac

Millipore

4 μg : 30 μg

07-449

H3K27me3 Millipore

4 μg : 30 μg

07-442

H3K9me3

4 μg : 30 μg

(Cecchini et al.,
2014)
(Cecchini et al.,
2014)(Cecchini et
al., 2014)
Developmental
Studies Hybridoma
Bank

Millipore

WB

1:1000

5 μg : 80 μg
5 μg : 80 μg

IP
(Ab:extract)

5 μg : 1 mg

1:1000

500 μl : 80
μg
5 μg : 80 μg

1:1000

1:1000

4 μg : 1.5 mg
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4 μg : 30 μg

07-463

H4K20me3 Millipore

ab1791

H3

abcam

1:2000

M-300

L1_ORF2p

Santa Cruz

1:1000

C-20

p130

Santa Cruz

1:1000

C-18

p107

Santa Cruz

1:1000

4012S

Mcm3

Cell Signaling

1:1000

H432

Cyclin A

Santa Cruz

1:1000

A2066

Actin

SIGMA

1:3000

11H10

Tubulin

Cell Signaling

1:2000

05-636

H2A.X
pSer139

Millipore

A300244A
A300246A

RPA32

Bethyl labs

1:1000

RPA32
pSer33

Bethyl labs

1:1000

F-2

PCNA

Santa Cruz

1:1000

C-20

BubR1

Santa Cruz

1:1000

ab7953

Cdk1

abcam

1:1000

C-19

Mad2

Santa Cruz

1:1000

CAP-D3

Dick lab

SMC2

Dick lab

5 μg : 80 μg

1:1000
1:1000
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Appendix G: PCR Conditions
PCR Conditions p53

PCR Conditions Rb1S

Master Mix per reaction
- 1 L MgCl2 (50mM)
- 2.5 L dNTPs (2mM)
- 2.5 L 10X PCR Buffer (200mM Tris
pH8, 500mM KCl)
- 0.62L 20M AM3 primer
- 0.62L 20M AM4 primer
- 0.27L 20M neo-sense primer
- 0.27L 20M neo-antisense primer
- 11 L Water
- 0.5L Taq (5units/µL)
Total 18L
+ 2L DNA sample

Master Mix per reaction
- 0.5 L MgCl2 (50mM)
- 2 L dNTPs (2mM)
- 2 L 10X PCR Buffer (200mM Tris
pH8, 500mM KCl)
- 1L 20M Rb1S_F
- 1L 20M Rb1S_R
- 11 L Water
- 0.5L Taq (5units/µL)
Total 18L
+ 2L DNA sample

Reaction Conditions
Program – P53 New
1. 94C
2:30
2. 94C
0:30
3. 58C
0:30
4. 72C
1:10
5. Go to Step #2, 29 times
6. 72C
10:00
7. 12C
hold

Reaction Conditions
Program – Rb1S_GENO
1. 94C
2:00
2. 94C
0:45
3. 57C
0:45
4. 72C
0:45
5. Go to Step #2, 39 times
6. 72C
5:00
7. 12C
hold

Expected Results:

Expected Results:

Mutant (Null) = 424 bp
Wild type = 548 bp

Mutant = 254 bp
Wild type = 153 bp

Primers
AM3: ATAGGTCGGCGGTTCAT
AM4: CCCGAGTATCTGGAAGACAG
Neo-sense:
GGAAGGGACTGGCTGCTATTG
Neo-antisense:
CAATATCACGGGTAGCCAACG

Primers
Rb1S_F:
ATGCATAGCTGCTGTCATCC
Rb1S_R:
GACTGTTGGCCAGTTTGGTT
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